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Abstract: TCDD is a reproductive toxicant and endocrine disruptor, yet the
mechanisms by which it causes these reproductive alterations are not fully
understood. In order to provide additional insight into the molecular
mechanisms that underlie TCDD’s reproductive toxicity, we assessed TCDDinduced transcriptional changes in the ovary as they relate to previously
described impacts on serum estradiol concentrations and altered follicular
development in zebrafish. In-silico computational approaches were used to
correlate candidate regulatory motifs with observed changes in gene
expression. Our data suggest that TCDD inhibits follicle maturation via
attenuated gonadotropin responsiveness and/or depressed estradiol
biosynthesis, and that interference of estrogen-regulated signal transduction
may also contribute to TCDD’s impacts on follicular development. TCDD may
also alter ovarian function by disrupting various signaling pathways such as
glucose and lipid metabolism, and regulation of transcription. Furthermore,
events downstream from initial TCDD molecular-targets likely contribute to
ovarian toxicity following chronic exposure to TCDD. Data presented here
provide further insight into the mechanisms by which TCDD disrupts follicular
development and reproduction in fish, and can be used to formulate new
hypotheses regarding previously documented ovarian toxicity.
Keywords: TCDD, ovary, zebrafish, follicular development, microarray,
endocrine disruptors

Introduction
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is a persistent
environmental contaminant that is a known reproductive toxicant and
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endocrine disruptor in nearly all vertebrates. The effects of TCDD on
reproduction and fertility have been studied extensively [1–3], and
evidence suggests that TCDD compromises both ovarian function and
follicular development. Female reproductive development is highly
complex, and is synchronized by intricate and highly regulated signal
transduction pathways that are integrated with the endocrine system.
This complexity has made it particularly difficult to identify the
molecular action of TCDD-induced ovarian toxicity. Although it is clear
that TCDD impacts maturation and ovulation of ovarian follicles, as
well as estradiol secretion [4–7], the mechanisms that underlie these
reproductive toxicities are complicated and poorly understood.
It is generally accepted that TCDD toxicity is mediated by the
aryl hydrocarbon receptor (AHR)-signaling cascade [8]. The ligandbound AHR complex is translocated to the nucleus where it dimerizes
with the aromatic hydrocarbon receptor nuclear translocator (ARNT)
protein. This heteromeric complex binds to the aryl hydrocarbonresponse element (AHRE) (TnGCGTG DNA motifs) located in the
regulatory regions of several genes (e.g., , cyp1a1) and can initiate or
suppress gene transcription [9–11]. While it is thought that such
transcriptional regulation mediates the toxicity of TCDD, specific roles
of these gene changes in dioxin-induced toxicity are not understood.
Additionally, some actions of TCDD may be AHR-independent and/or
result from downstream transcriptional changes.
Evidence suggests that disruptions in female reproduction by
TCDD are likely the result of a direct effect at the ovary [12–17]. Since
the AHR is expressed in the ovary, TCDD could disrupt critical cellular
signals that regulate follicular development and/or estradiol
biosynthesis via AHR-mediated alterations in gene transcription,
thereby contributing to the observed decrease in ovarian development
and reduced reproductive capacity. Alternatively, TCDD could interfere
with the hypothalamic-pituitary-gonadal (HPG) axis or estradiol
metabolism. For example, TCDD could negatively regulate estrogen
signaling by inducing oxidative metabolism of estrogens via the AHRpathway, by suppressing the expression and/or efficacy of the
estrogen receptors, or by inhibiting estradiol-regulated gene
expression [18–21].

Reproductive Toxicology, Vol. 25, No. 1 (January 2008): pg. 47-57. DOI. This article is © Elsevier and permission has been
granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be
further copied/distributed or hosted elsewhere without the express permission from Elsevier.

3

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Since the basic features of the HPG axis and AHR-signaling
pathways in fish are fundamentally similar to other vertebrates [22–
24], fish are excellent model systems with which to investigate the
effects of endocrine-disrupting chemicals on vertebrate reproductive
function. The zebrafish has proven to be an effective system for
investigation into the teratogenic effects of TCDD [25–27]. Zebrafish
are highly prolific with rapid follicular development, and many of the
receptors, enzymes, and peptide growth factors involved in follicular
development have been characterized (see Ge 2005 for review);
therefore, it is particularly suited for investigating TCDD’s effects on
the regulation of follicular development.
We have previously demonstrated that sublethal dietary
exposure to TCDD alters follicular development, egg production, and
serum 17β estradiol concentrations in zebrafish [4]. Here we
investigate the transcriptional events in the ovary that precede these
previously described histomorphologic and physiologic alterations. We
used quantitative RT-PCR to assess the effects on the expression of
several candidate genes important in the regulation of follicle
development, oocyte maturation, and vitellogenesis, and used cDNA
microarray technology to evaluate altered gene expression profiles to
identify other cellular pathways potentially impacted by TCDDexposure. Additionally, we used a functional genomics approach to
examine candidate regulatory motifs in relation to different expression
profiles in an effort to better clarify potential mechanisms of toxicity
following chronic exposure to TCDD.

Materials and Methods
Experimental animals
Adult female (AB strain, Zebrafish International Resource
Center) and male zebrafish (golden longfin, Ekwill Farms) were housed
separately and acclimated for several weeks prior to the initiation of
experiments. Fish were maintained at 26–28°C on a 14-hour light and
10-hour dark cycle in a flow-through buffered, de-chlorinated water
system and were spawned once weekly during the experiment.
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TCDD exposure and RNA extraction
Trout chow yielding a final concentration of approximately 0, 10,
40, or 100 ng TCDD/g food (ppb) was prepared as previously
described [28]. Females were fed brine shrimp nauplii daily, and
contaminated trout chow diet 5 of 7 days per week. Fish were fed en
masse to satiation, and based upon the average food consumed per
fish, received an estimated dose of 0, 0.08, 0.32, or 0.80 ng
TCDD/female/day. Based upon our previous work, fish accumulated
approximately 0, 0.6, 3, and 14 ng TCDD/g fish after 15 days, and
ovaries accumulated approximately 0.4, 2, and 5 ng TCDD/g ovary
(body burdens were not measured in this study). Following dietary
exposure, five females from each treatment group were euthanized
and ovaries were extracted and frozen in liquid nitrogen. Total RNA
was isolated from individual ovaries using Trizol reagent (Invitrogen)
and purified using an RNeasy MinElute cleanup kit (Qiagen) according
to manufacturer’s instructions. Individual samples were analyzed by
agarose gel electrophoresis to confirm the integrity of the 18S and 28S
ribosomal RNAs, and quantified by UV spectrophotometry at 260 nm
using a Nanodrop ND-1000 Spectrophotometer (Nanodrop
Technologies).

Quantitative RT-PCR (QPCR)
QPCR was used to quantify selected gene transcripts important
in both receptor- and non-receptor-mediated regulation of follicular
development, as well as estradiol biosynthesis, included: luteinizing
hormone receptor (lhr), follicle-stimulating hormone receptor (fshr),
estrogen receptors (esr1, esr2a, esr2b), epidermal growth factor (egf),
egf receptor (egfr), inhibins (inhbba, inhbb), steroidogenic acute
regulatory protein (star), side chain cleavage enzyme (cyp11a1), and
aromatase (cyp19a1a). cDNA was synthesized from 5 μg of total RNA
from individual samples (n = 3 from each treatment group) using
SuperscriptII reverse transcriptase (Invitrogen) and random hexamer
primers following manufacturer’s instructions. QPCR was performed
using the Stratagene Mx3000 system and the Full Velocity SYBR Green
QPCR Master Mix with the manufacturer’s instructions (Stratagene)
using gene-specific primers listed in Table 1. Agarose gel
electrophoresis and melting curve analysis confirmed that specific

Reproductive Toxicology, Vol. 25, No. 1 (January 2008): pg. 47-57. DOI. This article is © Elsevier and permission has been
granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be
further copied/distributed or hosted elsewhere without the express permission from Elsevier.

5

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

products of expected size were amplified. All QPCR reactions were run
in triplicate with negative (no template) controls. Relative gene
expression data (fold-change) was calculated using the comparative
quantification model [29] assuming 100% efficiency, using small
nuclear ribonuclear protein D1 polypeptide (snrpd1) as the reference
gene; snrpd1 is important for mRNA processing, and expression was
unaltered by TCDD exposure. QPCR on individual samples (n = 3 from
each treatment group) was also used to verify microarray expression
profiles. The gene-specific primers for these transcripts (cluster 4:
cyp1a1; cluster 2: sepp1a, lgals3l, and krt4; cluster 1: krml and vtg1;
cluster 3: tfa) are also listed also in Table 1. The seven transcripts
showed altered expression by at least 2-fold following exposure to at
least one dose of TCDD, and were selected for microarray verification
based upon their functional characterization, presence of candidate
regulatory motifs, and to represent each of the clusters in gene
expression (see details below and in Table 2).
Table 1. Primer sequences used for QPCR. Gene names are listed in the text
and Supplementary Tables.

Gene symbol Sense Primer

Antisense Primer

cyp1a1

ACTGGTGCGACTGGTTAATATGAG

GTCTTCGCATGTGTTGATAAGAG

cyp11a1

CAGGTTTTCACTGGAATCGG

CTGGTTAAAGATGCCATCCC

cyp19a1a

ACTTCCAGAAAAATGTTCCGAGTC

TCTGAGGATAAGCTGCACGC

egf

GCATCCAGAGAATGAACCTCGACGG TGATTTGTCCTGTTTGTGTGTCCGC

egfr

CTTACAAAGCCTGGAACGAAGAGCC CCTGACACACTTTCTTTTCCGGCG

esr1

TCCACATCCACACAGTAGGC

esr2a

AAGCTGCTGTGTCTGCTGGACTCGG TCATGCAGTGCAGGTGGTCCATGCC

esr2b

GGTGAAGTGTGTCATTTCTGTGCCG GTGTGATTTTTGGGGCTGGGC

fshr

AGCCGATTTGGATGCTTTAAAAGGC TCAGACAGATGTCAGTGCACTTGGG

inhbaa

GCACATTCAGAAGCCGACTGCC

TAAAGTCCGTCTGCCTGTGCGC

inhbb

CGAATTCGGTGGACAGACAAACGG

TCCGTTCATTATTAGGCTCGCGG

krml2.2

TATAAACTCAAGTGCGAAAGGC

ACCAGCAAACAATCTTATGC

krt4

CAAAACCAGTGTCACCACCG

CATCTCCTCATTAACAGGGG

lgals3l

GCTGTACAAGTGCATGTAAAGGG

CGTCTTTTATGCATGAAGCG

lhr

CAAAAAGGACGAGTCGCTGAAACGC GCAGAAGAAAAACAAGAAGCAGGGC

seppa1

AAATCTGACTTTAACTGGTCCAGTG ATGTTACATGACCTTTGCCC

snrpd1

CGTCACGATTGAGTGAAGAATGGC

TGAGATCTTCATCTCCTCGGCCC

star

ACCCACCTGTATTGTCATGCG

AATGGCTGCGTCTATACCCC

tfa

ATTAAGCACACTGTGGTCGG

AGCATGAACTGGCACTTGGG

vtg1

GAGATTGAACTGACTGCAGCC

ATTCCACATGAACATAGGCC

CTTTCTTGATCAGGGTGGGG
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Table 2. List of representative transcriptsa identified by microarray to be
dysregulated greater than 2-fold in one or more treatment group. Presence of
putative AHRE or ERE is noted. See Supplementary Tables 1–3 for complete
gene list plus location of putative response elements.

Gene symbol 10 ppb 40 ppb 100 ppb AHRE ERE
Ovarian development
fabp3

−2.92

−2.68

−4.14

tpte

−1.91

−1.45

−2.60

*

tph1l

−2.64

−1.53

1.19

*

vtg1

−7.38

−1.62

−1.83

*

*

*

*
*

Detoxification/oxidative stress
cyp1a

6.93

14.87

24.68

sepp1a

−1.71

−1.21

−2.48

serpina1

29.44

1.51

3.07

*

apoeb

−1.83

−1.09

−4.12

*

apom

6.16

1.04

1.32

−2.06

−1.85

−2.30

*

*

*

*

*

Lipid metabolism

lipf

Carbohydrate metabolism
ldha

−1.78

−1.45

−2.59

slc3a2

−2.35

−1.68

−3.05

Immune response/cellular repair
anxa1a

−2.20

−3.36

−7.06

*

cp

24.49

1.06

2.16

*

fgb

12.80

−1.82

−1.35

*
*

fgb

5.66

1.43

1.61

tfpib

−1.54

−1.95

−5.66

timeless

−2.92

1.88

1.07

*

krt4

−1.96

−2.93

−5.65

*

lgals3l

−1.89

−2.68

−2.56

*

*

Structure
*

Signal transduction/transcription/regulation of cell cycle
rab5b

2.45

1.34

2.13

*

*
*

rad1

−1.10

1.13

−2.16

rbp2a

−2.98

−2.39

−4.54

*

Igfbp1

5.58

−1.38

−1.47

*

Junb

−2.21

−1.88

−4.39

*

*

krml2.2

−2.59

−1.19

−2.41

*

*

lztfl1

−1.12

−1.12

−2.33

*

sp4

1.51

2.32

1.96

*

ing3

−2.29

1.17

−1.32

igfbp1
tfa

5.58

−1.38

−1.47

*

11.64

−2.09

−1.32

*
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Gene symbol 10 ppb 40 ppb 100 ppb AHRE ERE
ptena

−2.32

1.51

1.38

*

aGene

symbols are from Affymetrix probe identifiers and are organized into general functional groups.
Transcripts in bold were verified by QPCR.

Microarray hybridization and analysis
Differential ovarian gene expression was determined using the
Affymetrix Zebrafish Genome Array, which represents approximately
14,900 transcripts. Experiments were designed to comply with MIAME
guidelines [30]. In an effort to reduce variability, target synthesis
using pooled RNA (of equal quantity and comparable quality from 5
females per treatment group) [31–33], biotin-labeling, hybridizations,
and staining were performed using standard Affymetrix reagents and
methods (http://www.affymetrix.com/index.affx). Pooled samples
were run in duplicate such that a total of eight arrays were used.
Images were extracted from TIFF files using Microarray Suite
Version 5.0 (Affymetrix). Raw data can be viewed at the National
Center for Biotechnology Information Gene Expression Omnibus
website (http://www.ncbi.nlm.nih.gov/projects/geo/); series record
GSE4859. Data were transformed and normalized using GeneSpring
software (Agilent Technologies) and further analyzed using
Bioconductor 1.6 [34]. Expressed data were obtained by selecting
8732 probes present in all eight chips. Differentially expressed probes
were identified as those showing at least a 2-fold change in expression
in both replicates of one or more of the treatment groups compared
with control. The dysregulated transcripts were assigned to general
functional groups based upon their Gene Ontology terms, or an
annotated putative H. sapiens or M. musculus ortholog from SwissProt (http://us.expasy.org/sprot/). The dysregulated transcripts were
clustered using agglomerative hierarchical clustering [35] without
performing mean centering of expression values, and using Ward’s
method for merging clusters.

In-silico Transcription Factor Analysis
Possible cis-acting AHRE (GCGTG) and ERE
(AGGTCAnnnTGACCT) sequences were identified within the regulatory
region of differentially expressed genes as well as candidate genes
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determined by QPCR. The reference genes were 22877 RefSeq genes
and Ensemble predictions mapped to the draft zebrafish genome, and
the test sequences were RefSeqs overlapping with consensus
sequences of differentially expressed Affymetrix probes. Of the
dysregulated transcripts, 140 could be mapped to Ensemble genes and
were used for subsequent analyses. The 5′ regulatory sequences of
the reference and dysregulated genes were modeled by the 5′-UTR of
each RefSeq (5000 bp upstream sequences from the transcriptional
start site). Regulatory sequences were acquired from the June 2004
draft assembly of the zebrafish genome using the University of
California – Santa Cruz table browser [36] and were scanned for
possible transcription factor binding sites using TFBS [37], JASPAR
[38] for AHRE sequences at a 100% scoring threshold, and TRANSFAC
Public 7.0 [39] for ERE sequences at an 80% scoring threshold. To
compare control and differentially expressed sequences, the
hypergeometric distribution in R 2.1.0 was used to describe the
probability of drawing a sample the same size as the differentially
expressed sequences from the control sample with the same or fewer
transcription factor binding sites identified. A chi-squared test was
used to determine if there was a location bias of transcription factor
binding sites with respect to identified clusters. The starting position
distributions of AHREs and EREs within a cluster were compared with
the corresponding distributions in the entire Ensemble known gene
collection. Distributions for a cluster significantly different (p < 0.05)
from control suggested putative regulatory patterns.

Data analysis
Statistical analysis of QPCR data was performed using SigmaStat 2.0 (SPSS, Inc) and presented as means ± standard error of the
mean (SEM). Data were evaluated for homoscedasticity (Levene
Median test) and one-way analysis of variance (ANOVA) was used to
detect treatment-related effects on the expression of each candidate
transcript. Where significant differences were indicated between
treatment groups, and the data were homogeneous, pair-wise multiple
comparisons were conducted using the Tukey test. When tests for
homogeneous variance failed, the Kruskal-Wallis one way ANOVA on
ranks was used, and significant differences were evaluated using the
Dunn’s test. Pearson’s correlation was used to determine whether
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changes in gene expression identified by microarray were correlated
with changes in expression of the seven transcripts determined by
QPCR. For all analyses, significant differences were identified at p <
0.05.

Results
Effects on the regulation of follicular development and
estradiol biosynthesis
Dietary TCDD exposure suppressed the expression of all
examined candidate transcripts that are important in both receptorand non-receptor-mediated regulation of follicular development, as
well as estradiol biosynthesis (Figure 1A). The candidate genes were
down-regulated by at least 2-fold; overall changes in expression were
not dose-dependent. Locations of putative AHREs and EREs within the
regulatory region of the transcripts are illustrated in Figure 1B.

Figure 1. A. Fold changes in expression of several genes important for follicular
development determined by QPCR; normalized to snrpd1. *Denotes significant
changes in expression compared with control (p < 0.05); dose-dependent changes
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were not observed. B. Location of putative AHREs (filled ovals, this study; lined ovals
[86]; putative EREs (empty rectangles), and putative ½-EREs (lined rectangles [86]
within upstream regulatory regions. Arrow represents the transcriptional start site.

Effects of TCDD on Global Ovarian Gene Expression
Two hundred thirty-five probe sets (representing 229 unique
transcripts) were identified as being either induced or suppressed
greater than 2-fold following exposure to one or more TCDD
concentration. Overall, more transcripts were suppressed than were
induced with 37% (85/229), 7% (16/229), and 40% (92/229)of the
transcripts down-regulated and 11% (25/229), 4% (9/229), and 11%
(25/229) of the transcripts up-regulated in the 10, 40, and 100 ppb
treatment groups, respectively. QPCR using individual samples verified
microarray results for seven transcripts (Figure 2). The direction and
fold-change values for samples from individual animals were correlated
with changes in expression determined by microarray analysis of
pooled samples for all seven genes (p<0.01), demonstrating that our
approach successfully identified changes in gene expression across
treatment groups that could be validated with individual samples.

Figure 2. Validation of microarray results. Bars represent mean relative fold changes
in gene expression determined by QPCR; normalized to snrpd1. Letters or * denote
significant differences for that gene compared with control. Black and white lines
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represent fold-changes in expression determined by array analysis. (Pearson’s
correlation, p < 0.01).

Differentially expressed transcripts with known functions
(103/229) were assigned to general functional groups based upon the
top three Gene Ontology (GO) functions and known biologic functions,
and are important for signal transduction/transcription/regulation of
the cell cycle, as well as for glucose and lipid metabolism, immune
response/cellular repair, and structure (Table 2 and Figure 3).
Hierarchical clustering grouped transcripts into one of five clusters
(Figure 4A and Supplementary Table 1). On average, the 17
transcripts within the fifth cluster show minimal changes in gene
expression across treatment groups and are therefore not shown in
Figure 4 or discussed further (due to lack of statistical power). The
majority of functionally annotated transcripts within clusters one and
four regulate gene transcription or are important for signal
transduction, while most functionally annotated transcripts within
cluster two are important for maintaining structure, and those within
cluster three play a role in immune function (see Figure 4A).

Figure 3. Proportion of dysregulated ovarian transcripts within each general functional
group. The number in parentheses represents the number of transcripts out of 229
within each functional group.
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Figure 4. A. Gene expression (expressed as the log ratio compared with control)
patterns of four hierarchical gene clusters including the primary functional group
represented within each cluster. B. Proportion of dysregulated ovarian transcripts
within each general functional group that contain putative AHREs, ERES, both or
neither.

One hundred forty of the dysregulated transcripts were mapped
to Ensemble genes, and 89% of these (125/140 corresponding to 113
unique transcripts) were found to have putative AHREs in the
regulatory region of the gene (Figure 4B, Supplementary Tables 1 and
2), compared with 92% of the reference genes (21046/22877). Using
hypergeometric distribution to calculate the probability of finding only
125 or fewer genes out of 140 that were drawn from 22877, our data
suggest differentially expressed transcripts are not enriched for
putative AHREs in (p = 0.14). Estimated probability density curves
shown in Figure 5A illustrate the potential location bias of putative
AHREs for each cluster along with the location of putative AHREs for all
genes in the zebrafish genome for comparison. Upstream regions of
genes within cluster 2 have putative AHRE distributions that are
significantly different (p = 2.9 × 10−12) from those of the control gene
set, with AHREs distributed 3000 – 4000 bp and 1500 bp upstream of
the transcriptional start site (TSS). In cluster 3, AHREs tend to be
further upstream (~3500 bp) from the TSS than control (p = 2.0 ×
10−7), and in cluster 4, AHREs tend to be concentrated within 2000 bp
upstream of the TSS (p = 0.01). Of the 113 unique transcripts that
contain putative AHREs, 16% were upregulated and 51% were
downregulated across treatment groups; many function as
transcription factors and regulate the cell cycle (Figure 5).
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Figure 5. Probability density curves illustrate the potential location bias of putative
AHREs (A) and EREs (B) with respect to the translational start site for the transcripts
within each hierarchical cluster compared with reference. Note: Probability density
curves represent the probability distribution in terms of integrals, illustrated as a line
depicting the relative frequency that each response element is represented at that
location.

Approximately 49% of the mapped dysregulated probes (68/140
corresponding to 58 unique transcripts) were found to have putative
EREs in the regulatory region of the gene (Figure 4B, Supplementary
Tables 1 and 3); 17% of these transcripts were upregulated and 55%
were downregulated across treatment groups. Forty-two percent of the
reference genes (9608/22877) contained putative EREs in the
regulatory region; differentially expressed genes contained putative
EREs at a much higher rate than would be expected (p = 0.05).
Estimated probability density curves shown in Figure 5B illustrate the
potential location bias of putative EREs for each cluster. In cluster 1,
EREs tend to be centered around 2000 bp from the TSS (p = 3.0 ×
10−7). In cluster 3, EREs are largely concentrated at about 1800–2000
bp upstream of the TSS (p = 8.2 × 10−7) and in cluster 4, EREs tend
to be concentrated within 2000 bp upstream (p = 0.02). Many of these
transcripts function in carbohydrate and lipid metabolism, or regulation
of transcription or the cell cycle (Figure 4B).
Approximately 41% of the dysregulated probes contain both
putative AHRE and ERE in the regulatory region (Figure 4B,
Supplementary Table 1); approximately 20% of these transcripts were
upregulated, while the majority of the transcripts (51%) were
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downregulated across treatment groups. Approximately 40% of the
reference genes (9039/22877) contain putative AHREs and EREs in the
regulatory region; the dysregulated transcripts were not significantly
enriched for both AHREs and EREs (p = 0.35). As with those with
putative EREs, many of these transcripts are important for
carbohydrate and lipid metabolism or function as transcription factors
and regulate the cell cycle (Figure 4B).

Discussion
TCDD has been shown to perturb the regulation of vertebrate
follicular development and ovulation, as well as steroidogenesis in the
ovary [3–6;40]. Regulation of these processes is complex, integrating
receptor-mediated hormonal signals from the pituitary with locally
produced factors to form an intimate regulatory network within and
between follicles. This poses a challenge for identifying the molecular
mechanisms that regulate TCDD’s reproductive toxicity. Furthermore,
the sometimes subtle secondary and tertiary effects on gene
expression following chronic dioxin exposure can be difficult to
ascertain and to correlate with observed toxicities. This study
represents one of the first attempts to characterize the effects on
ovarian gene expression following exposure of fish to chronic,
sublethal concentrations of TCDD. Using a candidate-gene approach in
conjunction with a genomics approach, we have identified several
novel dioxin-responsive genes that with further study may better
clarify TCDD’s ovarian toxicity.

Effects on the regulation of follicular development and
estradiol biosynthesis
All of the candidate genes selected for QPCR analysis (those
important for receptor-and non-receptor mediated regulation of
follicular development and estradiol biosynthesis) show peak
expression in follicles that are in the mid-to-late stages of
vitellogenesis, and should therefore be highly expressed in whole
ovary of cycling females under normal conditions [41–44].
Gonadotropins are important regulators of follicular development, and
in zebrafish, have been shown to induce the expression of several
other genes important for oocyte development [41;45]. Suppression of
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both gonadotropin receptors suggests that impaired follicular
development may be the result of this suppression. Similar effects on
ovarian gonadotropin receptor expression have been shown in
mammals [6;46–48] and others suggest that TCDD’s anovulatory
effects are likely mediated directly at the ovary in an AHR-dependent
manner [49;50]. Collectively, this suggests that TCDD primarily acts at
the ovary to suppress expression of gonadotropin receptors.
Exposure to TCDD also downregulates the expression of several
genes important in estradiol biosynthesis (star, cyp11a1, and
cyp19a1a), and likely contributes to the previously observed reduced
serum estradiol concentrations [4]. While it has been proposed that
reduced estradiol concentrations following exposure to TCDD may
result from suppression of aromatase activity, the mechanism by
which TCDD disrupts ovarian steroidogenesis is not clear. Baba et al
[51] show that exposure to DMBA, an AHR agonist, is correlated with
increased estradiol concentrations and increased aromatase
expression, while others suggest that the target of TCDD-induced
suppression of estradiol is upstream of aromatase in the steroidogenic
pathway [52]. However, other in vitro and in vivo studies demonstrate
that exposure to TCDD decreases the expression and activity of
aromatase, and is correlated with decreased estradiol concentrations
[53–55]. While our data support findings in mammalian systems that
suggest TCDD-induced reductions in serum estradiol may result from
diminished aromatase expression/activity, impairing estradiol
biosynthesis, we cannot rule out star and cyp11a1 as potential targets.
Others have demonstrated that expression of star and cyp11a1 is
suppressed in the interregnal gland following exposure to βNF, lending
support for these transcripts as other potential targets for endocrine
disruption by AHR-ligands [56].
While not as well characterized in fish, estradiol also plays a role
in regulating follicle development and ovulation via ERs in the ovary.
Three forms of the ER (esr1, esr2a, esr2b) are expressed in the
zebrafish ovary, and all are capable of initiating transcription of genes
[57;58]. Here we show that all three forms of the ER are
downregulated following chronic exposure to TCDD, as has been
demonstrated for mammals [59;60]. By suppressing the expression of
ERs in the ovary, follicles may be unable to respond to estrogen
signaling and/or induce the transcription of estrogen-responsive genes
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important for ovarian development [61–64]. Our array data further
support this hypothesis in that more than half of transcripts with
putative EREs were downregulated in the ovaries of TCDD-treated fish.
Finally, while follicular development is primarily controlled by
gonadotropin hormones, various local factors released from granulosa
and theca cells as well as from oocytes, also mediate gonadotropin
signaling. Peptide growth factors such as inhibins and follistatins
potentiate the action of gonadotropins and maturation-inducing steroid
in the induction of final oocyte maturation [44]. Activin βA (Inhbaa)
promotes ovary and follicle growth, whereas activin βB (Inhbb) exerts
a tonic role throughout follicle development, and becomes critical at
the late stage of oocytes maturation and/or ovulation [65]. Epidermal
growth factor enhances the rate of oocyte maturation via gonadotropin
signaling, inhibits apoptosis, stimulates follicle cell proliferation, and
plays a role in controlling follicle survival and steroidogenesis [66;67].
TCDD exposure suppressed the expression of both forms of inhibin, as
well as egf and its receptor, although not significantly at all doses,
suggesting that impacts further upstream (e.g., expression of
gonadotropin receptors) may have a greater impact on follicular
development.

Effects of TCDD on Global Ovarian Gene Expression
While our microarray experimental design does not allow us to
make direct conclusions about the mechanisms that underlie TCDD’s
ovarian toxicity, we are still able to offer valuable insights into
additional cellular pathways and signal cascades that are altered by
chronic exposure to TCDD. TCDD disrupts several integrated cellular
pathways (including structure, glucose and lipid metabolism, immune
response, and regulation of transcription) reaffirming the complexity of
TCDD toxicity and identifying several new avenues for further study.
For example, chronic exposure to 10 ppb TCDD shows a trend for
greater alterations in the expression of genes important for
transcription/signal transduction (cluster 1) and immune response
genes (cluster 3) compared to chronic exposure to 40 and 100 ppb
TCDD. Exposure to 10 ppb TCDD for 15 days resulted in reduced
estradiol concentrations in zebrafish, but follicular development,
overall egg production and spawn success were not altered; follicular

Reproductive Toxicology, Vol. 25, No. 1 (January 2008): pg. 47-57. DOI. This article is © Elsevier and permission has been
granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be
further copied/distributed or hosted elsewhere without the express permission from Elsevier.

17

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

development, egg production and spawn success was reduced
following exposure to 40 and 100 ppb TCDD for 15 days [4].
Therefore, the roles that such cellular pathways play in the modulation
by TCDD of follicular development and reproductive success by TCDD
warrants further study.
Following chronic exposure to TCDD, we show that transcripts
such as keratins (krt 4, 8, and 18), collagens (col1a2, col5a2l), lectins
(lgals3l and lgals1l2), and actins (acta2) necessary for maintaining
structural integrity were suppressed. We verified the expression
profiles for two of these transcripts (krt 4 and lgals3l); expression
profiles for similar transcripts (cluster 2) suggest a trend for a dosedependent suppression of structure-related transcripts. TCDD has also
been shown to impact the expression of genes important for
maintaining and metabolizing the extracellular matrix in the
regenerating fin of zebrafish [68] and in the liver of medaka [69].
Since TCDD exposure is associated with wasting-syndrome, decreased
ovarian somatic index, and inhibited regenerative growth of the fin and
liver, the impacts of TCDD on the expression of structural proteins
warrants further consideration as an integral component of the
sublethal toxic response to TCDD.
Many of the ovarian transcripts disrupted by TCDD are
important for regulation of the cell cycle and signal transduction.
Genes such as cyp1a1 (cluster 4) show a trend for a dose-dependent
increase in their suppression, while others such as the large Maf
protein krml2.2 (cluster 1) are downregulated following chronic
exposure to 10 ppb TCDD but not 40 or 100 ppb TCDD. Most of the
genes within cluster 4 (15/17) have putative AHREs, and cyp1a1 is
known to be induced by exposure to TCDD in an AHRE-mediated
manner; therefore, investigation into whether the expression of such
transcripts is induced by TCDD in an AHRE-mediated manner warrants
further study. Large Maf proteins such as krml2.2 are important for
regulation of cell differentiation. While the function of large Maf
proteins in fish ovarian development is not known, krml2.2 plays a role
in the differentiation of cell lineages in developing embryos [70], and
large Maf proteins have been shown to be key regulators of gonad
morphogenesis in Drosophila [71]. Expression of another gene, tfa
(cluster 3) is also increased following chronic exposure to 10 ppb
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induced differentiation of granulosa cells [72;73]. Alterations in such
transcripts may account for observed alterations in follicular
development, and warrant further investigation. Similar impacts on the
expression of transcripts important for signal transduction and
regulation of cellular differentiation have been noted by others to occur
in embryonic heart and regenerating tail of zebrafish [68;74;75] as
well as liver, brain, and testis of medaka [76]. While the specific
transcriptional profiles within these different tissue types following
exposure to TCDD reflect tissue-specific targets of TCDD, overall
impacts on the regulation of important signaling molecules and
transcription factors likely constitute a common denominator in TCDD’s
toxicity.
Our work also identifies several novel pathways by which
chronic exposure to TCDD may alter ovarian development. For
example, both glucose and lipid metabolism may be altered in the
ovary as a result of TCDD exposure. Since glucose and lipids play
active roles in oogenesis and egg quality in fish [77], perhaps TCDDinduced disruption of these pathways contributes to the observed
impacts on ovarian development [4] as well as offspring survival [28];
this hypothesis warrants further consideration. Several genes
important for immune response also appear altered by TCDD
exposure. Alterations in the expression of transcripts involved in
immune function could induce an inflammatory response, negatively
impacting steroidogenesis and follicular development [78], or perhaps
interfere with normal ovarian development by restricting the removal
of apoptotic cells or cellular debris [79]. Such transcriptional changes
could also reflect responses from immune cells as the result of tissue
repair, as suggested by Volz et al. [69]. Additional studies are
necessary to elucidate the impacts of altered immune response on
ovarian development in fishes.

Insights into the mechanisms of TCDD-induced ovarian
toxicity
In-silico analysis of the regulatory region of dysregulated
transcripts have enabled us to further support hypotheses regarding
the mechanisms by which chronic exposure to TCDD induces ovarian
toxicity and to identify new avenues for continued research into

Reproductive Toxicology, Vol. 25, No. 1 (January 2008): pg. 47-57. DOI. This article is © Elsevier and permission has been
granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be
further copied/distributed or hosted elsewhere without the express permission from Elsevier.

19

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

TCDD’s sublethal toxic response in the ovary. The AHR-pathway
remains active in zebrafish ovary following chronic exposure to TCDD,
evidenced by increased cyp1a1 expression compared with control.
While AHR-mediated changes in gene expression likely contribute to
TCDD-induced ovarian toxicity, dysregulated transcripts identified by
microarray do not appear to be enriched for AHREs compared with
reference genes. While we cannot be sure which of these AHREs are
functional, others have reported similar findings in that not all TCDDinduced changes in gene expression could be correlated with the
presence of AHREs either by promoter analysis or determination of
AHR-dependence [69;80;81]. Collectively, these studies suggest that
TCDD-induced histopathologic alterations likely involve changes in the
expression of genes downstream from initial AHRE-activated
transcription in addition to direct AHRE-mediated changes in gene
expression (e.g., by altering the expression of transcription factors and
signaling proteins via the AHRE, leading to an alteration in the
expression of their target genes in a tissue-specific manner).
Our data also suggest that impacts on the expression of
estradiol-regulated genes may also be important for TCDD-induced
ovarian toxicity. Several propose that interactions between AHR and
ER pathways are inhibitory, and that AHR-ligands could suppress
expression of genes via the AHRE [19;82;83]. While dysregulated
transcripts identified by microarray are enriched for putative EREs,
presence of both AHRE and ERE was not different than for reference
genes; therefore no conclusions regarding potential
interaction/interference between the two signaling pathways can be
drawn from these data. Others suggest that when estrogen is present,
AHR ligands can attenuate estrogen signaling at an ERE site, and that
while the AHR is involved, the mechanism of action is independent
from AHRE-mediated signaling [20;84;85]. Our findings here lend
support to this hypothesis. Putative EREs were identified in the
promoter regions of lhr, fshr, and cyp19a1a, of which only cyp19a1a
has been demonstrated to be estrogen responsive in zebrafish [84].
Further, dysregulated transcripts identified by microarray appear to be
enriched for EREs compared with reference genes. Collectively these
studies suggest that the antiestrogenic actions of TCDD at the ovary
entail multiple and perhaps gene/promoter-specific molecular
mechanisms involving ER/AHR cross-talk, and warrant further study.
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Conclusions
Environmental compounds that disrupt hormone signaling can
exert a profound effect on reproduction. Our data suggest that TCDD
inhibits expression of key genes that regulate follicular development
and estradiol biosynthesis, and provide further evidence for a
mechanistic link for impairment of reproduction in fish exposed to
TCDD. Suppression of all of the candidate genes in this study following
chronic exposure to TCDD is consistent with previously described
reductions in serum 17β estradiol concentrations and attenuated
follicular development [4], and suggests that TCDD inhibits the
transition of pre-vitellogenic follicles to vitellogenic follicles via
attenuated gonadotropin responsiveness and/or reduced estradiol
biosynthesis. Overall lack of a dose response suggests that the ovary
is highly sensitive to TCDD, and that accumulations of less than 1 ng
TCDD/g female are sufficient to reduce reproductive capacity of female
zebrafish. Furthermore, TCDD appears to impact several integrated
cellular pathways, illustrating the complex and profound effects it has
on the reproductive system. Our data also suggest that ovarian
toxicities following chronic exposure to TCDD result from downstream
effects of AHR-mediated signal transduction pathways, or from
feedback reactions to cellular changes induced by TCDD. Further
examination of the relationships among altered structural integrity,
glucose and lipid metabolism, immune response, and regulation of
transcription in response to ovarian toxicity will better clarify the
mechanisms by which TCDD exerts its reproductive toxicity,
particularly its low-dose, long-term effects.
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Supplementary Table 1. Summary of cluster analysis and transcription factor analysis (unique transcripts)
Symbol
10ppb
40ppb
Cluster Affy ID
Description
SRY-box containing gene 21a
1
Dr.8215.1.A1_at
sox21a
-2.33
-1.32
1
Dr.7110.1.S1_at
zgc:77614
-3.04
-2.42
zgc:77059
1
Dr.6147.1.A1_at
zgc:77150
-2.95
-1.70
zgc:76913
1
Dr.2978.1.S1_at
vg3
-6.65
-1.67
vitellogenin 3, phosvitinless
1
Dr.25593.2.A1_at
wu:fa56g11
-3.90
-1.03
wu:fa56g11
1
Dr.25285.1.S1_at
zgc:73223
-2.47
-1.15
zgc:73223
1
Dr.25009.4.A1_at
wu:fb59c05
-7.93
-1.73
wu:fb59c05
Kreisler (mouse) maf-related leucine zipper
1
Dr.23470.1.S1_s_at
krml2.2
-3.67
-1.02
homolog 2.2
1
Dr.18893.1.S1_at
im:7138745
-2.73
-1.06
im:7138745
1
Dr.16681.1.A1_at
-2.17
1.07
NA
1
Dr.11971.1.A1_at
zgc:92317
-2.34
-1.06
zgc:91877
1
Dr.921.1.A1_at
timeless
-2.92
1.88
timeless homolog (Drosophila)
1
Dr.8090.1.A1_at
ndrg1l
-3.58
1.33
N-myc downstream regulated gene 1, like
procollagen-lysine 1, 2-oxoglutarate 51
Dr.7688.1.A1_at
plod1
-2.24
1.00
dioxygenase 1
1
Dr.25774.1.S1_at
-3.06
-1.59
NA
1
Dr.25498.1.S1_at
bzw1
-2.15
1.43
basic leucine zipper and W2 domains 1
1
Dr.25009.6.A1_a_at
vg1
-7.38
-1.62
vitellogenin 1
1
Dr.24920.1.S1_at
-2.56
-1.13
NA
1
Dr.24253.1.S1_at
stk3
-3.84
1.86
serine/threonine kinase 3 (STE20 homolog,
1
Dr.20140.1.A1_at
E2F4
-2.60
-1.64
NA
1
Dr.1991.1.A1_s_at
zgc:66417
-7.09
-1.19
zgc:66417
1
Dr.195.1.S2_at
ck2a1
-3.29
-1.04
casein kinase 2 alpha 1
1
Dr.18466.1.A1_at
-2.23
1.03
NA
1
Dr.17776.1.A1_at
tph1l
-2.64
-1.53
tryptophan hydroxylase 1, like
1
Dr.17113.1.A1_a_at
ptena
-2.32
1.51
phosphatase and tensin homolog A
1
Dr.13994.2.A1_a_at
zgc:101086
-2.37
-1.20
zgc:101086
1
Dr.13775.1.S1_at
-3.60
-1.20
NA
1
Dr.12714.1.A1_at
-5.65
-1.56
NA
1
Dr.10170.1.A1_at
-2.38
-1.23
NA
1
Dr.4412.13.A1_x_at
wu:fa56g11
-2.92
1.16
wu:fa56g11
1
Dr.16504.1.A1_at
-2.60
-1.33
NA
1
Dr.16380.1.A1_at
zgc:92068
-2.45
-1.26
zgc:86738
-3.55
-1.05
1
Dr.4412.12.A1_at
wu:fa56g11
wu:fa56g11
1
Dr.25593.1.S1_at
wu:fa56g11
-2.80
1.30
wu:fa56g11
1
Dr.13096.2.S1_at
zgc:86738
-3.95
1.18
zgc:77882
2
Dr.9682.1.A1_at
-4.11
-4.33
NA
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100ppb
-1.00
-7.29
-4.17
-1.79
-1.20
-1.11
-2.05

AHRE
Y
Y
Y
Y
Y
Y
Y

ERE
Y
Y
Y
Y
Y
Y
Y

-2.68
1.01
1.47
-1.46
1.07
-1.93

Y
Y
Y
Y
Y
Y

Y
Y
Y
Y

-1.43
-1.94
1.18
-1.83
-1.36
-1.83
-1.50
-5.92
-1.86
-1.56
1.19
1.38
-1.67
-1.50
-1.01
-1.64
-1.13
-1.90
-1.18
-1.32
1.06
-1.89
-3.91

Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y

Y

Y

Supplementary Table 1 (cont.). Summary of cluster analysis and transcription factor analysis (unique transcripts)
Symbol
10ppb
40ppb
Cluster Affy ID
Description
wu:fa92g05
2
Dr.956.1.S1_at
wu:fa92g05
-1.17
-1.36
2
Dr.913.1.S1_at
zgc:63909
-2.60
-1.62
zgc:63909
2
Dr.8723.1.S1_at
zgc:92903
-1.21
-1.61
zgc:92068
2
Dr.7626.1.A1_at
zgc:73257
-2.25
-1.15
zgc:73257
2
Dr.7236.1.A1_at
wu:fc31g04
-2.90
-1.25
wu:fc31g04
2
Dr.5853.1.A1_at
zgc:77059
-2.38
-1.03
zgc:76953
2
Dr.4387.1.S1_at
krt4
-1.96
-2.93
keratin 4
2
Dr.4249.1.S1_at
lipf
-2.06
-1.85
lipase, gastric
2
Dr.4212.1.S1_at
ldha
-1.78
-1.45
lactate dehydrogenase A4
2
Dr.25155.1.S1_s_at
ba1
-1.11
1.22
ba1 globin
2
Dr.24233.1.S1_at
fn1b
-1.03
-1.57
fibronectin 1b
2
Dr.24122.1.A1_at
zgc:77882
-2.49
-2.05
zgc:77614
2
Dr.20722.1.S1_at
zgc:56454
-2.14
-1.43
zgc:56454
2
Dr.16206.1.A1_s_at
wu:fo83d04
1.26
1.65
NA
2
Dr.1619.1.A1_at
wu:fb83a09
-3.44
-1.98
wu:fb83a09
2
Dr.15054.1.S1_at
rbp2a
-2.98
-2.39
retinol binding protein 2a, cellular
2
Dr.13689.1.S1_at
zgc:66449
-2.65
-1.76
zgc:66449
2
Dr.1260.1.S1_at
anxa2a
-2.42
-2.92
annexin A2a
2
Dr.12575.1.S1_at
dcp1a
-1.12
-1.10
decapping enzyme
2
Dr.10326.1.S1_at
junb
-2.21
-1.88
jun B proto-oncogene
2
Dr.890.1.S1_at
zgc:77517
-2.69
-1.18
zgc:77150
2
Dr.8045.1.S1_at
prtfdc1
-1.44
-1.12
phosphoribosyl transferase domain containing
2
Dr.59.1.S1_at
anxa1a
-2.20
-3.36
annexin A1a
2
Dr.3628.1.S1_at
rap1b
-1.79
-1.41
RAS related protein 1b
2
Dr.3512.1.A1_at
-1.86
-1.34
NA
2
Dr.3459.1.S1_at
cd163
-2.04
-1.47
Cd63 antigen
2
Dr.3180.1.A1_at
zgc:76913
-1.84
-2.40
zgc:76908
2
Dr.2363.1.S1_at
tagln2
-2.93
-2.27
transgelin 2
lectin, galactoside-binding, soluble, 3 (galectin
2
Dr.20815.3.A1_at
lgals3l
-1.89
-2.68
3)-like
2
Dr.20277.1.A1_at
acta2
-1.83
-1.27
actin, alpha 2, smooth muscle, aorta
2
Dr.18135.1.A1_at
wu:fl63a03
-1.07
1.07
wu:fl63a03
2
Dr.17850.1.S1_at
zgc:56592
-2.61
-2.05
zgc:56592
2
Dr.15930.1.A1_at
-1.51
-1.03
NA
2
Dr.15856.1.A1_at
-2.66
-1.10
NA
2
Dr.14748.1.S1_at
zgc:63985
-1.54
-1.52
zgc:63985
2
Dr.14041.1.S1_at
zgc:103597
-2.65
-1.91
zgc:103597
2
Dr.1377.1.A1_at
col1a2
-2.47
-1.44
collagen, type I, alpha 2
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100ppb
-2.22
-2.69
-3.77
-2.18
-2.87
-1.02
-5.65
-2.30
-2.59
-2.50
-2.69
-2.06
-2.95
1.23
-2.03
-4.54
-1.90
-4.84
-2.16
-4.39
-1.53
-3.05
-7.06
-2.40
-2.26
-3.70
-2.50
-2.21

AHRE
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y

-2.56
-2.65
-4.01
-3.41
-2.18
-2.12
-2.65
-1.97
-2.56

Y
Y
Y
Y
Y
Y
Y
Y
Y

ERE
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y

Supplementary Table 1 (cont.). Summary of cluster analysis and transcription factor analysis (unique transcripts)
Symbol
10ppb
40ppb
Cluster Affy ID
Description
keratin 18
2
Dr.1372.1.S1_at
krt18
-1.43
-1.76
2
Dr.1361.1.S1_at
wu:fa98f12
-1.91
-2.41
wu:fa98f12
2
Dr.1282.1.S1_at
krt8
-1.45
-1.89
keratin 8
2
Dr.1246.1.S1_at
apoeb
-1.83
-1.09
apolipoprotein Eb
2
Dr.12106.1.S1_at
lztfl1
-1.12
-1.12
leucine zipper transcription factor-like 1
2
Dr.1201.1.S1_at
zgc:56142
-2.46
-1.92
zgc:56142
2
Dr.11609.1.S1_at
LOC402847
-1.62
-1.54
2
Dr.11348.1.S1_at
zgc:86724
-3.04
-2.42
zgc:77517
2
Dr.10879.1.A1_at
wu:fe14f11
-1.82
-1.12
wu:fe14f11
2
Dr.10314.1.S1_a_at
mmp13
1.20
1.60
matrix metalloproteinase 13
2
AFFX-Dr-GAPDH-3_at
2
Dr.4048.1.S1_at
-2.15
-1.26
NA
2
Dr.2973.1.A1_at
-1.49
-2.39
NA
2
Dr.24341.1.S1_at
zgc:76953
-1.54
-1.10
zgc:76908
2
Dr.1411.1.S1_at
hbaa1
-1.10
1.27
hemoglobin alpha adult-1
Kreisler (mouse) maf-related leucine zipper
2
Dr.8198.1.A1_at
krml2
-2.59
-1.19
homolog 2
2
Dr.5809.1.A1_at
wu:fb11g12
-2.30
-1.57
wu:fb11g12
2
Dr.5513.1.S1_at
slc3a2
-2.35
-1.68
solute carrier family 3, member 2
2
Dr.23469.1.S1_s_at
wu:fj17g12
-2.30
-2.50
wu:fj17g12
2
Dr.18880.1.A1_at
-2.05
-1.26
NA
2
Dr.16206.1.A1_at
wu:fo83d04
-1.22
-1.06
wu:fo83d04
2
Dr.13510.1.S1_at
actr10
-1.80
-1.23
actin-related protein 10 homolog (S. cerevisiae)
2
Dr.12498.1.S1_at
rad1
-1.10
1.13
RAD1 homolog (S. pombe)
2
Dr.1194.1.S1_at
zgc:76908
-2.34
-1.85
zgc:76908
3
Dr.8390.1.S1_at
zgc:55420
3.84
-1.12
zgc:55420
3
Dr.728.4.S1_at
fgb
5.66
1.43
fibrinogen, B beta polypeptide
3
Dr.6550.1.A1_at
LOC407646
3.05
1.42
3
Dr.4797.1.S1_at
8.50
-1.19
NA
3
Dr.3581.1.S1_at
ctrb1
2.58
1.84
chymotrypsinogen B1
3
Dr.3025.3.S1_at
wu:fa04f09
17.52
1.37
wu:fa04f09
3
Dr.25379.1.S1_at
sb:cb37
5.19
1.73
sb:cb37
3
Dr.2426.1.S1_at
zgc:66321
5.00
-1.34
zgc:66321
serine (or cysteine) proteinase inhibitor, clade A
3
Dr.1605.1.S1_at
serpina1
29.44
1.51
(alpha-1 antiproteinase, antitrypsin), member 1
3
Dr.8587.1.A2_at
igfbp1
5.58
-1.38
insulin-like growth factor binding protein 1
12.80
-1.82
3
Dr.5462.1.S1_at
fgb
fibrinogen, B beta polypeptide
3
Dr.4907.1.S1_at
fgg
12.96
-1.66
fibrinogen, gamma polypeptide
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100ppb
-3.09
-4.90
-3.02
-4.12
-2.33
-3.71
-2.86
-7.29
-2.38
-2.51

AHRE
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y

-3.36
-1.77
-2.39
-2.64

ERE

Y
Y
Y
Y

-2.41
-7.28
-3.05
-2.56
-2.13
-6.09
-2.29
-2.16
-3.53
1.13
1.61
-1.09
1.20
-2.41
2.04
1.80
-1.29

Y
Y
Y
Y
Y
Y
Y
Y

Y
Y
Y
Y
Y
Y
Y
Y

3.07
-1.47
-1.35
-1.12

Y
Y
Y
Y

Y

Supplementary Table 1 (cont.). Summary of cluster analysis and transcription factor analysis (unique transcripts)
Symbol
10ppb
40ppb
Cluster Affy ID
Description
ceruloplasmin
3
Dr.3613.1.S1_at
cp
24.49
1.06
3
Dr.20270.1.S1_at
wu:fi20c07
12.95
-1.13
wu:fi20c07
3
Dr.1889.2.A1_a_at
tfa
11.64
-2.09
transferrin-a
3
Dr.5562.1.S1_at
si:ch211-219i10.1 si:ch211-219i10.1
16.55
1.24
3
Dr.1889.1.S1_at
tfa
9.49
-2.25
transferrin-a
4
Dr.7806.1.A1_at
-2.44
1.04
NA
4
Dr.26469.1.S1_at
sp4
1.51
2.32
sp4 transcription factor
4
Dr.16524.1.S1_at
wu:fc12b04
1.85
2.39
wu:fc12b04
4
Dr.13972.1.S1_at
zgc:64114
1.19
2.45
zgc:64114
4
Dr.13182.1.A1_at
rab5b
2.45
1.34
RAB5B, member RAS oncogene family
4
Dr.12833.1.A1_at
zgc:64213
-1.62
1.18
zgc:64213
4
Dr.1192.1.S1_at
wu:fb11h03
-1.60
-1.17
wu:fb11h03
4
Dr.9478.1.S1_at
cyp1a
6.93
14.87
cytochrome P450, family 1, subfamily A
4
Dr.9450.1.A1_at
zgc:63724
-1.46
1.74
zgc:63724
4
Dr.19990.1.S1_at
zgc:66101
1.57
1.55
zgc:66101
4
Dr.19877.1.S1_at
zgc:66133
1.72
2.17
zgc:66133
4
Dr.17662.1.S1_at
1.88
3.38
NA
4
Dr.15418.1.S1_at
wu:fc23f06
1.26
1.27
wu:fc23f06
4
AFFX-Dr-acta1-5_x_at
4
Dr.24858.1.S1_at
zgc:110540
1.37
2.56
zgc:110540
4
Dr.15555.1.S1_at
1.48
2.58
NA
4
Dr.1192.1.S1_a_at
wu:fb11h03
-2.96
-1.56
wu:fb11h03
5
Dr.26139.1.A1_x_at
NA
1.36
2.17
NA
5
Dr.25378.1.A1_at
zgc:110540
1.64
2.32
zgc:110540
5
Dr.24249.1.S1_at
zc3hdc5
1.60
1.54
zinc finger CCCH type domain containing 5
5
Dr.5002.1.A1_at
NA
1.74
2.33
NA
5
Dr.25086.1.A1_at
NA
1.43
1.30
NA
5
Dr.1368.7.S1_at
zgc:86724
1.26
1.38
zgc:86724
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100ppb
2.16
1.33
-1.32
1.12
-1.42
2.65
1.96
2.05
4.16
2.13
3.28
3.48
24.68
3.59
2.43
3.31
1.62
3.01
1.97
2.72
2.95
-1.07
1.48
1.02
1.78
1.03
1.30

AHRE
Y
Y
Y

ERE

Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y
Y

Y
Y
Y
Y
Y
Y
Y

Y
Y
Y
Y
Y
Y

Y
Y
Y

Supplementary Table 2. Location of putative AHREs
Gene ID
Transcript ID
ENSDARG00000000935
ENSDART00000001053
ENSDARG00000000935
ENSDART00000001053
ENSDARG00000000935
ENSDART00000001053
ENSDARG00000000935
ENSDART00000001053
ENSDARG00000001953
ENSDART00000003247
ENSDARG00000001953
ENSDART00000003247
ENSDARG00000001953
ENSDART00000003247
ENSDARG00000001953
ENSDART00000003247
ENSDARG00000002082
ENSDART00000005010
ENSDARG00000002082
ENSDART00000005010
ENSDARG00000002082
ENSDART00000005010
ENSDARG00000002082
ENSDART00000005010
ENSDARG00000002082
ENSDART00000005010
ENSDARG00000002667
ENSDART00000003004
ENSDARG00000002667
ENSDART00000003004
ENSDARG00000002667
ENSDART00000003004
ENSDARG00000002667
ENSDART00000003004
ENSDARG00000003216
ENSDART00000011967
ENSDARG00000003323
ENSDART00000017567
ENSDARG00000003323
ENSDART00000017567
ENSDARG00000003323
ENSDART00000017567
ENSDARG00000004060
ENSDART00000026017
ENSDARG00000004296
ENSDART00000027026
ENSDARG00000004296
ENSDART00000027026
ENSDARG00000004296
ENSDART00000027026
ENSDARG00000004296
ENSDART00000027026
ENSDARG00000004296
ENSDART00000027026
ENSDARG00000005186
ENSDART00000002285
ENSDARG00000005186
ENSDART00000002285
ENSDARG00000005186
ENSDART00000002285
ENSDARG00000005186
ENSDART00000002285
ENSDARG00000005186
ENSDART00000002285
ENSDARG00000005186
ENSDART00000002285
ENSDARG00000005186
ENSDART00000002285
ENSDARG00000005186
ENSDART00000002285
ENSDARG00000006074
ENSDART00000002186
ENSDARG00000006526
ENSDART00000017312
ENSDARG00000006526
ENSDART00000017312
ENSDARG00000006526
ENSDART00000017312
ENSDARG00000006526
ENSDART00000017312
ENSDARG00000006526
ENSDART00000017312
ENSDARG00000006526
ENSDART00000023692
ENSDARG00000006526
ENSDART00000023692
ENSDARG00000007219
ENSDART00000005791
ENSDARG00000007219
ENSDART00000005791
ENSDARG00000007219
ENSDART00000005791
ENSDARG00000007481
ENSDART00000058261
ENSDARG00000008867
ENSDART00000042250
ENSDARG00000008867
ENSDART00000042250
ENSDARG00000008867
ENSDART00000042250
ENSDARG00000008895
ENSDART00000055048
ENSDARG00000008969
ENSDART00000011701
ENSDARG00000008969
ENSDART00000011701
ENSDARG00000008969
ENSDART00000011701
ENSDARG00000008969
ENSDART00000011701
ENSDARG00000008969
ENSDART00000041987
ENSDARG00000008969
ENSDART00000041987
ENSDARG00000009483
ENSDART00000009889
ENSDARG00000009483
ENSDART00000009889
ENSDARG00000009483
ENSDART00000009889
ENSDARG00000009483
ENSDART00000009889
ENSDARG00000009483
ENSDART00000009889
ENSDARG00000009483
ENSDART00000009889
ENSDARG00000010312
ENSDART00000010537
ENSDARG00000010312
ENSDART00000010537
ENSDARG00000010312
ENSDART00000010537
ENSDARG00000010312
ENSDART00000010537
ENSDARG00000010420
ENSDART00000049420
ENSDARG00000010420
ENSDART00000049420
ENSDARG00000010481
ENSDART00000013575
ENSDARG00000010481
ENSDART00000013575
ENSDARG00000011312
ENSDART00000008698
ENSDARG00000011312
ENSDART00000008698
ENSDARG00000011312
ENSDART00000008698
ENSDARG00000011312
ENSDART00000008698
ENSDARG00000011312
ENSDART00000008698
ENSDARG00000011683
ENSDART00000013454
ENSDARG00000012395
ENSDART00000005436
ENSDARG00000012395
ENSDART00000005436
ENSDARG00000012395
ENSDART00000005436
ENSDARG00000012395
ENSDART00000005436
ENSDARG00000012936
ENSDART00000012450
ENSDARG00000012936
ENSDART00000012450
ENSDARG00000012936
ENSDART00000012450
ENSDARG00000012936
ENSDART00000012450
ENSDARG00000012936
ENSDART00000012450
ENSDARG00000012936
ENSDART00000012450
ENSDARG00000012936
ENSDART00000012450
ENSDARG00000012936
ENSDART00000012450
ENSDARG00000012936
ENSDART00000012450
ENSDARG00000013454
ENSDART00000019328
ENSDARG00000013454
ENSDART00000019328

Affy IDs
Dr.24249.1.S1_at
Dr.24249.1.S1_at
Dr.24249.1.S1_at
Dr.24249.1.S1_at
Dr.7626.1.A1_at,Dr.7626.2.S1_at
Dr.7626.1.A1_at,Dr.7626.2.S1_at
Dr.7626.1.A1_at,Dr.7626.2.S1_at
Dr.7626.1.A1_at,Dr.7626.2.S1_at
Dr.195.1.S1_at,Dr.195.1.S2_at,Dr.195.1.S1_at
Dr.195.1.S1_at,Dr.195.1.S2_at,Dr.195.1.S1_at
Dr.195.1.S1_at,Dr.195.1.S2_at,Dr.195.1.S1_at
Dr.195.1.S1_at,Dr.195.1.S2_at,Dr.195.1.S1_at
Dr.195.1.S1_at,Dr.195.1.S2_at,Dr.195.1.S1_at
Dr.23470.1.S1_s_at,Dr.8198.1.A1_at
Dr.23470.1.S1_s_at,Dr.8198.1.A1_at
Dr.23470.1.S1_s_at,Dr.8198.1.A1_at
Dr.23470.1.S1_s_at,Dr.8198.1.A1_at
Dr.1260.1.S1_at
Dr.12575.1.S1_at
Dr.12575.1.S1_at
Dr.12575.1.S1_at
Dr.3180.1.A1_at
Dr.2426.1.S1_at
Dr.2426.1.S1_at
Dr.2426.1.S1_at
Dr.2426.1.S1_at
Dr.2426.1.S1_at
Dr.26469.1.S1_at
Dr.26469.1.S1_at
Dr.26469.1.S1_at
Dr.26469.1.S1_at
Dr.26469.1.S1_at
Dr.26469.1.S1_at
Dr.26469.1.S1_at
Dr.26469.1.S1_at
Dr.15856.1.A1_at,Dr.13404.1.A1_at
Dr.24233.1.S1_at
Dr.24233.1.S1_at
Dr.24233.1.S1_at
Dr.24233.1.S1_at
Dr.24233.1.S1_at
Dr.24233.1.S1_at
Dr.24233.1.S1_at
Dr.25774.1.S1_at
Dr.25774.1.S1_at
Dr.25774.1.S1_at
Dr.5002.1.A1_at
Dr.3628.1.S1_at
Dr.3628.1.S1_at
Dr.3628.1.S1_at
Dr.1619.1.A1_at,Dr.1619.1.A1_at,Dr.1619.1.A1_at
Dr.5462.1.S1_at,Dr.5462.1.S1_at
Dr.5462.1.S1_at,Dr.5462.1.S1_at
Dr.5462.1.S1_at,Dr.5462.1.S1_at
Dr.5462.1.S1_at,Dr.5462.1.S1_at
Dr.5462.1.S1_at,Dr.5462.1.S1_at
Dr.5462.1.S1_at,Dr.5462.1.S1_at
Dr.25378.1.A1_at,Dr.24858.1.S1_at
Dr.25378.1.A1_at,Dr.24858.1.S1_at
Dr.25378.1.A1_at,Dr.24858.1.S1_at
Dr.25378.1.A1_at,Dr.24858.1.S1_at
Dr.25378.1.A1_at,Dr.24858.1.S1_at
Dr.25378.1.A1_at,Dr.24858.1.S1_at
Dr.3613.1.S1_at
Dr.3613.1.S1_at
Dr.3613.1.S1_at
Dr.3613.1.S1_at
Dr.8090.1.A1_at
Dr.8090.1.A1_at
Dr.25498.1.S1_at
Dr.25498.1.S1_at
Dr.24253.1.S1_at
Dr.24253.1.S1_at
Dr.24253.1.S1_at
Dr.24253.1.S1_at
Dr.24253.1.S1_at
Dr.8045.1.S1_at
Dr.10314.1.S1_a_at
Dr.10314.1.S1_a_at
Dr.10314.1.S1_a_at
Dr.10314.1.S1_a_at
Dr.24920.1.S1_at,Dr.3137.1.A1_at,Dr.5398.1.A1_at
Dr.24920.1.S1_at,Dr.3137.1.A1_at,Dr.5398.1.A1_at
Dr.24920.1.S1_at,Dr.3137.1.A1_at,Dr.5398.1.A1_at
Dr.24920.1.S1_at,Dr.3137.1.A1_at,Dr.5398.1.A1_at
Dr.24920.1.S1_at,Dr.3137.1.A1_at,Dr.5398.1.A1_at
Dr.24920.1.S1_at,Dr.3137.1.A1_at,Dr.5398.1.A1_at
Dr.24920.1.S1_at,Dr.3137.1.A1_at,Dr.5398.1.A1_at
Dr.24920.1.S1_at,Dr.3137.1.A1_at,Dr.5398.1.A1_at
Dr.24920.1.S1_at,Dr.3137.1.A1_at,Dr.5398.1.A1_at
Dr.16524.1.S1_at
Dr.16524.1.S1_at

Symbol
zc3hdc5
zc3hdc5
zc3hdc5
zc3hdc5
NP_998562.1
NP_998562.1
NP_998562.1
NP_998562.1
ck2a1
ck2a1
ck2a1
ck2a1
ck2a1
krml2.2
krml2.2
krml2.2
krml2.2
dcp1a
dcp1a
dcp1a
zgc:76913
zgc:66321
zgc:66321
zgc:66321
zgc:66321
zgc:66321
NP_956418.1
NP_956418.1
NP_956418.1
NP_956418.1
NP_956418.1
NP_956418.1
NP_956418.1
NP_956418.1
NP_956234.1
fn1b
fn1b
fn1b
fn1b
fn1b
fn1b
fn1b

Description
zinc finger CCCH type domain containing 5 [Source:RefSeq_peptide;Acc:NP_956530]
zinc finger CCCH type domain containing 5 [Source:RefSeq_peptide;Acc:NP_956530]
zinc finger CCCH type domain containing 5 [Source:RefSeq_peptide;Acc:NP_956530]
zinc finger CCCH type domain containing 5 [Source:RefSeq_peptide;Acc:NP_956530]
zgc:73257 [Source:RefSeq_peptide;Acc:NP_998562]
zgc:73257 [Source:RefSeq_peptide;Acc:NP_998562]
zgc:73257 [Source:RefSeq_peptide;Acc:NP_998562]
zgc:73257 [Source:RefSeq_peptide;Acc:NP_998562]
casein kinase 2 alpha 1 [Source:RefSeq_peptide;Acc:NP_571327]
casein kinase 2 alpha 1 [Source:RefSeq_peptide;Acc:NP_571327]
casein kinase 2 alpha 1 [Source:RefSeq_peptide;Acc:NP_571327]
casein kinase 2 alpha 1 [Source:RefSeq_peptide;Acc:NP_571327]
casein kinase 2 alpha 1 [Source:RefSeq_peptide;Acc:NP_571327]
Kreisler (mouse) maf-related leucine zipper homolog 2.2 [Source:RefSeq_peptide;Acc:NP_571917]
Kreisler (mouse) maf-related leucine zipper homolog 2.2 [Source:RefSeq_peptide;Acc:NP_571917]
Kreisler (mouse) maf-related leucine zipper homolog 2.2 [Source:RefSeq_peptide;Acc:NP_571917]
Kreisler (mouse) maf-related leucine zipper homolog 2.2 [Source:RefSeq_peptide;Acc:NP_571917]
annexin A2a (anxa2a), mRNA [Source:RefSeq_dna;Acc:NM_181761]
decapping enzyme [Source:RefSeq_peptide;Acc:NP_878313]
decapping enzyme [Source:RefSeq_peptide;Acc:NP_878313]
decapping enzyme [Source:RefSeq_peptide;Acc:NP_878313]
Unknown (protein for MGC:76913) [Source:RefSeq_peptide;Acc:NP_997844]
similar to alpha-1-microglobulin/bikunin precursor [Source:RefSeq_peptide;Acc:NP_957412]
similar to alpha-1-microglobulin/bikunin precursor [Source:RefSeq_peptide;Acc:NP_957412]
similar to alpha-1-microglobulin/bikunin precursor [Source:RefSeq_peptide;Acc:NP_957412]
similar to alpha-1-microglobulin/bikunin precursor [Source:RefSeq_peptide;Acc:NP_957412]
similar to alpha-1-microglobulin/bikunin precursor [Source:RefSeq_peptide;Acc:NP_957412]
sp4 transcription factor [Source:RefSeq_peptide;Acc:NP_956418]
sp4 transcription factor [Source:RefSeq_peptide;Acc:NP_956418]
sp4 transcription factor [Source:RefSeq_peptide;Acc:NP_956418]
sp4 transcription factor [Source:RefSeq_peptide;Acc:NP_956418]
sp4 transcription factor [Source:RefSeq_peptide;Acc:NP_956418]
sp4 transcription factor [Source:RefSeq_peptide;Acc:NP_956418]
sp4 transcription factor [Source:RefSeq_peptide;Acc:NP_956418]
sp4 transcription factor [Source:RefSeq_peptide;Acc:NP_956418]
uridine monophosphate kinase [Source:RefSeq_peptide;Acc:NP_956234]
fibronectin 1b (fn1b), mRNA [Source:RefSeq_dna;Acc:NM_001013261]
fibronectin 1b (fn1b), mRNA [Source:RefSeq_dna;Acc:NM_001013261]
fibronectin 1b (fn1b), mRNA [Source:RefSeq_dna;Acc:NM_001013261]
fibronectin 1b (fn1b), mRNA [Source:RefSeq_dna;Acc:NM_001013261]
fibronectin 1b (fn1b), mRNA [Source:RefSeq_dna;Acc:NM_001013261]
fibronectin 1b (fn1b), mRNA [Source:RefSeq_dna;Acc:NM_001013261]
fibronectin 1b (fn1b), mRNA [Source:RefSeq_dna;Acc:NM_001013261]

rap1b
rap1b
rap1b

RAS related protein 1b [Source:RefSeq_peptide;Acc:NP_955827]
RAS related protein 1b [Source:RefSeq_peptide;Acc:NP_955827]
RAS related protein 1b [Source:RefSeq_peptide;Acc:NP_955827]

fgb
fgb
fgb
fgb
fgb
fgb
zgc:110540
zgc:110540
zgc:110540
zgc:110540
zgc:110540
zgc:110540

fibrinogen, B beta polypeptide [Source:RefSeq_peptide;Acc:NP_997939]
fibrinogen, B beta polypeptide [Source:RefSeq_peptide;Acc:NP_997939]
fibrinogen, B beta polypeptide [Source:RefSeq_peptide;Acc:NP_997939]
fibrinogen, B beta polypeptide [Source:RefSeq_peptide;Acc:NP_997939]
fibrinogen, B beta polypeptide [Source:RefSeq_peptide;Acc:NP_997939]
fibrinogen, B beta polypeptide [Source:RefSeq_peptide;Acc:NP_997939]
deoxycytidine kinase [Source:RefSeq_peptide;Acc:NP_001014374]
deoxycytidine kinase [Source:RefSeq_peptide;Acc:NP_001014374]
deoxycytidine kinase [Source:RefSeq_peptide;Acc:NP_001014374]
deoxycytidine kinase [Source:RefSeq_peptide;Acc:NP_001014374]
deoxycytidine kinase [Source:RefSeq_peptide;Acc:NP_001014374]
deoxycytidine kinase [Source:RefSeq_peptide;Acc:NP_001014374]

ndrg1l
ndrg1l
NP_956002.1
NP_956002.1
stk3
stk3
stk3
stk3
stk3
NP_955812.2
mmp13
mmp13
mmp13
mmp13
NP_997813.1
NP_997813.1
NP_997813.1
NP_997813.1
NP_997813.1
NP_997813.1
NP_997813.1
NP_997813.1
NP_997813.1
wu:fc12b04
wu:fc12b04

N-myc downstream regulated gene 1, like [Source:RefSeq_peptide;Acc:NP_956986]
N-myc downstream regulated gene 1, like [Source:RefSeq_peptide;Acc:NP_956986]
basic leucine zipper and W2 domains 1 [Source:RefSeq_peptide;Acc:NP_956002]
basic leucine zipper and W2 domains 1 [Source:RefSeq_peptide;Acc:NP_956002]
serine/threonine kinase 3 (STE20 homolog, yeast) [Source:RefSeq_peptide;Acc:NP_955966]
serine/threonine kinase 3 (STE20 homolog, yeast) [Source:RefSeq_peptide;Acc:NP_955966]
serine/threonine kinase 3 (STE20 homolog, yeast) [Source:RefSeq_peptide;Acc:NP_955966]
serine/threonine kinase 3 (STE20 homolog, yeast) [Source:RefSeq_peptide;Acc:NP_955966]
serine/threonine kinase 3 (STE20 homolog, yeast) [Source:RefSeq_peptide;Acc:NP_955966]
HHGP protein [Source:RefSeq_peptide;Acc:NP_955812]
matrix metalloproteinase 13 [Source:RefSeq_peptide;Acc:NP_958911]
matrix metalloproteinase 13 [Source:RefSeq_peptide;Acc:NP_958911]
matrix metalloproteinase 13 [Source:RefSeq_peptide;Acc:NP_958911]
matrix metalloproteinase 13 [Source:RefSeq_peptide;Acc:NP_958911]
dishevelled 2, dsh homolog [Source:RefSeq_peptide;Acc:NP_997813]
dishevelled 2, dsh homolog [Source:RefSeq_peptide;Acc:NP_997813]
dishevelled 2, dsh homolog [Source:RefSeq_peptide;Acc:NP_997813]
dishevelled 2, dsh homolog [Source:RefSeq_peptide;Acc:NP_997813]
dishevelled 2, dsh homolog [Source:RefSeq_peptide;Acc:NP_997813]
dishevelled 2, dsh homolog [Source:RefSeq_peptide;Acc:NP_997813]
dishevelled 2, dsh homolog [Source:RefSeq_peptide;Acc:NP_997813]
dishevelled 2, dsh homolog [Source:RefSeq_peptide;Acc:NP_997813]
dishevelled 2, dsh homolog [Source:RefSeq_peptide;Acc:NP_997813]
protein-glutamine gamma-glutamyltransferase [Source:RefSeq_peptide;Acc:NP_997821]
protein-glutamine gamma-glutamyltransferase [Source:RefSeq_peptide;Acc:NP_997821]
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Start

End
-4874
-2211
210
748
-1683
-1087
-862
-347
-983
-941
-846
-726
-553
-248
-215
-248
-215
-3672
-2628
-2299
-170
-1103
-3749
-3743
-3737
-3725
30
-3691
-3596
-955
-844
-820
-791
-532
-383
-3203
-2209
-2163
-1504
-4430
-4387
-2223
-1263
-2349
-1147
-817
-12
-3595
-1533
-234
-1617
-3590
-3263
-2312
-2219
-311
-178
-1352
-1350
-1280
-1352
-1350
-1280
-3990
-1870
-1737
-125
-3038
-2860
-2137
-1647
-3610
-3392
-3025
-2651
-1477
-102
-2663
-2528
-2276
-2020
-3664
-4986
-1028
-901
-816
-4576
-748
-664
-276
-1511
-107

-4869
-2206
215
753
-1678
-1082
-857
-342
-978
-936
-841
-721
-548
-243
-210
-243
-210
-3667
-2623
-2294
-165
-1098
-3744
-3738
-3732
-3720
35
-3686
-3591
-950
-839
-815
-786
-527
-378
-3198
-2204
-2158
-1499
-4425
-4382
-2218
-1258
-2344
-1142
-812
-7
-3590
-1528
-229
-1612
-3585
-3258
-2307
-2214
-306
-173
-1347
-1345
-1275
-1347
-1345
-1275
-3985
-1865
-1732
-120
-3033
-2855
-2132
-1642
-3605
-3387
-3020
-2646
-1472
-97
-2658
-2523
-2271
-2015
-3659
-4981
-1023
-896
-811
-4571
-743
-659
-271
-1506
-102

Strand
-1
-1
-1
-1
-1
-1
-1
1
1
1
-1
1
1
1
1
1
1
-1
-1
-1
1
-1
1
1
1
1
1
1
1
-1
1
-1
1
-1
-1
1
1
-1
-1
1
-1
1
1
-1
-1
-1
1
-1
-1
-1
1
1
1
-1
-1
-1
1
-1
1
1
-1
1
1
-1
-1
1
1
1
-1
-1
1
-1
-1
-1
-1
-1
-1
-1
1
-1
1
1
1
-1
-1
1
-1
1
1
-1
-1
-1

Sequence
agcgtg
tgcgtg
tgcgtg
agcgtg
tgcgtg
ggcgtg
agcgtg
tgcgtg
agcgtg
cgcgtg
tgcgtg
ggcgtg
ggcgtg
ggcgtg
agcgtg
ggcgtg
agcgtg
agcgtg
tgcgtg
ggcgtg
agcgtg
tgcgtg
tgcgtg
tgcgtg
tgcgtg
tgcgtg
tgcgtg
tgcgtg
agcgtg
tgcgtg
ggcgtg
agcgtg
ggcgtg
ggcgtg
tgcgtg
ggcgtg
ggcgtg
ggcgtg
tgcgtg
ggcgtg
agcgtg
agcgtg
tgcgtg
agcgtg
agcgtg
agcgtg
cgcgtg
cgcgtg
tgcgtg
agcgtg
cgcgtg
agcgtg
ggcgtg
tgcgtg
cgcgtg
tgcgtg
tgcgtg
cgcgtg
cgcgtg
agcgtg
cgcgtg
cgcgtg
agcgtg
tgcgtg
ggcgtg
ggcgtg
tgcgtg
agcgtg
agcgtg
ggcgtg
tgcgtg
agcgtg
agcgtg
agcgtg
agcgtg
agcgtg
ggcgtg
tgcgtg
ggcgtg
ggcgtg
cgcgtg
agcgtg
cgcgtg
agcgtg
ggcgtg
tgcgtg
tgcgtg
cgcgtg
ggcgtg
ggcgtg
agcgtg
ggcgtg

Supplementary Table 2 (cont.). Location of putative AHREs
Gene ID
Transcript ID
Affy IDs
Dr.17662.1.S1_at
ENSDARG00000013481
ENSDART00000007454
ENSDARG00000013613
ENSDART00000018408
Dr.16504.1.A1_at
ENSDARG00000013613
ENSDART00000018408
Dr.16504.1.A1_at
ENSDARG00000013613
ENSDART00000018408
Dr.16504.1.A1_at
ENSDARG00000013646
ENSDARG00000014209
ENSDARG00000014209
ENSDARG00000014209
ENSDARG00000014429

ENSDART00000019664
ENSDART00000023208
ENSDART00000023208
ENSDART00000023208
ENSDART00000017280

ENSDARG00000014629

ENSDART00000020883

ENSDARG00000014629

ENSDART00000020883

ENSDARG00000014629

ENSDART00000049779

ENSDARG00000014629

ENSDART00000049779

ENSDARG00000014629

ENSDART00000066174

ENSDARG00000014629
ENSDARG00000014947
ENSDARG00000014947
ENSDARG00000014947
ENSDARG00000014947
ENSDARG00000014947
ENSDARG00000014947
ENSDARG00000014947
ENSDARG00000014947
ENSDARG00000014947
ENSDARG00000014947
ENSDARG00000014947
ENSDARG00000014947
ENSDARG00000015866
ENSDARG00000015866
ENSDARG00000015866
ENSDARG00000015866
ENSDARG00000015866
ENSDARG00000015866
ENSDARG00000016059
ENSDARG00000016059
ENSDARG00000016059
ENSDARG00000016059
ENSDARG00000016448
ENSDARG00000016771
ENSDARG00000016771
ENSDARG00000016771
ENSDARG00000016771
ENSDARG00000016771
ENSDARG00000016771
ENSDARG00000016771
ENSDARG00000016771
ENSDARG00000016771
ENSDARG00000016771
ENSDARG00000016825
ENSDARG00000016825
ENSDARG00000016825
ENSDARG00000016825
ENSDARG00000016825
ENSDARG00000016825
ENSDARG00000017619
ENSDARG00000017619
ENSDARG00000017619
ENSDARG00000017619
ENSDARG00000017619
ENSDARG00000017619
ENSDARG00000017619
ENSDARG00000017619
ENSDARG00000017619
ENSDARG00000017619
ENSDARG00000017619
ENSDARG00000017619
ENSDARG00000017619
ENSDARG00000017619
ENSDARG00000017619
ENSDARG00000017619
ENSDARG00000017619
ENSDARG00000017619
ENSDARG00000017619
ENSDARG00000017619
ENSDARG00000017619
ENSDARG00000017619
ENSDARG00000017624
ENSDARG00000017624
ENSDARG00000017624
ENSDARG00000018404
ENSDARG00000018404
ENSDARG00000018404
ENSDARG00000018529
ENSDARG00000018529
ENSDARG00000018529

ENSDART00000066174
ENSDART00000026576
ENSDART00000026576
ENSDART00000026576
ENSDART00000026576
ENSDART00000026576
ENSDART00000026576
ENSDART00000026576
ENSDART00000026576
ENSDART00000026576
ENSDART00000026576
ENSDART00000026576
ENSDART00000026576
ENSDART00000019110
ENSDART00000019110
ENSDART00000058963
ENSDART00000058963
ENSDART00000058964
ENSDART00000058964
ENSDART00000021065
ENSDART00000021065
ENSDART00000021065
ENSDART00000021065
ENSDART00000014979
ENSDART00000003845
ENSDART00000003845
ENSDART00000003845
ENSDART00000003845
ENSDART00000003845
ENSDART00000003845
ENSDART00000003845
ENSDART00000003845
ENSDART00000003845
ENSDART00000003845
ENSDART00000050238
ENSDART00000050238
ENSDART00000050238
ENSDART00000050238
ENSDART00000050238
ENSDART00000050238
ENSDART00000026842
ENSDART00000026842
ENSDART00000026842
ENSDART00000026842
ENSDART00000026842
ENSDART00000026842
ENSDART00000026842
ENSDART00000038499
ENSDART00000038499
ENSDART00000038499
ENSDART00000038499
ENSDART00000026842
ENSDART00000026842
ENSDART00000026842
ENSDART00000026842
ENSDART00000026842
ENSDART00000026842
ENSDART00000026842
ENSDART00000038499
ENSDART00000038499
ENSDART00000038499
ENSDART00000038499
ENSDART00000012644
ENSDART00000012644
ENSDART00000012644
ENSDART00000020750
ENSDART00000020750
ENSDART00000020750
ENSDART00000020541
ENSDART00000020541
ENSDART00000020541

Dr.1605.1.S1_at
Dr.15930.1.A1_at
Dr.15930.1.A1_at
Dr.15930.1.A1_at
Dr.4907.1.S1_at
Dr.921.1.A1_at,DrAffx.2.64.S1_at,Dr.921.1.A1_at,DrAffx.2.64.S1_at,Dr.921.1.
A1_at,DrAffx.2.64.S1_at
Dr.921.1.A1_at,DrAffx.2.64.S1_at,Dr.921.1.A1_at,DrAffx.2.64.S1_at,Dr.921.1.
A1_at,DrAffx.2.64.S1_at
Dr.921.1.A1_at,DrAffx.2.64.S1_at,Dr.921.1.A1_at,DrAffx.2.64.S1_at,Dr.921.1.
A1_at,DrAffx.2.64.S1_at
Dr.921.1.A1_at,DrAffx.2.64.S1_at,Dr.921.1.A1_at,DrAffx.2.64.S1_at,Dr.921.1.
A1_at,DrAffx.2.64.S1_at
Dr.921.1.A1_at,DrAffx.2.64.S1_at,Dr.921.1.A1_at,DrAffx.2.64.S1_at,Dr.921.1.
A1_at,DrAffx.2.64.S1_at
Dr.921.1.A1_at,DrAffx.2.64.S1_at,Dr.921.1.A1_at,DrAffx.2.64.S1_at,Dr.921.1.
A1_at,DrAffx.2.64.S1_at
Dr.8587.1.A1_at,Dr.8587.1.A2_at
Dr.8587.1.A1_at,Dr.8587.1.A2_at
Dr.8587.1.A1_at,Dr.8587.1.A2_at
Dr.8587.1.A1_at,Dr.8587.1.A2_at
Dr.8587.1.A1_at,Dr.8587.1.A2_at
Dr.8587.1.A1_at,Dr.8587.1.A2_at
Dr.8587.1.A1_at,Dr.8587.1.A2_at
Dr.8587.1.A1_at,Dr.8587.1.A2_at
Dr.8587.1.A1_at,Dr.8587.1.A2_at
Dr.8587.1.A1_at,Dr.8587.1.A2_at
Dr.8587.1.A1_at,Dr.8587.1.A2_at
Dr.8587.1.A1_at,Dr.8587.1.A2_at
Dr.728.4.S1_at,Dr.728.4.S1_at,Dr.728.4.S1_at
Dr.728.4.S1_at,Dr.728.4.S1_at,Dr.728.4.S1_at
Dr.728.4.S1_at,Dr.728.4.S1_at,Dr.728.4.S1_at
Dr.728.4.S1_at,Dr.728.4.S1_at,Dr.728.4.S1_at
Dr.728.4.S1_at,Dr.728.4.S1_at,Dr.728.4.S1_at
Dr.728.4.S1_at,Dr.728.4.S1_at,Dr.728.4.S1_at
Dr.13182.1.A1_at
Dr.13182.1.A1_at
Dr.13182.1.A1_at
Dr.13182.1.A1_at
Dr.2978.1.S1_at
Dr.1889.2.A1_a_at,Dr.1889.1.S1_at
Dr.1889.2.A1_a_at,Dr.1889.1.S1_at
Dr.1889.2.A1_a_at,Dr.1889.1.S1_at
Dr.1889.2.A1_a_at,Dr.1889.1.S1_at
Dr.1889.2.A1_a_at,Dr.1889.1.S1_at
Dr.1889.2.A1_a_at,Dr.1889.1.S1_at
Dr.1889.2.A1_a_at,Dr.1889.1.S1_at
Dr.1889.2.A1_a_at,Dr.1889.1.S1_at
Dr.1889.2.A1_a_at,Dr.1889.1.S1_at
Dr.1889.2.A1_a_at,Dr.1889.1.S1_at
Dr.25009.6.A1_a_at,Dr.25009.1.S1_a_at
Dr.25009.6.A1_a_at,Dr.25009.1.S1_a_at
Dr.25009.6.A1_a_at,Dr.25009.1.S1_a_at
Dr.25009.6.A1_a_at,Dr.25009.1.S1_a_at
Dr.25009.6.A1_a_at,Dr.25009.1.S1_a_at
Dr.25009.6.A1_a_at,Dr.25009.1.S1_a_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.4387.1.S1_at
Dr.4387.1.S1_at
Dr.4387.1.S1_at
Dr.1372.1.S1_at
Dr.1372.1.S1_at
Dr.1372.1.S1_at
Dr.4249.1.S1_at
Dr.4249.1.S1_at
Dr.4249.1.S1_at

Symbol
bty
zgc:112421
zgc:112421
zgc:112421
serpina1
NP_001017836.1
NP_001017836.1
NP_001017836.1
fgg

Description
bloodthirsty (bty), mRNA [Source:RefSeq_dna;Acc:NM_001020475]
hypothetical protein LOC554118 [Source:RefSeq_peptide;Acc:NP_001019585]
hypothetical protein LOC554118 [Source:RefSeq_peptide;Acc:NP_001019585]
hypothetical protein LOC554118 [Source:RefSeq_peptide;Acc:NP_001019585]
serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
[Source:RefSeq_peptide;Acc:NP_001013277]
hypothetical protein LOC550534 [Source:RefSeq_peptide;Acc:NP_001017836]
hypothetical protein LOC550534 [Source:RefSeq_peptide;Acc:NP_001017836]
hypothetical protein LOC550534 [Source:RefSeq_peptide;Acc:NP_001017836]
fibrinogen gamma polypeptide [Source:RefSeq_peptide;Acc:NP_998219]

igfbp1
igfbp1
igfbp1
igfbp1
igfbp1
igfbp1
igfbp1
igfbp1
igfbp1
igfbp1
igfbp1
igfbp1

insulin-like growth factor binding protein 1 [Source:RefSeq_peptide;Acc:NP_775390]
insulin-like growth factor binding protein 1 [Source:RefSeq_peptide;Acc:NP_775390]
insulin-like growth factor binding protein 1 [Source:RefSeq_peptide;Acc:NP_775390]
insulin-like growth factor binding protein 1 [Source:RefSeq_peptide;Acc:NP_775390]
insulin-like growth factor binding protein 1 [Source:RefSeq_peptide;Acc:NP_775390]
insulin-like growth factor binding protein 1 [Source:RefSeq_peptide;Acc:NP_775390]
insulin-like growth factor binding protein 1 [Source:RefSeq_peptide;Acc:NP_775390]
insulin-like growth factor binding protein 1 [Source:RefSeq_peptide;Acc:NP_775390]
insulin-like growth factor binding protein 1 [Source:RefSeq_peptide;Acc:NP_775390]
insulin-like growth factor binding protein 1 [Source:RefSeq_peptide;Acc:NP_775390]
insulin-like growth factor binding protein 1 [Source:RefSeq_peptide;Acc:NP_775390]
insulin-like growth factor binding protein 1 [Source:RefSeq_peptide;Acc:NP_775390]

rab5b
rab5b
rab5b
rab5b
vg3
tfa
tfa
tfa
tfa
tfa
tfa
tfa
tfa
tfa
tfa
NP_739573.1
NP_739573.1
NP_739573.1
NP_739573.1
NP_739573.1
NP_739573.1

RAB5B, member RAS oncogene family [Source:RefSeq_peptide;Acc:NP_998050]
RAB5B, member RAS oncogene family [Source:RefSeq_peptide;Acc:NP_998050]
RAB5B, member RAS oncogene family [Source:RefSeq_peptide;Acc:NP_998050]
RAB5B, member RAS oncogene family [Source:RefSeq_peptide;Acc:NP_998050]
Vitellogenin 3 (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q9DFT9]
transferrin-a [Source:RefSeq_peptide;Acc:NP_001015057]
transferrin-a [Source:RefSeq_peptide;Acc:NP_001015057]
transferrin-a [Source:RefSeq_peptide;Acc:NP_001015057]
transferrin-a [Source:RefSeq_peptide;Acc:NP_001015057]
transferrin-a [Source:RefSeq_peptide;Acc:NP_001015057]
transferrin-a [Source:RefSeq_peptide;Acc:NP_001015057]
transferrin-a [Source:RefSeq_peptide;Acc:NP_001015057]
transferrin-a [Source:RefSeq_peptide;Acc:NP_001015057]
transferrin-a [Source:RefSeq_peptide;Acc:NP_001015057]
transferrin-a [Source:RefSeq_peptide;Acc:NP_001015057]
vitellogenin 1 [Source:RefSeq_peptide;Acc:NP_739573]
vitellogenin 1 [Source:RefSeq_peptide;Acc:NP_739573]
vitellogenin 1 [Source:RefSeq_peptide;Acc:NP_739573]
vitellogenin 1 [Source:RefSeq_peptide;Acc:NP_739573]
vitellogenin 1 [Source:RefSeq_peptide;Acc:NP_739573]
vitellogenin 1 [Source:RefSeq_peptide;Acc:NP_739573]

krt4
krt4
krt4
krt18
krt18
krt18
lipf
lipf
lipf

keratin 4 [Source:RefSeq_peptide;Acc:NP_571584]
keratin 4 [Source:RefSeq_peptide;Acc:NP_571584]
keratin 4 [Source:RefSeq_peptide;Acc:NP_571584]
keratin 18 [Source:RefSeq_peptide;Acc:NP_848524]
keratin 18 [Source:RefSeq_peptide;Acc:NP_848524]
keratin 18 [Source:RefSeq_peptide;Acc:NP_848524]
lipase, gastric [Source:RefSeq_peptide;Acc:NP_998569]
lipase, gastric [Source:RefSeq_peptide;Acc:NP_998569]
lipase, gastric [Source:RefSeq_peptide;Acc:NP_998569]
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Start
-1542
-1875
-1475
-1422

End
-1537
-1870
-1470
-1417

Strand
-1
-1
-1
-1

Sequence
tgcgtg
cgcgtg
tgcgtg
agcgtg

-4808
-3248
-2763
-4258
-4836

-4803
-3243
-2758
-4253
-4831

-1
1
1
-1
1

agcgtg
agcgtg
agcgtg
ggcgtg
cgcgtg

-4912

-4907

-1

tgcgtg

-4071

-4066

-1

agcgtg

-4912

-4907

-1

tgcgtg

-4071

-4066

-1

agcgtg

-4912

-4907

-1

tgcgtg

-4071
-3978
-3265
-2732
-1510
-1468
-1419
-1375
-1229
-1076
-229
-220
-72
-3239
-401
-3537
-699
-3239
-401
-3042
-2041
-672
-4468
-1530
-3533
-3351
-2761
-2755
-4965
-3533
-3351
-2761
-2755
-4965
-3552
-2451
-1138
-3552
-2451
-1138
-3793
-3785
-3587
-3364
-2980
-2502
-1174
-2596
-4243
-4239
-4053
-3793
-3785
-3587
-3364
-2980
-2502
-1174
-2596
-4243
-4239
-4053
-1874
-1435
-9
-2408
-4641
-37
-1538
-1050
-858

-4066
-3973
-3260
-2727
-1505
-1463
-1414
-1370
-1224
-1071
-224
-215
-67
-3234
-396
-3532
-694
-3234
-396
-3037
-2036
-667
-4463
-1525
-3528
-3346
-2756
-2750
-4960
-3528
-3346
-2756
-2750
-4960
-3547
-2446
-1133
-3547
-2446
-1133
-3788
-3780
-3582
-3359
-2975
-2497
-1169
-2591
-4238
-4234
-4048
-3788
-3780
-3582
-3359
-2975
-2497
-1169
-2591
-4238
-4234
-4048
-1869
-1430
-4
-2403
-4636
-32
-1533
-1045
-853

-1
-1
-1
-1
1
-1
-1
1
1
-1
-1
-1
1
-1
1
-1
1
-1
1
-1
1
1
1
-1
1
1
-1
-1
-1
1
1
-1
-1
-1
1
-1
-1
1
-1
-1
1
1
-1
1
1
1
-1
1
-1
-1
-1
1
1
-1
1
1
1
-1
1
-1
-1
-1
1
-1
-1
1
-1
1
1
1
1

agcgtg
tgcgtg
tgcgtg
tgcgtg
cgcgtg
cgcgtg
cgcgtg
tgcgtg
cgcgtg
cgcgtg
agcgtg
agcgtg
agcgtg
tgcgtg
cgcgtg
tgcgtg
cgcgtg
tgcgtg
cgcgtg
tgcgtg
agcgtg
agcgtg
agcgtg
tgcgtg
tgcgtg
agcgtg
cgcgtg
tgcgtg
tgcgtg
tgcgtg
agcgtg
cgcgtg
tgcgtg
tgcgtg
cgcgtg
tgcgtg
tgcgtg
cgcgtg
tgcgtg
tgcgtg
tgcgtg
tgcgtg
tgcgtg
ggcgtg
agcgtg
tgcgtg
tgcgtg
tgcgtg
tgcgtg
tgcgtg
tgcgtg
tgcgtg
tgcgtg
tgcgtg
ggcgtg
agcgtg
tgcgtg
tgcgtg
tgcgtg
tgcgtg
tgcgtg
tgcgtg
tgcgtg
tgcgtg
tgcgtg
ggcgtg
cgcgtg
tgcgtg
cgcgtg
ggcgtg
agcgtg

Supplementary Table 2 (cont.). Location of putative AHREs
Gene ID
Transcript ID
Affy IDs
Dr.4249.1.S1_at
ENSDARG00000018529
ENSDART00000020541
ENSDARG00000018921
ENSDART00000023006
Dr.9450.1.A1_at
ENSDARG00000018921
ENSDART00000023006
Dr.9450.1.A1_at
ENSDARG00000018921
ENSDART00000023006
Dr.9450.1.A1_at
ENSDARG00000018921
ENSDART00000023006
Dr.9450.1.A1_at
Dr.18039.1.S1_at,Dr.11348.1.S1_x_at,Dr.11348.1.S1_at,Dr.18039.1.S1_at,Dr.
11348.1.S1_x_at,Dr.11348.1.S1_at,Dr.18039.1.S1_at,Dr.11348.1.S1_x_at,Dr.
ENSDARG00000019057
ENSDART00000003224
11348.1.S1_at
Dr.18039.1.S1_at,Dr.11348.1.S1_x_at,Dr.11348.1.S1_at,Dr.18039.1.S1_at,Dr.
11348.1.S1_x_at,Dr.11348.1.S1_at,Dr.18039.1.S1_at,Dr.11348.1.S1_x_at,Dr.
ENSDARG00000019057
ENSDART00000048630
11348.1.S1_at
Dr.18039.1.S1_at,Dr.11348.1.S1_x_at,Dr.11348.1.S1_at,Dr.18039.1.S1_at,Dr.
11348.1.S1_x_at,Dr.11348.1.S1_at,Dr.18039.1.S1_at,Dr.11348.1.S1_x_at,Dr.
ENSDARG00000019057
ENSDART00000050015
11348.1.S1_at
ENSDARG00000019302
ENSDART00000007649
Dr.25285.1.S1_at,Dr.11211.1.S1_at
ENSDARG00000019302
ENSDART00000007649
Dr.25285.1.S1_at,Dr.11211.1.S1_at
ENSDARG00000019302
ENSDART00000007649
Dr.25285.1.S1_at,Dr.11211.1.S1_at
ENSDARG00000019302
ENSDART00000007649
Dr.25285.1.S1_at,Dr.11211.1.S1_at
ENSDARG00000019469
ENSDART00000011211
Dr.24253.1.S1_at
ENSDARG00000019469
ENSDART00000011211
Dr.24253.1.S1_at
ENSDARG00000019469
ENSDART00000011211
Dr.24253.1.S1_at
ENSDARG00000019469
ENSDART00000011211
Dr.24253.1.S1_at
ENSDARG00000019469
ENSDART00000011211
Dr.24253.1.S1_at
ENSDARG00000019469
ENSDART00000011211
Dr.24253.1.S1_at
ENSDARG00000019469
ENSDART00000011211
Dr.24253.1.S1_at
ENSDARG00000019469
ENSDART00000011211
Dr.24253.1.S1_at
ENSDARG00000019469
ENSDART00000011211
Dr.24253.1.S1_at
ENSDARG00000019469
ENSDART00000011211
Dr.24253.1.S1_at
ENSDARG00000019469
ENSDART00000011211
Dr.24253.1.S1_at
ENSDARG00000019469
ENSDART00000011211
Dr.24253.1.S1_at
ENSDARG00000019469
ENSDART00000011211
Dr.24253.1.S1_at
ENSDARG00000019469
ENSDART00000011211
Dr.24253.1.S1_at
ENSDARG00000019469
ENSDART00000011211
Dr.24253.1.S1_at
ENSDARG00000019862
ENSDART00000009054
Dr.913.1.S1_at
ENSDARG00000019862
ENSDART00000009054
Dr.913.1.S1_at
ENSDARG00000019862
ENSDART00000009054
Dr.913.1.S1_at
ENSDARG00000020007
ENSDART00000042990
Dr.1377.1.A1_at,Dr.23532.1.A1_at,Dr.5521.1.S1_at
ENSDARG00000020007
ENSDART00000042990
Dr.1377.1.A1_at,Dr.23532.1.A1_at,Dr.5521.1.S1_at
ENSDARG00000020007
ENSDART00000042990
Dr.1377.1.A1_at,Dr.23532.1.A1_at,Dr.5521.1.S1_at
ENSDARG00000020007
ENSDART00000042990
Dr.1377.1.A1_at,Dr.23532.1.A1_at,Dr.5521.1.S1_at
ENSDARG00000020007
ENSDART00000042990
Dr.1377.1.A1_at,Dr.23532.1.A1_at,Dr.5521.1.S1_at
ENSDARG00000020007
ENSDART00000042990
Dr.1377.1.A1_at,Dr.23532.1.A1_at,Dr.5521.1.S1_at
ENSDARG00000020190
ENSDART00000003437
Dr.25086.1.A1_at
ENSDARG00000020190
ENSDART00000003437
Dr.25086.1.A1_at
ENSDARG00000020485
ENSDART00000011573
Dr.10314.1.S1_a_at
ENSDARG00000020485
ENSDART00000011573
Dr.10314.1.S1_a_at
ENSDARG00000020485
ENSDART00000011573
Dr.10314.1.S1_a_at
ENSDARG00000020485
ENSDART00000011573
Dr.10314.1.S1_a_at
ENSDARG00000020485
ENSDART00000011573
Dr.10314.1.S1_a_at
ENSDARG00000020893
ENSDART00000004693
Dr.17850.1.S1_at
ENSDARG00000020893
ENSDART00000004693
Dr.17850.1.S1_at
ENSDARG00000021443
ENSDART00000014168
Dr.24122.1.A1_at
ENSDARG00000021443
ENSDART00000014168
Dr.24122.1.A1_at
ENSDARG00000022295
ENSDART00000029465
Dr.15418.1.S1_at
ENSDARG00000022295
ENSDART00000029465
Dr.15418.1.S1_at
Dr.5562.1.S1_at

Symbol
lipf
NP_956912.1
NP_956912.1
NP_956912.1
NP_956912.1

Description
lipase, gastric [Source:RefSeq_peptide;Acc:NP_998569]
hypothetical protein LOC393590 [Source:RefSeq_peptide;Acc:NP_956912]
hypothetical protein LOC393590 [Source:RefSeq_peptide;Acc:NP_956912]
hypothetical protein LOC393590 [Source:RefSeq_peptide;Acc:NP_956912]
hypothetical protein LOC393590 [Source:RefSeq_peptide;Acc:NP_956912]

zgc:73223
zgc:73223
zgc:73223
zgc:73223
stk3
stk3
stk3
stk3
stk3
stk3
stk3
stk3
stk3
stk3
stk3
stk3
stk3
stk3
stk3
zgc:63909
zgc:63909
zgc:63909
col1a2
col1a2
col1a2
col1a2
col1a2
col1a2

hypothetical protein MGC73223 [Source:RefSeq_peptide;Acc:NP_957126]
hypothetical protein MGC73223 [Source:RefSeq_peptide;Acc:NP_957126]
hypothetical protein MGC73223 [Source:RefSeq_peptide;Acc:NP_957126]
hypothetical protein MGC73223 [Source:RefSeq_peptide;Acc:NP_957126]
serine/threonine kinase 3 (STE20 homolog, yeast) [Source:RefSeq_peptide;Acc:NP_955966]
serine/threonine kinase 3 (STE20 homolog, yeast) [Source:RefSeq_peptide;Acc:NP_955966]
serine/threonine kinase 3 (STE20 homolog, yeast) [Source:RefSeq_peptide;Acc:NP_955966]
serine/threonine kinase 3 (STE20 homolog, yeast) [Source:RefSeq_peptide;Acc:NP_955966]
serine/threonine kinase 3 (STE20 homolog, yeast) [Source:RefSeq_peptide;Acc:NP_955966]
serine/threonine kinase 3 (STE20 homolog, yeast) [Source:RefSeq_peptide;Acc:NP_955966]
serine/threonine kinase 3 (STE20 homolog, yeast) [Source:RefSeq_peptide;Acc:NP_955966]
serine/threonine kinase 3 (STE20 homolog, yeast) [Source:RefSeq_peptide;Acc:NP_955966]
serine/threonine kinase 3 (STE20 homolog, yeast) [Source:RefSeq_peptide;Acc:NP_955966]
serine/threonine kinase 3 (STE20 homolog, yeast) [Source:RefSeq_peptide;Acc:NP_955966]
serine/threonine kinase 3 (STE20 homolog, yeast) [Source:RefSeq_peptide;Acc:NP_955966]
serine/threonine kinase 3 (STE20 homolog, yeast) [Source:RefSeq_peptide;Acc:NP_955966]
serine/threonine kinase 3 (STE20 homolog, yeast) [Source:RefSeq_peptide;Acc:NP_955966]
serine/threonine kinase 3 (STE20 homolog, yeast) [Source:RefSeq_peptide;Acc:NP_955966]
serine/threonine kinase 3 (STE20 homolog, yeast) [Source:RefSeq_peptide;Acc:NP_955966]
tropomyosin 4 isoform 2 [Source:RefSeq_peptide;Acc:NP_998323]
tropomyosin 4 isoform 2 [Source:RefSeq_peptide;Acc:NP_998323]
tropomyosin 4 isoform 2 [Source:RefSeq_peptide;Acc:NP_998323]
collagen, type I, alpha 2 [Source:RefSeq_peptide;Acc:NP_892013]
collagen, type I, alpha 2 [Source:RefSeq_peptide;Acc:NP_892013]
collagen, type I, alpha 2 [Source:RefSeq_peptide;Acc:NP_892013]
collagen, type I, alpha 2 [Source:RefSeq_peptide;Acc:NP_892013]
collagen, type I, alpha 2 [Source:RefSeq_peptide;Acc:NP_892013]
collagen, type I, alpha 2 [Source:RefSeq_peptide;Acc:NP_892013]

zgc:56592
zgc:56592
NP_955943.1
NP_955943.1
wu:fc23f06
wu:fc23f06

zgc:56592 [Source:RefSeq_peptide;Acc:NP_998573]
zgc:56592 [Source:RefSeq_peptide;Acc:NP_998573]
CCCH zinc finger protein C3H-2 [Source:RefSeq_peptide;Acc:NP_955943]
CCCH zinc finger protein C3H-2 [Source:RefSeq_peptide;Acc:NP_955943]
transcription factor 2 like protein [Source:RefSeq_peptide;Acc:NP_919353]
transcription factor 2 like protein [Source:RefSeq_peptide;Acc:NP_919353]
Novel protein similar to vertebrate apolipoprotein B (Including Ag(X) antigen) (APOB).
[Source:Uniprot/SPTREMBL;Acc:Q5TZ29]
Novel protein similar to vertebrate apolipoprotein B (Including Ag(X) antigen) (APOB).
[Source:Uniprot/SPTREMBL;Acc:Q5TZ29]
hypothetical protein LOC406828 [Source:RefSeq_peptide;Acc:NP_998672]
hypothetical protein LOC406828 [Source:RefSeq_peptide;Acc:NP_998672]
hypothetical protein LOC406828 [Source:RefSeq_peptide;Acc:NP_998672]
hypothetical protein LOC406828 [Source:RefSeq_peptide;Acc:NP_998672]
hypothetical protein LOC406828 [Source:RefSeq_peptide;Acc:NP_998672]
hypothetical protein LOC406828 [Source:RefSeq_peptide;Acc:NP_998672]
hypothetical protein LOC406828 [Source:RefSeq_peptide;Acc:NP_998672]
hypothetical protein LOC406828 [Source:RefSeq_peptide;Acc:NP_998672]
Novel protein (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q7ZZ84]
Novel protein (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q7ZZ84]
Hypothetical protein (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q6NWE8]
Hypothetical protein (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q6NWE8]
Hypothetical protein (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q6NWE8]
Hypothetical protein (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q6NWE8]
Hypothetical protein (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q6NWE8]

0
-1589
-1563
-1559
25

End
5
-1584
-1558
-1554
30

Strand
-1
1
1
1
-1

Sequence
agcgtg
tgcgtg
tgcgtg
tgcgtg
cgcgtg

-3377

-3372

-1

tgcgtg

-3377

-3372

-1

tgcgtg

-3377
-3810
-2001
-348
-4447
-3963
-2701
-4704
-1423
-1407
-1232
-1189
-1139
-1084
-1056
-1016
-623
-159
-4337
-4922
-3027
-2322
-1865
-3691
-2964
-2808
-909
-234
6
-2407
-4030
-3871
-3757
-4843
-1953
-1091
-1911
-4527
-3319
-71
-4671
-152

-3372
-3805
-1996
-343
-4442
-3958
-2696
-4699
-1418
-1402
-1227
-1184
-1134
-1079
-1051
-1011
-618
-154
-4332
-4917
-3022
-2317
-1860
-3686
-2959
-2803
-904
-229
11
-2402
-4025
-3866
-3752
-4838
-1948
-1086
-1906
-4522
-3314
-66
-4666
-147

-1
1
1
-1
1
-1
-1
-1
-1
1
-1
-1
-1
-1
-1
-1
1
-1
-1
-1
1
1
1
-1
1
1
-1
-1
-1
-1
1
-1
1
-1
1
1
1
-1
1
1
1
1

tgcgtg
agcgtg
tgcgtg
tgcgtg
tgcgtg
agcgtg
ggcgtg
agcgtg
agcgtg
ggcgtg
tgcgtg
tgcgtg
tgcgtg
cgcgtg
cgcgtg
cgcgtg
cgcgtg
tgcgtg
agcgtg
agcgtg
tgcgtg
agcgtg
agcgtg
cgcgtg
cgcgtg
tgcgtg
tgcgtg
cgcgtg
tgcgtg
agcgtg
ggcgtg
tgcgtg
agcgtg
ggcgtg
tgcgtg
ggcgtg
ggcgtg
cgcgtg
cgcgtg
ggcgtg
ggcgtg
agcgtg

-2584

-2579

-1

tgcgtg

-780
-3618
-3588
-2611
-2515
-4711
-1933
-1521
-162
-2931
-2240
-1626
-1593
-1573
-1569
-1565

-775
-3613
-3583
-2606
-2510
-4706
-1928
-1516
-157
-2926
-2235
-1621
-1588
-1568
-1564
-1560

1
1
-1
-1
-1
1
1
1
-1
1
-1
1
-1
-1
-1
-1

tgcgtg
agcgtg
agcgtg
agcgtg
tgcgtg
tgcgtg
tgcgtg
cgcgtg
tgcgtg
tgcgtg
tgcgtg
agcgtg
tgcgtg
tgcgtg
tgcgtg
tgcgtg

ENSDARG00000022767

ENSDART00000028709

ENSDARG00000022767
ENSDARG00000023820
ENSDARG00000023820
ENSDARG00000023820
ENSDARG00000023820
ENSDARG00000023820
ENSDARG00000023820
ENSDARG00000023820
ENSDARG00000023820
ENSDARG00000024017
ENSDARG00000024017
ENSDARG00000024480
ENSDARG00000024480
ENSDARG00000024480
ENSDARG00000024480
ENSDARG00000024480

ENSDART00000028709
ENSDART00000038657
ENSDART00000038657
ENSDART00000038657
ENSDART00000038657
ENSDART00000038657
ENSDART00000038657
ENSDART00000038657
ENSDART00000038657
ENSDART00000033943
ENSDART00000033943
ENSDART00000034117
ENSDART00000034117
ENSDART00000034117
ENSDART00000034117
ENSDART00000034117

ENSDARG00000024892

ENSDART00000033228

.2.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.1.A1_at,Dr.3025.3.S1_at
Dr.3025.2.S1_at,Dr.3025.3.S1_at,Dr.25331.1.S1_at,Dr.25379.1.S1_at,Dr.3025

-3817

-3812

-1

agcgtg

ENSDARG00000024892

ENSDART00000033228

.2.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.1.A1_at,Dr.3025.3.S1_at
Dr.3025.2.S1_at,Dr.3025.3.S1_at,Dr.25331.1.S1_at,Dr.25379.1.S1_at,Dr.3025

-3698

-3693

-1

agcgtg

ENSDARG00000024892

ENSDART00000033228

.2.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.1.A1_at,Dr.3025.3.S1_at
Dr.3025.2.S1_at,Dr.3025.3.S1_at,Dr.25331.1.S1_at,Dr.25379.1.S1_at,Dr.3025

-2476

-2471

-1

cgcgtg

ENSDARG00000024892

ENSDART00000033228

.2.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.1.A1_at,Dr.3025.3.S1_at
Dr.3025.2.S1_at,Dr.3025.3.S1_at,Dr.25331.1.S1_at,Dr.25379.1.S1_at,Dr.3025

-4576

-4571

1

ggcgtg

ENSDARG00000024892

ENSDART00000033228

.2.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.1.A1_at,Dr.3025.3.S1_at
Dr.3025.2.S1_at,Dr.3025.3.S1_at,Dr.25331.1.S1_at,Dr.25379.1.S1_at,Dr.3025

-4314

-4309

1

agcgtg

ENSDARG00000024892

ENSDART00000033228

.2.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.1.A1_at,Dr.3025.3.S1_at

-4209

-4204

1

tgcgtg

Dr.5562.1.S1_at
Dr.8390.1.S1_at
Dr.8390.1.S1_at
Dr.8390.1.S1_at
Dr.8390.1.S1_at
Dr.8390.1.S1_at
Dr.8390.1.S1_at
Dr.8390.1.S1_at
Dr.8390.1.S1_at
Dr.16681.1.A1_at
Dr.16681.1.A1_at
Dr.3512.1.A1_at
Dr.3512.1.A1_at
Dr.3512.1.A1_at
Dr.3512.1.A1_at
Dr.3512.1.A1_at
Dr.3025.2.S1_at,Dr.3025.3.S1_at,Dr.25331.1.S1_at,Dr.25379.1.S1_at,Dr.3025

Q5BLC2_BRARE

Start

Q5BLC2_BRARE
zgc:55420
zgc:55420
zgc:55420
zgc:55420
zgc:55420
zgc:55420
zgc:55420
zgc:55420
mamdc1
mamdc1
Q6NWE8_BRARE
Q6NWE8_BRARE
Q6NWE8_BRARE
Q6NWE8_BRARE
Q6NWE8_BRARE
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Supplementary Table 2 (cont.). Location of putative AHREs
Gene ID
Transcript ID
Symbol
Affy IDs
Dr.3025.2.S1_at,Dr.3025.3.S1_at,Dr.25331.1.S1_at,Dr.25379.1.S1_at,Dr.3025

Description

Start

End

Strand

Sequence

ENSDARG00000024892

ENSDART00000061058

.2.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.1.A1_at,Dr.3025.3.S1_at
Dr.3025.2.S1_at,Dr.3025.3.S1_at,Dr.25331.1.S1_at,Dr.25379.1.S1_at,Dr.3025

-1600

-1595

-1

tgcgtg

ENSDARG00000024892

ENSDART00000061058

.2.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.1.A1_at,Dr.3025.3.S1_at
Dr.3025.2.S1_at,Dr.3025.3.S1_at,Dr.25331.1.S1_at,Dr.25379.1.S1_at,Dr.3025

-4093

-4088

-1

ggcgtg

ENSDARG00000024892

ENSDART00000033228

.2.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.1.A1_at,Dr.3025.3.S1_at
Dr.3025.2.S1_at,Dr.3025.3.S1_at,Dr.25331.1.S1_at,Dr.25379.1.S1_at,Dr.3025

-3817

-3812

-1

agcgtg

ENSDARG00000024892

ENSDART00000033228

.2.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.1.A1_at,Dr.3025.3.S1_at
Dr.3025.2.S1_at,Dr.3025.3.S1_at,Dr.25331.1.S1_at,Dr.25379.1.S1_at,Dr.3025

-3698

-3693

-1

agcgtg

ENSDARG00000024892

ENSDART00000033228

.2.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.1.A1_at,Dr.3025.3.S1_at
Dr.3025.2.S1_at,Dr.3025.3.S1_at,Dr.25331.1.S1_at,Dr.25379.1.S1_at,Dr.3025

-2476

-2471

-1

cgcgtg

ENSDARG00000024892

ENSDART00000033228

.2.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.1.A1_at,Dr.3025.3.S1_at
Dr.3025.2.S1_at,Dr.3025.3.S1_at,Dr.25331.1.S1_at,Dr.25379.1.S1_at,Dr.3025

-4576

-4571

1

ggcgtg

ENSDARG00000024892

ENSDART00000033228

.2.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.1.A1_at,Dr.3025.3.S1_at
Dr.3025.2.S1_at,Dr.3025.3.S1_at,Dr.25331.1.S1_at,Dr.25379.1.S1_at,Dr.3025

-4314

-4309

1

agcgtg

ENSDARG00000024892

ENSDART00000033228

.2.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.1.A1_at,Dr.3025.3.S1_at
Dr.3025.2.S1_at,Dr.3025.3.S1_at,Dr.25331.1.S1_at,Dr.25379.1.S1_at,Dr.3025

-4209

-4204

1

tgcgtg

ENSDARG00000024892

ENSDART00000061058

.2.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.1.A1_at,Dr.3025.3.S1_at
Dr.3025.2.S1_at,Dr.3025.3.S1_at,Dr.25331.1.S1_at,Dr.25379.1.S1_at,Dr.3025

-1600

-1595

-1

tgcgtg

ENSDARG00000024892
ENSDARG00000025147
ENSDARG00000025147
ENSDARG00000025147
ENSDARG00000025147
ENSDARG00000025147
ENSDARG00000025147
ENSDARG00000025147
ENSDARG00000025147
ENSDARG00000025254

ENSDART00000061058
ENSDART00000031047
ENSDART00000031047
ENSDART00000031047
ENSDART00000031047
ENSDART00000031047
ENSDART00000031047
ENSDART00000031047
ENSDART00000031047
ENSDART00000037694

-4093
-3469
-3453
-3028
-3000
-2960
-2663
-2645
-2555
-2330

-4088
-3464
-3448
-3023
-2995
-2955
-2658
-2640
-2550
-2325

-1
-1
1
-1
-1
-1
1
1
1
1

ggcgtg
agcgtg
ggcgtg
cgcgtg
cgcgtg
cgcgtg
tgcgtg
tgcgtg
cgcgtg
agcgtg

ENSDARG00000025400

ENSDART00000044869

-2534

-2529

1

tgcgtg

ENSDARG00000025400

ENSDART00000044869

ENSDARG00000025400

ENSDART00000046418

.2.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.1.A1_at,Dr.3025.3.S1_at
Dr.3459.1.S1_at
Dr.3459.1.S1_at
Dr.3459.1.S1_at
Dr.3459.1.S1_at
Dr.3459.1.S1_at
Dr.3459.1.S1_at
Dr.3459.1.S1_at
Dr.3459.1.S1_at
Dr.1201.1.S1_at
Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25
009.4.A1_at
Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25
009.4.A1_at
Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25
009.4.A1_at
Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25
009.4.A1_at
Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25
009.4.A1_at
Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25
009.4.A1_at
Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25
009.4.A1_at
Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25
009.4.A1_at
Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25
009.4.A1_at
Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25
009.4.A1_at
Dr.9478.1.S1_at
Dr.9478.1.S1_at
Dr.9478.1.S1_at
Dr.9478.1.S1_at
Dr.9478.1.S1_at
Dr.9478.1.S1_at
Dr.9478.1.S1_at
Dr.9478.1.S1_at
Dr.9478.1.S1_at
Dr.9478.1.S1_at
Dr.9478.1.S1_at
Dr.9478.1.S1_at
Dr.9478.1.S1_at
Dr.9478.1.S1_at
Dr.9478.1.S1_at
Dr.9478.1.S1_at
Dr.12833.1.A1_at
Dr.12833.1.A1_at
Dr.12833.1.A1_at
Dr.12833.1.A1_at
Dr.12833.1.A1_at
Dr.26139.1.A1_at,Dr.26139.1.A1_x_at
Dr.26139.1.A1_at,Dr.26139.1.A1_x_at
Dr.26139.1.A1_at,Dr.26139.1.A1_x_at
Dr.26139.1.A1_at,Dr.26139.1.A1_x_at
Dr.26139.1.A1_at,Dr.26139.1.A1_x_at
Dr.26139.1.A1_at,Dr.26139.1.A1_x_at
Dr.26139.1.A1_at,Dr.26139.1.A1_x_at
Dr.26139.1.A1_at,Dr.26139.1.A1_x_at
Dr.26139.1.A1_at,Dr.26139.1.A1_x_at
Dr.26139.1.A1_at,Dr.26139.1.A1_x_at
Dr.59.1.S1_at
Dr.59.1.S1_at

ENSDARG00000025400

ENSDART00000046418

ENSDARG00000025400

ENSDART00000061150

ENSDARG00000025400

ENSDART00000061150

ENSDARG00000025400

ENSDART00000061161

ENSDARG00000025400

ENSDART00000061161

ENSDARG00000025400

ENSDART00000061165

ENSDARG00000025400
ENSDARG00000026039
ENSDARG00000026039
ENSDARG00000026039
ENSDARG00000026039
ENSDARG00000026039
ENSDARG00000026039
ENSDARG00000026039
ENSDARG00000026039
ENSDARG00000026039
ENSDARG00000026039
ENSDARG00000026039
ENSDARG00000026039
ENSDARG00000026039
ENSDARG00000026039
ENSDARG00000026039
ENSDARG00000026039
ENSDARG00000026090
ENSDARG00000026090
ENSDARG00000026090
ENSDARG00000026090
ENSDARG00000026090
ENSDARG00000026680
ENSDARG00000026680
ENSDARG00000026680
ENSDARG00000026680
ENSDARG00000026680
ENSDARG00000026680
ENSDARG00000026680
ENSDARG00000026680
ENSDARG00000026680
ENSDARG00000026680
ENSDARG00000026726
ENSDARG00000026726

ENSDART00000061165
ENSDART00000038200
ENSDART00000038200
ENSDART00000038200
ENSDART00000038200
ENSDART00000038200
ENSDART00000038200
ENSDART00000038200
ENSDART00000038200
ENSDART00000038200
ENSDART00000038200
ENSDART00000038200
ENSDART00000038200
ENSDART00000038200
ENSDART00000038200
ENSDART00000038200
ENSDART00000038200
ENSDART00000035302
ENSDART00000035302
ENSDART00000035302
ENSDART00000035302
ENSDART00000035302
ENSDART00000036600
ENSDART00000036600
ENSDART00000036600
ENSDART00000036600
ENSDART00000036600
ENSDART00000036600
ENSDART00000036600
ENSDART00000036600
ENSDART00000036600
ENSDART00000036600
ENSDART00000031665
ENSDART00000031665

cd163
cd163
cd163
cd163
cd163
cd163
cd163
cd163
zgc:56142

cyp1a
cyp1a
cyp1a
cyp1a
cyp1a
cyp1a
cyp1a
cyp1a
cyp1a
cyp1a
cyp1a
cyp1a
cyp1a
cyp1a
cyp1a
cyp1a
zgc:64213
zgc:64213
zgc:64213
zgc:64213
zgc:64213
slc25a14
slc25a14
slc25a14
slc25a14
slc25a14
slc25a14
slc25a14
slc25a14
slc25a14
slc25a14
anxa1a
anxa1a

Cd63 antigen [Source:RefSeq_peptide;Acc:NP_955837]
Cd63 antigen [Source:RefSeq_peptide;Acc:NP_955837]
Cd63 antigen [Source:RefSeq_peptide;Acc:NP_955837]
Cd63 antigen [Source:RefSeq_peptide;Acc:NP_955837]
Cd63 antigen [Source:RefSeq_peptide;Acc:NP_955837]
Cd63 antigen [Source:RefSeq_peptide;Acc:NP_955837]
Cd63 antigen [Source:RefSeq_peptide;Acc:NP_955837]
Cd63 antigen [Source:RefSeq_peptide;Acc:NP_955837]
hypothetical protein LOC406276 [Source:RefSeq_peptide;Acc:NP_998168]

cytochrome P450, family 1, subfamily A [Source:RefSeq_peptide;Acc:NP_571954]
cytochrome P450, family 1, subfamily A [Source:RefSeq_peptide;Acc:NP_571954]
cytochrome P450, family 1, subfamily A [Source:RefSeq_peptide;Acc:NP_571954]
cytochrome P450, family 1, subfamily A [Source:RefSeq_peptide;Acc:NP_571954]
cytochrome P450, family 1, subfamily A [Source:RefSeq_peptide;Acc:NP_571954]
cytochrome P450, family 1, subfamily A [Source:RefSeq_peptide;Acc:NP_571954]
cytochrome P450, family 1, subfamily A [Source:RefSeq_peptide;Acc:NP_571954]
cytochrome P450, family 1, subfamily A [Source:RefSeq_peptide;Acc:NP_571954]
cytochrome P450, family 1, subfamily A [Source:RefSeq_peptide;Acc:NP_571954]
cytochrome P450, family 1, subfamily A [Source:RefSeq_peptide;Acc:NP_571954]
cytochrome P450, family 1, subfamily A [Source:RefSeq_peptide;Acc:NP_571954]
cytochrome P450, family 1, subfamily A [Source:RefSeq_peptide;Acc:NP_571954]
cytochrome P450, family 1, subfamily A [Source:RefSeq_peptide;Acc:NP_571954]
cytochrome P450, family 1, subfamily A [Source:RefSeq_peptide;Acc:NP_571954]
cytochrome P450, family 1, subfamily A [Source:RefSeq_peptide;Acc:NP_571954]
cytochrome P450, family 1, subfamily A [Source:RefSeq_peptide;Acc:NP_571954]
hypothetical protein LOC393393 [Source:RefSeq_peptide;Acc:NP_956715]
hypothetical protein LOC393393 [Source:RefSeq_peptide;Acc:NP_956715]
hypothetical protein LOC393393 [Source:RefSeq_peptide;Acc:NP_956715]
hypothetical protein LOC393393 [Source:RefSeq_peptide;Acc:NP_956715]
hypothetical protein LOC393393 [Source:RefSeq_peptide;Acc:NP_956715]
solute carrier family 25 (mitochondrial carrier, brain), member 14 [Source:RefSeq_peptide;Acc:NP_956458]
solute carrier family 25 (mitochondrial carrier, brain), member 14 [Source:RefSeq_peptide;Acc:NP_956458]
solute carrier family 25 (mitochondrial carrier, brain), member 14 [Source:RefSeq_peptide;Acc:NP_956458]
solute carrier family 25 (mitochondrial carrier, brain), member 14 [Source:RefSeq_peptide;Acc:NP_956458]
solute carrier family 25 (mitochondrial carrier, brain), member 14 [Source:RefSeq_peptide;Acc:NP_956458]
solute carrier family 25 (mitochondrial carrier, brain), member 14 [Source:RefSeq_peptide;Acc:NP_956458]
solute carrier family 25 (mitochondrial carrier, brain), member 14 [Source:RefSeq_peptide;Acc:NP_956458]
solute carrier family 25 (mitochondrial carrier, brain), member 14 [Source:RefSeq_peptide;Acc:NP_956458]
solute carrier family 25 (mitochondrial carrier, brain), member 14 [Source:RefSeq_peptide;Acc:NP_956458]
solute carrier family 25 (mitochondrial carrier, brain), member 14 [Source:RefSeq_peptide;Acc:NP_956458]
annexin A1a [Source:RefSeq_peptide;Acc:NP_861423]
annexin A1a [Source:RefSeq_peptide;Acc:NP_861423]
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-652

-647

1

tgcgtg

-2534

-2529

1

tgcgtg

-652

-647

1

tgcgtg

-2633

-2628

1

tgcgtg

-751

-746

1

tgcgtg

-2534

-2529

1

tgcgtg

-652

-647

1

tgcgtg

-2534

-2529

1

tgcgtg

-652
-3607
-3509
-2574
-2532
-2503
-2383
-2367
-2270
-2238
-2201
-4632
-461
-4546
-4538
-364
-222
-3919
-4467
-4463
-4459
-4154
-3320
-3147
-1685
-917
-401
-3320
-3147
-1685
-917
-401
-117
-4436

-647
-3602
-3504
-2569
-2527
-2498
-2378
-2362
-2265
-2233
-2196
-4627
-456
-4541
-4533
-359
-217
-3914
-4462
-4458
-4454
-4149
-3315
-3142
-1680
-912
-396
-3315
-3142
-1680
-912
-396
-112
-4431

1
1
1
-1
-1
1
-1
-1
-1
-1
1
1
-1
1
1
-1
1
-1
1
1
1
1
1
-1
1
-1
1
1
-1
1
-1
1
1
-1

tgcgtg
ggcgtg
tgcgtg
tgcgtg
cgcgtg
agcgtg
agcgtg
cgcgtg
tgcgtg
cgcgtg
cgcgtg
cgcgtg
tgcgtg
tgcgtg
tgcgtg
ggcgtg
tgcgtg
tgcgtg
cgcgtg
tgcgtg
tgcgtg
cgcgtg
ggcgtg
agcgtg
agcgtg
tgcgtg
tgcgtg
ggcgtg
agcgtg
agcgtg
tgcgtg
tgcgtg
cgcgtg
agcgtg

Supplementary Table 2 (cont.). Location of putative AHREs
Gene ID
Transcript ID
Affy IDs
Dr.1192.1.S1_at,Dr.1192.1.S1_a_at
ENSDARG00000027088
ENSDART00000039267
ENSDARG00000027088
ENSDART00000039267
Dr.1192.1.S1_at,Dr.1192.1.S1_a_at
ENSDARG00000027088
ENSDART00000039267
Dr.1192.1.S1_at,Dr.1192.1.S1_a_at
ENSDARG00000027088
ENSDART00000039267
Dr.1192.1.S1_at,Dr.1192.1.S1_a_at
ENSDARG00000027088
ENSDART00000039267
Dr.1192.1.S1_at,Dr.1192.1.S1_a_at
ENSDARG00000027088
ENSDART00000039267
Dr.1192.1.S1_at,Dr.1192.1.S1_a_at
ENSDARG00000027669
ENSDART00000035274
Dr.1991.1.A1_s_at
ENSDARG00000027669
ENSDART00000035274
Dr.1991.1.A1_s_at
Dr.25593.2.A1_at,Dr.25593.1.S1_at,Dr.4412.12.A1_at,Dr.25593.2.A1_at,Dr.25

Symbol
wu:fb11h03
wu:fb11h03
wu:fb11h03
wu:fb11h03
wu:fb11h03
wu:fb11h03
zgc:66417
zgc:66417

Description
prostaglandin D2 synthase [Source:RefSeq_peptide;Acc:NP_998799]
prostaglandin D2 synthase [Source:RefSeq_peptide;Acc:NP_998799]
prostaglandin D2 synthase [Source:RefSeq_peptide;Acc:NP_998799]
prostaglandin D2 synthase [Source:RefSeq_peptide;Acc:NP_998799]
prostaglandin D2 synthase [Source:RefSeq_peptide;Acc:NP_998799]
prostaglandin D2 synthase [Source:RefSeq_peptide;Acc:NP_998799]
hypothetical protein LOC387303 [Source:RefSeq_peptide;Acc:NP_956419]
hypothetical protein LOC387303 [Source:RefSeq_peptide;Acc:NP_956419]

Start
-4658
-166
-136
-4658
-166
-136
-2874
-129

End
-4653
-161
-131
-4653
-161
-131
-2869
-124

Strand
1
-1
1
1
-1
1
1
-1

Sequence
tgcgtg
tgcgtg
tgcgtg
tgcgtg
tgcgtg
tgcgtg
tgcgtg
ggcgtg

ENSDARG00000027924

ENSDART00000024900

593.1.S1_at,Dr.4412.12.A1_at,Dr.25527.1.A1_x_at,Dr.25527.1.A1_at
Dr.25593.2.A1_at,Dr.25593.1.S1_at,Dr.4412.12.A1_at,Dr.25593.2.A1_at,Dr.25

-3372

-3367

-1

agcgtg

ENSDARG00000027924

ENSDART00000024900

593.1.S1_at,Dr.4412.12.A1_at,Dr.25527.1.A1_x_at,Dr.25527.1.A1_at
Dr.25593.2.A1_at,Dr.25593.1.S1_at,Dr.4412.12.A1_at,Dr.25593.2.A1_at,Dr.25

-2691

-2686

-1

agcgtg

ENSDARG00000027924

ENSDART00000024900

593.1.S1_at,Dr.4412.12.A1_at,Dr.25527.1.A1_x_at,Dr.25527.1.A1_at
Dr.25593.2.A1_at,Dr.25593.1.S1_at,Dr.4412.12.A1_at,Dr.25593.2.A1_at,Dr.25

-1910

-1905

1

tgcgtg

ENSDARG00000027924

ENSDART00000024900

593.1.S1_at,Dr.4412.12.A1_at,Dr.25527.1.A1_x_at,Dr.25527.1.A1_at
Dr.25593.2.A1_at,Dr.25593.1.S1_at,Dr.4412.12.A1_at,Dr.25593.2.A1_at,Dr.25

-4427

-4422

1

cgcgtg

ENSDARG00000027924

ENSDART00000047994

593.1.S1_at,Dr.4412.12.A1_at,Dr.25527.1.A1_x_at,Dr.25527.1.A1_at
Dr.25593.2.A1_at,Dr.25593.1.S1_at,Dr.4412.12.A1_at,Dr.25593.2.A1_at,Dr.25

-4195

-4190

1

tgcgtg

ENSDARG00000027924

ENSDART00000024900

593.1.S1_at,Dr.4412.12.A1_at,Dr.25527.1.A1_x_at,Dr.25527.1.A1_at
Dr.25593.2.A1_at,Dr.25593.1.S1_at,Dr.4412.12.A1_at,Dr.25593.2.A1_at,Dr.25

-3372

-3367

-1

agcgtg

ENSDARG00000027924

ENSDART00000024900

593.1.S1_at,Dr.4412.12.A1_at,Dr.25527.1.A1_x_at,Dr.25527.1.A1_at
Dr.25593.2.A1_at,Dr.25593.1.S1_at,Dr.4412.12.A1_at,Dr.25593.2.A1_at,Dr.25

-2691

-2686

-1

agcgtg

ENSDARG00000027924

ENSDART00000024900

593.1.S1_at,Dr.4412.12.A1_at,Dr.25527.1.A1_x_at,Dr.25527.1.A1_at
Dr.25593.2.A1_at,Dr.25593.1.S1_at,Dr.4412.12.A1_at,Dr.25593.2.A1_at,Dr.25

-1910

-1905

1

tgcgtg

ENSDARG00000027924

ENSDART00000024900

593.1.S1_at,Dr.4412.12.A1_at,Dr.25527.1.A1_x_at,Dr.25527.1.A1_at
Dr.25593.2.A1_at,Dr.25593.1.S1_at,Dr.4412.12.A1_at,Dr.25593.2.A1_at,Dr.25

-4427

-4422

1

cgcgtg

ENSDARG00000027924

ENSDART00000047994

593.1.S1_at,Dr.4412.12.A1_at,Dr.25527.1.A1_x_at,Dr.25527.1.A1_at
Dr.25593.2.A1_at,Dr.25593.1.S1_at,Dr.4412.12.A1_at,Dr.25593.2.A1_at,Dr.25

-4195

-4190

1

tgcgtg

ENSDARG00000027924

ENSDART00000024900

593.1.S1_at,Dr.4412.12.A1_at,Dr.25527.1.A1_x_at,Dr.25527.1.A1_at
Dr.25593.2.A1_at,Dr.25593.1.S1_at,Dr.4412.12.A1_at,Dr.25593.2.A1_at,Dr.25

-3372

-3367

-1

agcgtg

ENSDARG00000027924

ENSDART00000024900

593.1.S1_at,Dr.4412.12.A1_at,Dr.25527.1.A1_x_at,Dr.25527.1.A1_at
Dr.25593.2.A1_at,Dr.25593.1.S1_at,Dr.4412.12.A1_at,Dr.25593.2.A1_at,Dr.25

-2691

-2686

-1

agcgtg

ENSDARG00000027924

ENSDART00000024900

593.1.S1_at,Dr.4412.12.A1_at,Dr.25527.1.A1_x_at,Dr.25527.1.A1_at
Dr.25593.2.A1_at,Dr.25593.1.S1_at,Dr.4412.12.A1_at,Dr.25593.2.A1_at,Dr.25

-1910

-1905

1

tgcgtg

ENSDARG00000027924

ENSDART00000024900

593.1.S1_at,Dr.4412.12.A1_at,Dr.25527.1.A1_x_at,Dr.25527.1.A1_at
Dr.25593.2.A1_at,Dr.25593.1.S1_at,Dr.4412.12.A1_at,Dr.25593.2.A1_at,Dr.25

-4427

-4422

1

cgcgtg

ENSDARG00000027924
ENSDARG00000028618
ENSDARG00000028618
ENSDARG00000028784
ENSDARG00000029086
ENSDARG00000030236
ENSDARG00000030236
ENSDARG00000030662
ENSDARG00000030662
ENSDARG00000030662
ENSDARG00000030662
ENSDARG00000031664
ENSDARG00000031664
ENSDARG00000031664
ENSDARG00000031854
ENSDARG00000031854
ENSDARG00000031854
ENSDARG00000031854
ENSDARG00000031854
ENSDARG00000031854
ENSDARG00000033770
ENSDARG00000033770
ENSDARG00000033770
ENSDARG00000033770
ENSDARG00000033770
ENSDARG00000033770
ENSDARG00000033770
ENSDARG00000033770
ENSDARG00000033949
ENSDARG00000033949
ENSDARG00000034351
ENSDARG00000035160
ENSDARG00000035666
ENSDARG00000035666
ENSDARG00000035666
ENSDARG00000035666
ENSDARG00000035743
ENSDARG00000036082
ENSDARG00000036082
ENSDARG00000036082

ENSDART00000047994
ENSDART00000028260
ENSDART00000028260
ENSDART00000044410
ENSDART00000041921
ENSDART00000011928
ENSDART00000011928
ENSDART00000048550
ENSDART00000048550
ENSDART00000048550
ENSDART00000048550
ENSDART00000049339
ENSDART00000049339
ENSDART00000049339
ENSDART00000043418
ENSDART00000043418
ENSDART00000043418
ENSDART00000050805
ENSDART00000050805
ENSDART00000050805
ENSDART00000011961
ENSDART00000011961
ENSDART00000011961
ENSDART00000011961
ENSDART00000011961
ENSDART00000011961
ENSDART00000011961
ENSDART00000011961
ENSDART00000045135
ENSDART00000045135
ENSDART00000043771
ENSDART00000050933
ENSDART00000051733
ENSDART00000051733
ENSDART00000051733
ENSDART00000051733
ENSDART00000051853
ENSDART00000052385
ENSDART00000052385
ENSDART00000052385

593.1.S1_at,Dr.4412.12.A1_at,Dr.25527.1.A1_x_at,Dr.25527.1.A1_at
Dr.890.1.S1_at
Dr.890.1.S1_at
Dr.12714.1.A1_at
Dr.1282.1.S1_at
Dr.1368.7.S1_at
Dr.1368.7.S1_at
Dr.9682.1.A1_at
Dr.9682.1.A1_at
Dr.9682.1.A1_at
Dr.9682.1.A1_at
Dr.8215.1.A1_at
Dr.8215.1.A1_at
Dr.8215.1.A1_at
Dr.7688.1.A1_at,Dr.7688.1.A1_at
Dr.7688.1.A1_at,Dr.7688.1.A1_at
Dr.7688.1.A1_at,Dr.7688.1.A1_at
Dr.7688.1.A1_at,Dr.7688.1.A1_at
Dr.7688.1.A1_at,Dr.7688.1.A1_at
Dr.7688.1.A1_at,Dr.7688.1.A1_at
Dr.25009.6.A1_a_at
Dr.25009.6.A1_a_at
Dr.25009.6.A1_a_at
Dr.25009.6.A1_a_at
Dr.25009.6.A1_a_at
Dr.25009.6.A1_a_at
Dr.25009.6.A1_a_at
Dr.25009.6.A1_a_at
Dr.18466.1.A1_at
Dr.18466.1.A1_at
Dr.2363.1.S1_at
Dr.13775.1.S1_at
Dr.4797.1.S1_at
Dr.4797.1.S1_at
Dr.4797.1.S1_at
Dr.4797.1.S1_at
Dr.14748.1.S1_at
Dr.15819.1.A1_at,Dr.17776.1.A1_at
Dr.15819.1.A1_at,Dr.17776.1.A1_at
Dr.15819.1.A1_at,Dr.17776.1.A1_at

-4195
-3818
-102
-551
-3387
-1028
77
-3682
-1444
-301
-4904
-2414
-311
-213
-4616
-769
-545
-4616
-769
-545
-3386
-2983
-2703
-2417
-2381
-1870
-4407
-4306
-3737
-1464
-1492
-40
-3118
-3045
-1406
-859
-1043
-3632
-1852
-1701

-4190
-3813
-97
-546
-3382
-1023
82
-3677
-1439
-296
-4899
-2409
-306
-208
-4611
-764
-540
-4611
-764
-540
-3381
-2978
-2698
-2412
-2376
-1865
-4402
-4301
-3732
-1459
-1487
-35
-3113
-3040
-1401
-854
-1038
-3627
-1847
-1696

1
-1
1
-1
-1
-1
-1
1
1
-1
-1
1
-1
1
-1
1
-1
-1
1
-1
-1
1
-1
-1
1
1
-1
1
1
1
1
1
-1
1
1
1
1
1
1
-1

tgcgtg
tgcgtg
cgcgtg
agcgtg
cgcgtg
tgcgtg
agcgtg
tgcgtg
cgcgtg
tgcgtg
agcgtg
agcgtg
ggcgtg
cgcgtg
tgcgtg
cgcgtg
ggcgtg
tgcgtg
cgcgtg
ggcgtg
cgcgtg
ggcgtg
tgcgtg
tgcgtg
tgcgtg
tgcgtg
ggcgtg
cgcgtg
tgcgtg
agcgtg
agcgtg
agcgtg
ggcgtg
agcgtg
ggcgtg
tgcgtg
agcgtg
tgcgtg
agcgtg
agcgtg

zgc:77517
zgc:77517

hypothetical protein LOC393540 [Source:RefSeq_peptide;Acc:NP_956862]
hypothetical protein LOC393540 [Source:RefSeq_peptide;Acc:NP_956862]

krt8
zgc:91877
zgc:91877

keratin 8 [Source:RefSeq_peptide;Acc:NP_956374]
hypothetical protein LOC337397 [Source:RefSeq_peptide;Acc:NP_997941]
hypothetical protein LOC337397 [Source:RefSeq_peptide;Acc:NP_997941]

sox21a
sox21a
sox21a

SRY-box 21 [Source:RefSeq_peptide;Acc:NP_571361]
SRY-box 21 [Source:RefSeq_peptide;Acc:NP_571361]
SRY-box 21 [Source:RefSeq_peptide;Acc:NP_571361]

vg1
vg1
vg1
vg1
vg1
vg1
vg1
vg1
NP_001017680.1
NP_001017680.1
tagln2

Vitellogenin 1 (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q8JH36]
Vitellogenin 1 (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q8JH36]
Vitellogenin 1 (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q8JH36]
Vitellogenin 1 (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q8JH36]
Vitellogenin 1 (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q8JH36]
Vitellogenin 1 (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q8JH36]
Vitellogenin 1 (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q8JH36]
Vitellogenin 1 (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q8JH36]
hypothetical protein LOC550375 [Source:RefSeq_peptide;Acc:NP_001017680]
hypothetical protein LOC550375 [Source:RefSeq_peptide;Acc:NP_001017680]
transgelin 2 [Source:RefSeq_peptide;Acc:NP_963870]

Q6DGW1_BRARE
Q6DGW1_BRARE
Q6DGW1_BRARE
Q6DGW1_BRARE
zgc:63985
NP_001001843.1
NP_001001843.1
NP_001001843.1

Hypothetical protein (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q6DGW1]
Hypothetical protein (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q6DGW1]
Hypothetical protein (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q6DGW1]
Hypothetical protein (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q6DGW1]
Unknown (protein for MGC:63985) [Source:RefSeq_peptide;Acc:NP_956252]
tryptophan hydroxylase 1, like [Source:RefSeq_peptide;Acc:NP_001001843]
tryptophan hydroxylase 1, like [Source:RefSeq_peptide;Acc:NP_001001843]
tryptophan hydroxylase 1, like [Source:RefSeq_peptide;Acc:NP_001001843]
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Supplementary Table 2 (cont.). Location of putative AHREs
Gene ID
Transcript ID
Affy IDs
Dr.15819.1.A1_at,Dr.17776.1.A1_at
ENSDARG00000036082
ENSDART00000052385
ENSDARG00000036082
ENSDART00000052385
Dr.15819.1.A1_at,Dr.17776.1.A1_at
ENSDARG00000036470
ENSDART00000052991
Dr.10326.1.S1_at
ENSDARG00000036481
ENSDART00000053001
Dr.6550.1.A1_at
ENSDARG00000036517
ENSDART00000053070
Dr.1411.1.S1_at
ENSDARG00000036517
ENSDART00000053070
Dr.1411.1.S1_at
ENSDARG00000036518
ENSDART00000043748
Dr.25155.1.S1_s_at
ENSDARG00000036518
ENSDART00000043748
Dr.25155.1.S1_s_at
ENSDARG00000036518
ENSDART00000043748
Dr.25155.1.S1_s_at
ENSDARG00000036519
ENSDART00000053072
Dr.1411.1.S1_at
ENSDARG00000036521
ENSDART00000053073
Dr.25155.1.S1_s_at
ENSDARG00000036521
ENSDART00000053073
Dr.25155.1.S1_s_at
ENSDARG00000036527
ENSDART00000053078
Dr.1411.1.S1_at
ENSDARG00000036527
ENSDART00000053078
Dr.1411.1.S1_at
ENSDARG00000036528
ENSDART00000053080
Dr.8723.1.S1_at
ENSDARG00000036528
ENSDART00000053080
Dr.8723.1.S1_at
ENSDARG00000036529
ENSDART00000053081
Dr.25155.1.S1_s_at
ENSDARG00000036529
ENSDART00000053081
Dr.25155.1.S1_s_at
ENSDARG00000036529
ENSDART00000053081
Dr.25155.1.S1_s_at
ENSDARG00000036531
ENSDART00000053083
Dr.1411.1.S1_at
ENSDARG00000036533
ENSDART00000053086
Dr.10170.1.A1_at,Dr.10170.1.A1_at
ENSDARG00000036533
ENSDART00000053086
Dr.10170.1.A1_at,Dr.10170.1.A1_at
ENSDARG00000036533
ENSDART00000053086
Dr.10170.1.A1_at,Dr.10170.1.A1_at
ENSDARG00000036533
ENSDART00000053086
Dr.10170.1.A1_at,Dr.10170.1.A1_at
ENSDARG00000036533
ENSDART00000053086
Dr.10170.1.A1_at,Dr.10170.1.A1_at
ENSDARG00000036533
ENSDART00000053086
Dr.10170.1.A1_at,Dr.10170.1.A1_at
ENSDARG00000036533
ENSDART00000053086
Dr.10170.1.A1_at,Dr.10170.1.A1_at
ENSDARG00000036533
ENSDART00000053087
Dr.10170.1.A1_at,Dr.10170.1.A1_at
ENSDARG00000036533
ENSDART00000053087
Dr.10170.1.A1_at,Dr.10170.1.A1_at
ENSDARG00000036533
ENSDART00000053087
Dr.10170.1.A1_at,Dr.10170.1.A1_at
ENSDARG00000036533
ENSDART00000053087
Dr.10170.1.A1_at,Dr.10170.1.A1_at
ENSDARG00000036533
ENSDART00000053087
Dr.10170.1.A1_at,Dr.10170.1.A1_at
ENSDARG00000036533
ENSDART00000053087
Dr.10170.1.A1_at,Dr.10170.1.A1_at
ENSDARG00000036533
ENSDART00000053087
Dr.10170.1.A1_at,Dr.10170.1.A1_at
ENSDARG00000036535
ENSDART00000042396
Dr.25155.1.S1_s_at
ENSDARG00000036535
ENSDART00000042396
Dr.25155.1.S1_s_at
ENSDARG00000037281
ENSDART00000054230
Dr.4907.1.S1_at
ENSDARG00000037618
ENSDART00000054788
Dr.13972.1.S1_at
ENSDARG00000037618
ENSDART00000054788
Dr.13972.1.S1_at
ENSDARG00000037618
ENSDART00000054788
Dr.13972.1.S1_at
ENSDARG00000037618
ENSDART00000054788
Dr.13972.1.S1_at
ENSDARG00000037618
ENSDART00000054788
Dr.13972.1.S1_at
ENSDARG00000037618
ENSDART00000054788
Dr.13972.1.S1_at
ENSDARG00000037618
ENSDART00000054788
Dr.13972.1.S1_at
ENSDARG00000037618
ENSDART00000054788
Dr.13972.1.S1_at
ENSDARG00000037618
ENSDART00000054788
Dr.13972.1.S1_at
ENSDARG00000037618
ENSDART00000054788
Dr.13972.1.S1_at
ENSDARG00000038321
ENSDART00000055897
Dr.9682.1.A1_at
ENSDARG00000038321
ENSDART00000055897
Dr.9682.1.A1_at
ENSDARG00000038321
ENSDART00000055897
Dr.9682.1.A1_at
ENSDARG00000038321
ENSDART00000055897
Dr.9682.1.A1_at
ENSDARG00000038622
ENSDART00000056382
Dr.20270.1.S1_at
ENSDARG00000038622
ENSDART00000056382
Dr.20270.1.S1_at
ENSDARG00000038622
ENSDART00000056382
Dr.20270.1.S1_at
ENSDARG00000038622
ENSDART00000056382
Dr.20270.1.S1_at
ENSDARG00000038622
ENSDART00000056382
Dr.20270.1.S1_at
ENSDARG00000038622
ENSDART00000056382
Dr.20270.1.S1_at
ENSDARG00000038812
ENSDART00000056679
Dr.20140.1.A1_at
ENSDARG00000038813
ENSDART00000056680
Dr.20140.1.A1_at
ENSDARG00000039027
ENSDART00000056969
Dr.4797.1.S1_at,Dr.4797.1.S1_at
ENSDARG00000039027
ENSDART00000056969
Dr.4797.1.S1_at,Dr.4797.1.S1_at
ENSDARG00000039027
ENSDART00000056969
Dr.4797.1.S1_at,Dr.4797.1.S1_at
ENSDARG00000039027
ENSDART00000056969
Dr.4797.1.S1_at,Dr.4797.1.S1_at
ENSDARG00000039728
ENSDART00000037346
Dr.3581.1.S1_at,Dr.3581.1.S1_a_at
ENSDARG00000039747
ENSDART00000058095
Dr.4797.1.S1_at
ENSDARG00000039747
ENSDART00000058095
Dr.4797.1.S1_at
ENSDARG00000039747
ENSDART00000058095
Dr.4797.1.S1_at
ENSDARG00000039747
ENSDART00000058095
Dr.4797.1.S1_at
ENSDARG00000039841
ENSDART00000058272
Dr.7110.1.S1_at
AFFX-Dr-GAPDH-3_at,AFFX-Dr-GAPDH-M_at,Dr.1194.1.S1_at,AFFX-DrENSDARG00000039914
ENSDART00000058384
GAPDH-5_at
AFFX-Dr-GAPDH-3_at,AFFX-Dr-GAPDH-M_at,Dr.1194.1.S1_at,AFFX-DrENSDARG00000039914
ENSDART00000058384
GAPDH-5_at
AFFX-Dr-GAPDH-3_at,AFFX-Dr-GAPDH-M_at,Dr.1194.1.S1_at,AFFX-DrENSDARG00000039914
ENSDART00000058384
GAPDH-5_at
AFFX-Dr-GAPDH-3_at,AFFX-Dr-GAPDH-M_at,Dr.1194.1.S1_at,AFFX-DrENSDARG00000039914
ENSDART00000058384
GAPDH-5_at
AFFX-Dr-GAPDH-3_at,AFFX-Dr-GAPDH-M_at,Dr.1194.1.S1_at,AFFX-DrENSDARG00000039914
ENSDART00000058384
GAPDH-5_at
AFFX-Dr-GAPDH-3_at,AFFX-Dr-GAPDH-M_at,Dr.1194.1.S1_at,AFFX-DrENSDARG00000039914
ENSDART00000058384
GAPDH-5_at
AFFX-Dr-GAPDH-3_at,AFFX-Dr-GAPDH-M_at,Dr.1194.1.S1_at,AFFX-DrENSDARG00000039914
ENSDART00000058384
GAPDH-5_at
AFFX-Dr-GAPDH-3_at,AFFX-Dr-GAPDH-M_at,Dr.1194.1.S1_at,AFFX-DrENSDARG00000039914
ENSDART00000058384
GAPDH-5_at
AFFX-Dr-GAPDH-3_at,AFFX-Dr-GAPDH-M_at,Dr.1194.1.S1_at,AFFX-DrENSDARG00000039914
ENSDART00000058384
GAPDH-5_at
AFFX-Dr-GAPDH-3_at,AFFX-Dr-GAPDH-M_at,Dr.1194.1.S1_at,AFFX-DrENSDARG00000039914
ENSDART00000058384
GAPDH-5_at
AFFX-Dr-GAPDH-3_at,AFFX-Dr-GAPDH-M_at,Dr.1194.1.S1_at,AFFX-DrENSDARG00000039914
ENSDART00000058384
GAPDH-5_at

Symbol
NP_001001843.1
NP_001001843.1
junb
Q6PG35_BRARE
si:xx-by187g17.1
si:xx-by187g17.1
ba2l
ba2l
ba2l
hbaa1
ba2
ba2
si:xx-by187g17.1
si:xx-by187g17.1
NP_001002461.1
NP_001002461.1
ba2l
ba2l
ba2l
hbaa1

Description
tryptophan hydroxylase 1, like [Source:RefSeq_peptide;Acc:NP_001001843]
tryptophan hydroxylase 1, like [Source:RefSeq_peptide;Acc:NP_001001843]
jun B proto-oncogene [Source:RefSeq_peptide;Acc:NP_998721]
LOC407646 protein (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q6PG35]
Novel protein similar to zebrafish hemoglobin alpha-adult 1 (Hbaa1). [Source:Uniprot/SPTREMBL;Acc:Q6ZM17]
Novel protein similar to zebrafish hemoglobin alpha-adult 1 (Hbaa1). [Source:Uniprot/SPTREMBL;Acc:Q6ZM17]
Hemoglobin beta-1 chain (BetaA1 globin). [Source:Uniprot/SWISSPROT;Acc:Q90486]
Hemoglobin beta-1 chain (BetaA1 globin). [Source:Uniprot/SWISSPROT;Acc:Q90486]
Hemoglobin beta-1 chain (BetaA1 globin). [Source:Uniprot/SWISSPROT;Acc:Q90486]
Hemoglobin alpha chain (Alpha globin aa1). [Source:Uniprot/SWISSPROT;Acc:Q90487]
Hemoglobin beta-1 chain (BetaA1 globin). [Source:Uniprot/SWISSPROT;Acc:Q90486]
Hemoglobin beta-1 chain (BetaA1 globin). [Source:Uniprot/SWISSPROT;Acc:Q90486]
hemoglobin alpha adult-1 (hbaa1), mRNA [Source:RefSeq_dna;Acc:NM_131257]
hemoglobin alpha adult-1 (hbaa1), mRNA [Source:RefSeq_dna;Acc:NM_131257]
zgc:92903 [Source:RefSeq_peptide;Acc:NP_001002461]
zgc:92903 [Source:RefSeq_peptide;Acc:NP_001002461]
Hemoglobin beta-1 chain (BetaA1 globin). [Source:Uniprot/SWISSPROT;Acc:Q90486]
Hemoglobin beta-1 chain (BetaA1 globin). [Source:Uniprot/SWISSPROT;Acc:Q90486]
Hemoglobin beta-1 chain (BetaA1 globin). [Source:Uniprot/SWISSPROT;Acc:Q90486]
Hemoglobin alpha chain (Alpha globin aa1). [Source:Uniprot/SWISSPROT;Acc:Q90487]

ba2
ba2
NP_998219.1
zgc:64114
zgc:64114
zgc:64114
zgc:64114
zgc:64114
zgc:64114
zgc:64114
zgc:64114
zgc:64114
zgc:64114

Hemoglobin beta-1 chain (BetaA1 globin). [Source:Uniprot/SWISSPROT;Acc:Q90486]
Hemoglobin beta-1 chain (BetaA1 globin). [Source:Uniprot/SWISSPROT;Acc:Q90486]
fibrinogen gamma polypeptide [Source:RefSeq_peptide;Acc:NP_998219]
hypothetical protein LOC378866 [Source:RefSeq_peptide;Acc:NP_956401]
hypothetical protein LOC378866 [Source:RefSeq_peptide;Acc:NP_956401]
hypothetical protein LOC378866 [Source:RefSeq_peptide;Acc:NP_956401]
hypothetical protein LOC378866 [Source:RefSeq_peptide;Acc:NP_956401]
hypothetical protein LOC378866 [Source:RefSeq_peptide;Acc:NP_956401]
hypothetical protein LOC378866 [Source:RefSeq_peptide;Acc:NP_956401]
hypothetical protein LOC378866 [Source:RefSeq_peptide;Acc:NP_956401]
hypothetical protein LOC378866 [Source:RefSeq_peptide;Acc:NP_956401]
hypothetical protein LOC378866 [Source:RefSeq_peptide;Acc:NP_956401]
hypothetical protein LOC378866 [Source:RefSeq_peptide;Acc:NP_956401]

NP_991178.1
NP_991178.1

E2F transcription factor 4, p107/p130-binding [Source:RefSeq_peptide;Acc:NP_991178]
E2F transcription factor 4, p107/p130-binding [Source:RefSeq_peptide;Acc:NP_991178]

ctrb1

chymotrypsinogen B1 [Source:RefSeq_peptide;Acc:NP_997783]

zgc:77614

hypothetical protein LOC393868 [Source:RefSeq_peptide;Acc:NP_957188]

zgc:76908
zgc:76908
zgc:76908
zgc:76908
zgc:76908
zgc:76908
zgc:76908
zgc:76908
zgc:76908
zgc:76908
zgc:76908

glyceraldehyde 3-phosphate dehydrogenase [Source:RefSeq_peptide;Acc:NP_998259]
glyceraldehyde 3-phosphate dehydrogenase [Source:RefSeq_peptide;Acc:NP_998259]
glyceraldehyde 3-phosphate dehydrogenase [Source:RefSeq_peptide;Acc:NP_998259]
glyceraldehyde 3-phosphate dehydrogenase [Source:RefSeq_peptide;Acc:NP_998259]
glyceraldehyde 3-phosphate dehydrogenase [Source:RefSeq_peptide;Acc:NP_998259]
glyceraldehyde 3-phosphate dehydrogenase [Source:RefSeq_peptide;Acc:NP_998259]
glyceraldehyde 3-phosphate dehydrogenase [Source:RefSeq_peptide;Acc:NP_998259]
glyceraldehyde 3-phosphate dehydrogenase [Source:RefSeq_peptide;Acc:NP_998259]
glyceraldehyde 3-phosphate dehydrogenase [Source:RefSeq_peptide;Acc:NP_998259]
glyceraldehyde 3-phosphate dehydrogenase [Source:RefSeq_peptide;Acc:NP_998259]
glyceraldehyde 3-phosphate dehydrogenase [Source:RefSeq_peptide;Acc:NP_998259]
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Start
-240
-56
-66
-4651
-2107
-4586
-3361
-1341
-4481
-2950
-3811
-1332
-2104
-4583
-1100
-48
-3358
-1341
-4476
-2943
-3938
-3823
-3765
-3350
-4669
-4994
-4937
-3902
-3787
-3729
-3314
-4633
-4958
-4901
-3804
-1325
-4801
-3332
-4700
-1223
-1219
-1203
-1199
-578
-351
-243
-30
-3855
-1979
-346
-4477
-1704
-4665
-1420
-1399
-1221
-1057
-3847
-3732
-2978
-862
-540
-4068
-4839
-2916
-2797
-2399
-1967
-2848

End
-235
-51
-61
-4646
-2102
-4581
-3356
-1336
-4476
-2945
-3806
-1327
-2099
-4578
-1095
-43
-3353
-1336
-4471
-2938
-3933
-3818
-3760
-3345
-4664
-4989
-4932
-3897
-3782
-3724
-3309
-4628
-4953
-4896
-3799
-1320
-4796
-3327
-4695
-1218
-1214
-1198
-1194
-573
-346
-238
-25
-3850
-1974
-341
-4472
-1699
-4660
-1415
-1394
-1216
-1052
-3842
-3727
-2973
-857
-535
-4063
-4834
-2911
-2792
-2394
-1962
-2843

Strand
-1
1
-1
-1
-1
1
1
-1
-1
1
1
-1
-1
1
-1
1
1
-1
-1
1
-1
-1
1
1
1
-1
-1
-1
-1
1
1
1
-1
-1
1
-1
1
1
-1
-1
-1
-1
-1
-1
1
-1
-1
1
-1
-1
1
1
1
1
-1
1
-1
1
1
-1
-1
1
-1
-1
-1
1
1
-1
1

Sequence
agcgtg
cgcgtg
ggcgtg
tgcgtg
tgcgtg
tgcgtg
tgcgtg
tgcgtg
tgcgtg
cgcgtg
tgcgtg
tgcgtg
tgcgtg
tgcgtg
agcgtg
tgcgtg
tgcgtg
tgcgtg
tgcgtg
cgcgtg
cgcgtg
tgcgtg
ggcgtg
agcgtg
agcgtg
ggcgtg
ggcgtg
cgcgtg
tgcgtg
ggcgtg
agcgtg
agcgtg
ggcgtg
ggcgtg
tgcgtg
tgcgtg
cgcgtg
ggcgtg
cgcgtg
tgcgtg
tgcgtg
tgcgtg
tgcgtg
tgcgtg
ggcgtg
ggcgtg
tgcgtg
tgcgtg
ggcgtg
tgcgtg
agcgtg
agcgtg
ggcgtg
ggcgtg
ggcgtg
tgcgtg
tgcgtg
ggcgtg
ggcgtg
agcgtg
tgcgtg
ggcgtg
agcgtg
ggcgtg
ggcgtg
agcgtg
agcgtg
tgcgtg
tgcgtg

-3815

-3810

1

-2730

-2725

1

agcgtg

-1064

-1059

1

tgcgtg

-3815

-3810

1

agcgtg

-2730

-2725

1

agcgtg

-1064

-1059

1

tgcgtg

-3815

-3810

1

agcgtg

-2730

-2725

1

agcgtg

-1064

-1059

1

tgcgtg

-3815

-3810

1

agcgtg

-2730

-2725

1

agcgtg

agcgtg

Supplementary Table 2 (cont.). Location of putative AHREs
Gene ID
Transcript ID
Affy IDs
AFFX-Dr-GAPDH-3_at,AFFX-Dr-GAPDH-M_at,Dr.1194.1.S1_at,AFFX-DrENSDARG00000039914
ENSDART00000058384
GAPDH-5_at
ENSDARG00000040086
ENSDART00000058629
AFFX-Dr-acta1-5_x_at
ENSDARG00000040086
ENSDART00000058629
AFFX-Dr-acta1-5_x_at
ENSDARG00000040086
ENSDART00000058629
AFFX-Dr-acta1-5_x_at
ENSDARG00000040248
ENSDART00000047377
Dr.11971.1.A1_at
ENSDARG00000040248
ENSDART00000047377
Dr.11971.1.A1_at
ENSDARG00000040295
ENSDART00000058965
Dr.1246.1.S1_at
ENSDARG00000040295
ENSDART00000058965
Dr.1246.1.S1_at
ENSDARG00000040295
ENSDART00000058965
Dr.1246.1.S1_at
ENSDARG00000040295
ENSDART00000058965
Dr.1246.1.S1_at
ENSDARG00000040527
ENSDART00000059311
Dr.20722.1.S1_at
ENSDARG00000040527
ENSDART00000059311
Dr.20722.1.S1_at
ENSDARG00000040527
ENSDART00000059311
Dr.20722.1.S1_at
ENSDARG00000040528
ENSDART00000059314
Dr.5853.1.A1_at
ENSDARG00000040528
ENSDART00000059314
Dr.5853.1.A1_at
ENSDARG00000040856
ENSDART00000059886
Dr.4212.1.S1_at
ENSDARG00000040856
ENSDART00000059886
Dr.4212.1.S1_at
ENSDARG00000040856
ENSDART00000059886
Dr.4212.1.S1_at
ENSDARG00000040856
ENSDART00000059886
Dr.4212.1.S1_at
ENSDARG00000040856
ENSDART00000059886
Dr.4212.1.S1_at
AFFX-Dr-GAPDH-3_at,AFFX-Dr-GAPDH-M_at,Dr.1194.1.S1_at,AFFX-DrENSDARG00000041384
ENSDART00000060668
GAPDH-5_at
AFFX-Dr-GAPDH-3_at,AFFX-Dr-GAPDH-M_at,Dr.1194.1.S1_at,AFFX-DrENSDARG00000041384
ENSDART00000060668
GAPDH-5_at
AFFX-Dr-GAPDH-3_at,AFFX-Dr-GAPDH-M_at,Dr.1194.1.S1_at,AFFX-DrENSDARG00000041384
ENSDART00000060668
GAPDH-5_at
AFFX-Dr-GAPDH-3_at,AFFX-Dr-GAPDH-M_at,Dr.1194.1.S1_at,AFFX-DrENSDARG00000041384
ENSDART00000060668
GAPDH-5_at
AFFX-Dr-GAPDH-3_at,AFFX-Dr-GAPDH-M_at,Dr.1194.1.S1_at,AFFX-DrENSDARG00000041384
ENSDART00000060668
GAPDH-5_at
AFFX-Dr-GAPDH-3_at,AFFX-Dr-GAPDH-M_at,Dr.1194.1.S1_at,AFFX-DrENSDARG00000041384
ENSDART00000060668
GAPDH-5_at
AFFX-Dr-GAPDH-3_at,AFFX-Dr-GAPDH-M_at,Dr.1194.1.S1_at,AFFX-DrENSDARG00000041384
ENSDART00000060668
GAPDH-5_at
AFFX-Dr-GAPDH-3_at,AFFX-Dr-GAPDH-M_at,Dr.1194.1.S1_at,AFFX-DrENSDARG00000041384
ENSDART00000060668
GAPDH-5_at
AFFX-Dr-GAPDH-3_at,AFFX-Dr-GAPDH-M_at,Dr.1194.1.S1_at,AFFX-DrENSDARG00000041384
ENSDART00000060668
GAPDH-5_at
AFFX-Dr-GAPDH-3_at,AFFX-Dr-GAPDH-M_at,Dr.1194.1.S1_at,AFFX-DrENSDARG00000041384
ENSDART00000060668
GAPDH-5_at
AFFX-Dr-GAPDH-3_at,AFFX-Dr-GAPDH-M_at,Dr.1194.1.S1_at,AFFX-DrENSDARG00000041384
ENSDART00000060668
GAPDH-5_at
AFFX-Dr-GAPDH-3_at,AFFX-Dr-GAPDH-M_at,Dr.1194.1.S1_at,AFFX-DrENSDARG00000041384
ENSDART00000060668
GAPDH-5_at
ENSDARG00000041633
ENSDART00000041093
Dr.23812.1.A1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
ENSDARG00000041633
ENSDART00000041093
Dr.23812.1.A1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
ENSDARG00000041633
ENSDART00000041093
Dr.23812.1.A1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
ENSDARG00000041633
ENSDART00000041093
Dr.23812.1.A1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
ENSDARG00000041633
ENSDART00000041093
Dr.23812.1.A1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
ENSDARG00000041633
ENSDART00000041093
Dr.23812.1.A1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.23812.1.A1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.238
ENSDARG00000041639
ENSDART00000044076
12.1.A1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.23812.1.A1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.238
ENSDARG00000041639
ENSDART00000044076
12.1.A1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.23812.1.A1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.238
ENSDARG00000041639
ENSDART00000046454
12.1.A1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.23812.1.A1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.238
ENSDARG00000041639
ENSDART00000046454
12.1.A1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.23812.1.A1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.238
ENSDARG00000041639
ENSDART00000047098
12.1.A1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.23812.1.A1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.238
ENSDARG00000041639
ENSDART00000047098
12.1.A1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.23812.1.A1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.238
ENSDARG00000041639
ENSDART00000044076
12.1.A1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.23812.1.A1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.238
ENSDARG00000041639
ENSDART00000044076
12.1.A1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.23812.1.A1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.238
ENSDARG00000041639
ENSDART00000046454
12.1.A1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.23812.1.A1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.238
ENSDARG00000041639
ENSDART00000046454
12.1.A1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.23812.1.A1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.238
ENSDARG00000041639
ENSDART00000047098
12.1.A1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.23812.1.A1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.238
ENSDARG00000041639
ENSDART00000047098
12.1.A1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
ENSDARG00000041645
ENSDART00000046443
Dr.25379.1.S1_at,Dr.3025.2.S1_at,Dr.3025.3.S1_at
ENSDARG00000041645
ENSDART00000046443
Dr.25379.1.S1_at,Dr.3025.2.S1_at,Dr.3025.3.S1_at
ENSDARG00000041653
ENSDART00000061046
Dr.25331.1.S1_at,Dr.25379.1.S1_at,Dr.25331.1.S1_at,Dr.25379.1.S1_at
ENSDARG00000041653
ENSDART00000061046
Dr.25331.1.S1_at,Dr.25379.1.S1_at,Dr.25331.1.S1_at,Dr.25379.1.S1_at
ENSDARG00000041653
ENSDART00000061046
Dr.25331.1.S1_at,Dr.25379.1.S1_at,Dr.25331.1.S1_at,Dr.25379.1.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.16397.1.A1_at,Dr.25379.1.S1_at,Dr.302
ENSDARG00000041685
ENSDART00000006984
5.3.S1_at,Dr.16397.1.A1_at,Dr.3025.2.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.16397.1.A1_at,Dr.25379.1.S1_at,Dr.302
ENSDARG00000041685
ENSDART00000006984
5.3.S1_at,Dr.16397.1.A1_at,Dr.3025.2.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.16397.1.A1_at,Dr.25379.1.S1_at,Dr.302
ENSDARG00000041685
ENSDART00000006984
5.3.S1_at,Dr.16397.1.A1_at,Dr.3025.2.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.16397.1.A1_at,Dr.25379.1.S1_at,Dr.302
ENSDARG00000041685
ENSDART00000061093
5.3.S1_at,Dr.16397.1.A1_at,Dr.3025.2.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.16397.1.A1_at,Dr.25379.1.S1_at,Dr.302
ENSDARG00000041685
ENSDART00000061093
5.3.S1_at,Dr.16397.1.A1_at,Dr.3025.2.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.16397.1.A1_at,Dr.25379.1.S1_at,Dr.302
ENSDARG00000041685
ENSDART00000061093
5.3.S1_at,Dr.16397.1.A1_at,Dr.3025.2.S1_at,Dr.3025.3.S1_at

Symbol
zgc:76908
NP_999949.1
NP_999949.1
NP_999949.1
zgc:92317
zgc:92317
apoeb
apoeb
apoeb
apoeb
NP_956583.1
NP_956583.1
NP_956583.1
zgc:77059
zgc:77059
ldha
ldha
ldha
ldha
ldha
zgc:76908
zgc:76908
zgc:76908
zgc:76908
zgc:76908
zgc:76908
zgc:76908
zgc:76908
zgc:76908
zgc:76908
zgc:76908
zgc:76908

Description
glyceraldehyde 3-phosphate dehydrogenase [Source:RefSeq_peptide;Acc:NP_998259]
actin, alpha, cardiac muscle [Source:RefSeq_peptide;Acc:NP_999949]
actin, alpha, cardiac muscle [Source:RefSeq_peptide;Acc:NP_999949]
actin, alpha, cardiac muscle [Source:RefSeq_peptide;Acc:NP_999949]
hypothetical protein LOC449545 [Source:RefSeq_peptide;Acc:NP_001005587]
hypothetical protein LOC449545 [Source:RefSeq_peptide;Acc:NP_001005587]
Apolipoprotein Eb precursor (Apo-Eb). [Source:Uniprot/SWISSPROT;Acc:O42364]
Apolipoprotein Eb precursor (Apo-Eb). [Source:Uniprot/SWISSPROT;Acc:O42364]
Apolipoprotein Eb precursor (Apo-Eb). [Source:Uniprot/SWISSPROT;Acc:O42364]
Apolipoprotein Eb precursor (Apo-Eb). [Source:Uniprot/SWISSPROT;Acc:O42364]
similar to yolk sac gene 2 [Source:RefSeq_peptide;Acc:NP_956583]
similar to yolk sac gene 2 [Source:RefSeq_peptide;Acc:NP_956583]
similar to yolk sac gene 2 [Source:RefSeq_peptide;Acc:NP_956583]
hypothetical protein LOC405809 [Source:RefSeq_peptide;Acc:NP_998038]
hypothetical protein LOC405809 [Source:RefSeq_peptide;Acc:NP_998038]
L-lactate dehydrogenase A chain (EC 1.1.1.27) (LDH-A). [Source:Uniprot/SWISSPROT;Acc:Q9PVK5]
L-lactate dehydrogenase A chain (EC 1.1.1.27) (LDH-A). [Source:Uniprot/SWISSPROT;Acc:Q9PVK5]
L-lactate dehydrogenase A chain (EC 1.1.1.27) (LDH-A). [Source:Uniprot/SWISSPROT;Acc:Q9PVK5]
L-lactate dehydrogenase A chain (EC 1.1.1.27) (LDH-A). [Source:Uniprot/SWISSPROT;Acc:Q9PVK5]
L-lactate dehydrogenase A chain (EC 1.1.1.27) (LDH-A). [Source:Uniprot/SWISSPROT;Acc:Q9PVK5]
glyceraldehyde 3-phosphate dehydrogenase [Source:RefSeq_peptide;Acc:NP_998259]
glyceraldehyde 3-phosphate dehydrogenase [Source:RefSeq_peptide;Acc:NP_998259]
glyceraldehyde 3-phosphate dehydrogenase [Source:RefSeq_peptide;Acc:NP_998259]
glyceraldehyde 3-phosphate dehydrogenase [Source:RefSeq_peptide;Acc:NP_998259]
glyceraldehyde 3-phosphate dehydrogenase [Source:RefSeq_peptide;Acc:NP_998259]
glyceraldehyde 3-phosphate dehydrogenase [Source:RefSeq_peptide;Acc:NP_998259]
glyceraldehyde 3-phosphate dehydrogenase [Source:RefSeq_peptide;Acc:NP_998259]
glyceraldehyde 3-phosphate dehydrogenase [Source:RefSeq_peptide;Acc:NP_998259]
glyceraldehyde 3-phosphate dehydrogenase [Source:RefSeq_peptide;Acc:NP_998259]
glyceraldehyde 3-phosphate dehydrogenase [Source:RefSeq_peptide;Acc:NP_998259]
glyceraldehyde 3-phosphate dehydrogenase [Source:RefSeq_peptide;Acc:NP_998259]
glyceraldehyde 3-phosphate dehydrogenase [Source:RefSeq_peptide;Acc:NP_998259]
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Start

End

Strand

Sequence

-1064
-2725
-2623
-1522
-944
-169
-113
13
-4207
-4051
-1851
-4278
-4908
-3738
-2096
-3868
-3547
-1164
-974
-87

-1059
-2720
-2618
-1517
-939
-164
-108
18
-4202
-4046
-1846
-4273
-4903
-3733
-2091
-3863
-3542
-1159
-969
-82

1
1
-1
-1
1
1
1
-1
-1
-1
1
-1
-1
-1
-1
1
-1
1
1
-1

tgcgtg
tgcgtg
tgcgtg
ggcgtg
agcgtg
cgcgtg
cgcgtg
agcgtg
tgcgtg
agcgtg
tgcgtg
cgcgtg
agcgtg
ggcgtg
ggcgtg
tgcgtg
ggcgtg
tgcgtg
agcgtg
ggcgtg

-3815

-3810

1

agcgtg

-2730

-2725

1

agcgtg

-1064

-1059

1

tgcgtg

-3815

-3810

1

agcgtg

-2730

-2725

1

agcgtg

-1064

-1059

1

tgcgtg

-3815

-3810

1

agcgtg

-2730

-2725

1

agcgtg

-1064

-1059

1

tgcgtg

-3815

-3810

1

agcgtg

-2730

-2725

1

agcgtg

-1064
-3205
-2759
-4067
-3205
-2759
-4067

-1059
-3200
-2754
-4062
-3200
-2754
-4062

1
1
1
-1
1
1
-1

tgcgtg
tgcgtg
ggcgtg
tgcgtg
tgcgtg
ggcgtg
tgcgtg

-3594

-3589

-1

tgcgtg

-103

-98

-1

cgcgtg

-1247

-1242

-1

tgcgtg

-4991

-4986

1

agcgtg

-3555

-3550

-1

tgcgtg

-3173

-3168

1

agcgtg

-3594

-3589

-1

tgcgtg

-103

-98

-1

cgcgtg

-1247

-1242

-1

tgcgtg

-4991

-4986

1

agcgtg

-3555

-3550

-1

tgcgtg

-3173
-323
-323
-2939
-2138
-1137

-3168
-318
-318
-2934
-2133
-1132

1
1
1
1
1
-1

agcgtg
tgcgtg
tgcgtg
agcgtg
tgcgtg
tgcgtg

-3122

-3117

-1

tgcgtg

-2882

-2877

-1

agcgtg

-629

-624

-1

ggcgtg

-3476

-3471

1

ggcgtg

-3106

-3101

-1

tgcgtg

-2371

-2366

-1

ggcgtg

Supplementary Table 2 (cont.). Location of putative AHREs
Gene ID
Transcript ID
Affy IDs
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.16397.1.A1_at,Dr.25379.1.S1_at,Dr.302
ENSDARG00000041685
ENSDART00000061098
5.3.S1_at,Dr.16397.1.A1_at,Dr.3025.2.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.16397.1.A1_at,Dr.25379.1.S1_at,Dr.302
ENSDARG00000041685
ENSDART00000061098
5.3.S1_at,Dr.16397.1.A1_at,Dr.3025.2.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.16397.1.A1_at,Dr.25379.1.S1_at,Dr.302
ENSDARG00000041685
ENSDART00000061098
5.3.S1_at,Dr.16397.1.A1_at,Dr.3025.2.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.16397.1.A1_at,Dr.25379.1.S1_at,Dr.302
ENSDARG00000041685
ENSDART00000006984
5.3.S1_at,Dr.16397.1.A1_at,Dr.3025.2.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.16397.1.A1_at,Dr.25379.1.S1_at,Dr.302
ENSDARG00000041685
ENSDART00000006984
5.3.S1_at,Dr.16397.1.A1_at,Dr.3025.2.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.16397.1.A1_at,Dr.25379.1.S1_at,Dr.302
ENSDARG00000041685
ENSDART00000006984
5.3.S1_at,Dr.16397.1.A1_at,Dr.3025.2.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.16397.1.A1_at,Dr.25379.1.S1_at,Dr.302
ENSDARG00000041685
ENSDART00000061093
5.3.S1_at,Dr.16397.1.A1_at,Dr.3025.2.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.16397.1.A1_at,Dr.25379.1.S1_at,Dr.302
ENSDARG00000041685
ENSDART00000061093
5.3.S1_at,Dr.16397.1.A1_at,Dr.3025.2.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.16397.1.A1_at,Dr.25379.1.S1_at,Dr.302
ENSDARG00000041685
ENSDART00000061093
5.3.S1_at,Dr.16397.1.A1_at,Dr.3025.2.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.16397.1.A1_at,Dr.25379.1.S1_at,Dr.302
ENSDARG00000041685
ENSDART00000061098
5.3.S1_at,Dr.16397.1.A1_at,Dr.3025.2.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.16397.1.A1_at,Dr.25379.1.S1_at,Dr.302
ENSDARG00000041685
ENSDART00000061098
5.3.S1_at,Dr.16397.1.A1_at,Dr.3025.2.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.16397.1.A1_at,Dr.25379.1.S1_at,Dr.302
ENSDARG00000041685
ENSDART00000061098
5.3.S1_at,Dr.16397.1.A1_at,Dr.3025.2.S1_at,Dr.3025.3.S1_at
ENSDARG00000041769
ENSDART00000061219
Dr.7806.1.A1_at
ENSDARG00000041769
ENSDART00000061219
Dr.7806.1.A1_at
ENSDARG00000041769
ENSDART00000061219
Dr.7806.1.A1_at
ENSDARG00000041774
ENSDART00000061223
Dr.25009.6.A1_a_at
ENSDARG00000041774
ENSDART00000061223
Dr.25009.6.A1_a_at
ENSDARG00000041774
ENSDART00000061223
Dr.25009.6.A1_a_at
ENSDARG00000041813
ENSDART00000061279
Dr.7806.1.A1_at
ENSDARG00000041813
ENSDART00000061279
Dr.7806.1.A1_at
ENSDARG00000041813
ENSDART00000061279
Dr.7806.1.A1_at
ENSDARG00000041997
ENSDART00000061544
Dr.12106.1.S1_at
ENSDARG00000041997
ENSDART00000061544
Dr.12106.1.S1_at
ENSDARG00000041997
ENSDART00000061544
Dr.12106.1.S1_at
ENSDARG00000041997
ENSDART00000061544
Dr.12106.1.S1_at
ENSDARG00000041997
ENSDART00000061544
Dr.12106.1.S1_at
ENSDARG00000041997
ENSDART00000061544
Dr.12106.1.S1_at
ENSDARG00000041997
ENSDART00000061544
Dr.12106.1.S1_at
ENSDARG00000041997
ENSDART00000061544
Dr.12106.1.S1_at
ENSDARG00000041997
ENSDART00000061544
Dr.12106.1.S1_at
ENSDARG00000041997
ENSDART00000061544
Dr.12106.1.S1_at
ENSDARG00000041997
ENSDART00000061544
Dr.12106.1.S1_at
ENSDARG00000041997
ENSDART00000061544
Dr.12106.1.S1_at
ENSDARG00000041997
ENSDART00000061544
Dr.12106.1.S1_at
ENSDARG00000041997
ENSDART00000061544
Dr.12106.1.S1_at
ENSDARG00000041997
ENSDART00000061544
Dr.12106.1.S1_at
ENSDARG00000041997
ENSDART00000061544
Dr.12106.1.S1_at
ENSDARG00000041997
ENSDART00000061544
Dr.12106.1.S1_at
ENSDARG00000042035
ENSDART00000061601
Dr.7110.1.S1_at
ENSDARG00000042035
ENSDART00000061601
Dr.7110.1.S1_at
ENSDARG00000042036
ENSDART00000061605
Dr.7110.1.S1_at
ENSDARG00000042036
ENSDART00000061605
Dr.7110.1.S1_at
ENSDARG00000042036
ENSDART00000061605
Dr.7110.1.S1_at
ENSDARG00000042036
ENSDART00000061605
Dr.7110.1.S1_at
ENSDARG00000042036
ENSDART00000061605
Dr.7110.1.S1_at
ENSDARG00000042036
ENSDART00000061605
Dr.7110.1.S1_at
ENSDARG00000042040
ENSDART00000061613
Dr.7110.1.S1_at
ENSDARG00000042040
ENSDART00000061613
Dr.7110.1.S1_at
ENSDARG00000042040
ENSDART00000061613
Dr.7110.1.S1_at
ENSDARG00000042040
ENSDART00000061613
Dr.7110.1.S1_at
ENSDARG00000042040
ENSDART00000061613
Dr.7110.1.S1_at
ENSDARG00000042040
ENSDART00000061613
Dr.7110.1.S1_at
ENSDARG00000042040
ENSDART00000061613
Dr.7110.1.S1_at
ENSDARG00000042040
ENSDART00000061613
Dr.7110.1.S1_at
ENSDARG00000042046
ENSDART00000061618
Dr.7110.1.S1_at
ENSDARG00000042050
ENSDART00000061623
Dr.7110.1.S1_at
ENSDARG00000042050
ENSDART00000061623
Dr.7110.1.S1_at
ENSDARG00000042102
ENSDART00000061707
Dr.13689.1.S1_at
ENSDARG00000042391
ENSDART00000062156
Dr.14748.1.S1_at
ENSDARG00000042391
ENSDART00000062156
Dr.14748.1.S1_at
ENSDARG00000043218
ENSDART00000063453
Dr.15054.1.S1_at
ENSDARG00000043218
ENSDART00000063453
Dr.15054.1.S1_at
ENSDARG00000043218
ENSDART00000063453
Dr.15054.1.S1_at
ENSDARG00000043218
ENSDART00000063453
Dr.15054.1.S1_at
ENSDARG00000043320
ENSDART00000063596
Dr.14268.1.A1_at,Dr.18893.1.S1_at
ENSDARG00000043320
ENSDART00000063596
Dr.14268.1.A1_at,Dr.18893.1.S1_at
ENSDARG00000043320
ENSDART00000063596
Dr.14268.1.A1_at,Dr.18893.1.S1_at
ENSDARG00000043592

ENSDART00000064008

ENSDARG00000043592

ENSDART00000064008

ENSDARG00000043592

ENSDART00000064008

ENSDARG00000043592

ENSDART00000064010

ENSDARG00000043592

ENSDART00000064010

ENSDARG00000043592
ENSDARG00000043618

ENSDART00000064010
ENSDART00000064041

Dr.17113.1.A1_a_at,Dr.3889.1.A1_at,Dr.17113.1.A1_a_at,Dr.3889.1.A1_at
Dr.17113.1.A1_a_at,Dr.3889.1.A1_at,Dr.17113.1.A1_a_at,Dr.3889.1.A1_at
Dr.17113.1.A1_a_at,Dr.3889.1.A1_at,Dr.17113.1.A1_a_at,Dr.3889.1.A1_at
Dr.17113.1.A1_a_at,Dr.3889.1.A1_at,Dr.17113.1.A1_a_at,Dr.3889.1.A1_at
Dr.17113.1.A1_a_at,Dr.3889.1.A1_at,Dr.17113.1.A1_a_at,Dr.3889.1.A1_at
Dr.17113.1.A1_a_at,Dr.3889.1.A1_at,Dr.17113.1.A1_a_at,Dr.3889.1.A1_at

Symbol

Description

NP_001014360.1
NP_001014360.1
NP_001014360.1

hypothetical protein LOC541525 [Source:RefSeq_peptide;Acc:NP_001014360]
hypothetical protein LOC541525 [Source:RefSeq_peptide;Acc:NP_001014360]
hypothetical protein LOC541525 [Source:RefSeq_peptide;Acc:NP_001014360]

NP_001014360.1
NP_001014360.1
NP_001014360.1
NP_955881.1
NP_955881.1
NP_955881.1
NP_955881.1
NP_955881.1
NP_955881.1
NP_955881.1
NP_955881.1
NP_955881.1
NP_955881.1
NP_955881.1
NP_955881.1
NP_955881.1
NP_955881.1
NP_955881.1
NP_955881.1
NP_955881.1
zgc:77614
zgc:77614
zgc:77614
zgc:77614
zgc:77614
zgc:77614
zgc:77614
zgc:77614

hypothetical protein LOC541525 [Source:RefSeq_peptide;Acc:NP_001014360]
hypothetical protein LOC541525 [Source:RefSeq_peptide;Acc:NP_001014360]
hypothetical protein LOC541525 [Source:RefSeq_peptide;Acc:NP_001014360]
leucine zipper transcription factor-like 1 [Source:RefSeq_peptide;Acc:NP_955881]
leucine zipper transcription factor-like 1 [Source:RefSeq_peptide;Acc:NP_955881]
leucine zipper transcription factor-like 1 [Source:RefSeq_peptide;Acc:NP_955881]
leucine zipper transcription factor-like 1 [Source:RefSeq_peptide;Acc:NP_955881]
leucine zipper transcription factor-like 1 [Source:RefSeq_peptide;Acc:NP_955881]
leucine zipper transcription factor-like 1 [Source:RefSeq_peptide;Acc:NP_955881]
leucine zipper transcription factor-like 1 [Source:RefSeq_peptide;Acc:NP_955881]
leucine zipper transcription factor-like 1 [Source:RefSeq_peptide;Acc:NP_955881]
leucine zipper transcription factor-like 1 [Source:RefSeq_peptide;Acc:NP_955881]
leucine zipper transcription factor-like 1 [Source:RefSeq_peptide;Acc:NP_955881]
leucine zipper transcription factor-like 1 [Source:RefSeq_peptide;Acc:NP_955881]
leucine zipper transcription factor-like 1 [Source:RefSeq_peptide;Acc:NP_955881]
leucine zipper transcription factor-like 1 [Source:RefSeq_peptide;Acc:NP_955881]
leucine zipper transcription factor-like 1 [Source:RefSeq_peptide;Acc:NP_955881]
leucine zipper transcription factor-like 1 [Source:RefSeq_peptide;Acc:NP_955881]
leucine zipper transcription factor-like 1 [Source:RefSeq_peptide;Acc:NP_955881]
leucine zipper transcription factor-like 1 [Source:RefSeq_peptide;Acc:NP_955881]
hypothetical protein LOC393868 [Source:RefSeq_peptide;Acc:NP_957188]
hypothetical protein LOC393868 [Source:RefSeq_peptide;Acc:NP_957188]
hypothetical protein LOC393868 [Source:RefSeq_peptide;Acc:NP_957188]
hypothetical protein LOC393868 [Source:RefSeq_peptide;Acc:NP_957188]
hypothetical protein LOC393868 [Source:RefSeq_peptide;Acc:NP_957188]
hypothetical protein LOC393868 [Source:RefSeq_peptide;Acc:NP_957188]
hypothetical protein LOC393868 [Source:RefSeq_peptide;Acc:NP_957188]
hypothetical protein LOC393868 [Source:RefSeq_peptide;Acc:NP_957188]

zgc:77614
zgc:77614
zgc:77614
zgc:66449
zgc:63985
zgc:63985
rbp2a
rbp2a
rbp2a
rbp2a

hypothetical protein LOC393868 [Source:RefSeq_peptide;Acc:NP_957188]
hypothetical protein LOC393868 [Source:RefSeq_peptide;Acc:NP_957188]
hypothetical protein LOC393868 [Source:RefSeq_peptide;Acc:NP_957188]
Unknown (protein for MGC:66449) [Source:RefSeq_peptide;Acc:NP_956095]
zgc:63985 (zgc:63985), mRNA [Source:RefSeq_dna;Acc:NM_199958]
zgc:63985 (zgc:63985), mRNA [Source:RefSeq_dna;Acc:NM_199958]
retinol binding protein 2a, cellular [Source:RefSeq_peptide;Acc:NP_694549]
retinol binding protein 2a, cellular [Source:RefSeq_peptide;Acc:NP_694549]
retinol binding protein 2a, cellular [Source:RefSeq_peptide;Acc:NP_694549]
retinol binding protein 2a, cellular [Source:RefSeq_peptide;Acc:NP_694549]

ptena
ptena
ptena
ptena
ptena
ptena

phosphatase and tensin-like protein A [Source:RefSeq_peptide;Acc:NP_957002]
phosphatase and tensin-like protein A [Source:RefSeq_peptide;Acc:NP_957002]
phosphatase and tensin-like protein A [Source:RefSeq_peptide;Acc:NP_957002]
phosphatase and tensin-like protein A [Source:RefSeq_peptide;Acc:NP_957002]
phosphatase and tensin-like protein A [Source:RefSeq_peptide;Acc:NP_957002]
phosphatase and tensin-like protein A [Source:RefSeq_peptide;Acc:NP_957002]

Dr.7236.1.A1_at,Dr.7236.1.A1_at
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Start

End

Strand

Sequence

-2312

-2307

-1

tgcgtg

-2072

-2067

-1

agcgtg

-4585

-4580

1

agcgtg

-3122

-3117

-1

tgcgtg

-2882

-2877

-1

agcgtg

-629

-624

-1

ggcgtg

-3476

-3471

1

ggcgtg

-3106

-3101

-1

tgcgtg

-2371

-2366

-1

ggcgtg

-2312

-2307

-1

tgcgtg

-2072

-2067

-1

agcgtg

-4585
-1147
-593
-11
-3462
-3163
-2354
-1147
-593
-11
-3994
-3121
-3028
-2933
-2886
-2842
-2749
-1985
-1912
-1723
-1616
-1309
-1225
-1129
-204
-4007
-4005
-2073
-1107
-3478
-2685
-1952
-4240
-4141
-4030
-3458
-3452
-3296
-3099
-4806
-2894
-2740
-1791
-1760
-3571
-1913
-2802
-1900
-1043
-2638
-2352
-1487
-4225
-4981
-557
-251

-4580
-1142
-588
-6
-3457
-3158
-2349
-1142
-588
-6
-3989
-3116
-3023
-2928
-2881
-2837
-2744
-1980
-1907
-1718
-1611
-1304
-1220
-1124
-199
-4002
-4000
-2068
-1102
-3473
-2680
-1947
-4235
-4136
-4025
-3453
-3447
-3291
-3094
-4801
-2889
-2735
-1786
-1755
-3566
-1908
-2797
-1895
-1038
-2633
-2347
-1482
-4220
-4976
-552
-246

1
1
1
1
1
-1
1
1
1
1
-1
-1
-1
-1
-1
-1
-1
1
-1
1
1
-1
1
-1
1
-1
1
1
1
1
-1
-1
-1
1
-1
1
-1
-1
1
-1
-1
-1
1
1
-1
-1
-1
-1
1
1
1
1
1
1
1
1

agcgtg
agcgtg
tgcgtg
cgcgtg
tgcgtg
tgcgtg
tgcgtg
agcgtg
tgcgtg
cgcgtg
tgcgtg
tgcgtg
tgcgtg
tgcgtg
ggcgtg
tgcgtg
tgcgtg
ggcgtg
cgcgtg
agcgtg
cgcgtg
agcgtg
agcgtg
agcgtg
ggcgtg
cgcgtg
cgcgtg
tgcgtg
agcgtg
cgcgtg
agcgtg
agcgtg
cgcgtg
ggcgtg
tgcgtg
cgcgtg
cgcgtg
agcgtg
tgcgtg
agcgtg
agcgtg
agcgtg
tgcgtg
tgcgtg
ggcgtg
agcgtg
cgcgtg
tgcgtg
agcgtg
ggcgtg
cgcgtg
tgcgtg
agcgtg
tgcgtg
ggcgtg
agcgtg

-734

-729

-1

cgcgtg

-561

-556

-1

agcgtg

-527

-522

-1

tgcgtg

-533

-528

-1

cgcgtg

-360

-355

-1

agcgtg

-326
-2734

-321
-2729

-1
-1

tgcgtg
cgcgtg

Supplementary Table 2 (cont.). Location of putative AHREs
Gene ID
Transcript ID
Affy IDs
Dr.7236.1.A1_at,Dr.7236.1.A1_at
ENSDARG00000043618
ENSDART00000064041
ENSDARG00000043618
ENSDART00000064044
Dr.7236.1.A1_at,Dr.7236.1.A1_at
ENSDARG00000043618
ENSDART00000064044
Dr.7236.1.A1_at,Dr.7236.1.A1_at
ENSDARG00000043670

ENSDART00000024462

ENSDARG00000043670
ENSDARG00000043692
ENSDARG00000043692
ENSDARG00000043692
ENSDARG00000043692
ENSDARG00000043692
ENSDARG00000043692
ENSDARG00000043692
ENSDARG00000043960
ENSDARG00000043960
ENSDARG00000043960
ENSDARG00000043960
ENSDARG00000043990
ENSDARG00000043997
ENSDARG00000043997
ENSDARG00000043997
ENSDARG00000043997
ENSDARG00000044001
ENSDARG00000044001
ENSDARG00000044002
ENSDARG00000044002
ENSDARG00000044002
ENSDARG00000044002
ENSDARG00000044002
ENSDARG00000044002
ENSDARG00000044002
ENSDARG00000044002
ENSDARG00000044002
ENSDARG00000044101
ENSDARG00000044101
ENSDARG00000044125
ENSDARG00000044125
ENSDARG00000044176
ENSDARG00000044176
ENSDARG00000044176
ENSDARG00000044176
ENSDARG00000044176
ENSDARG00000044176
ENSDARG00000044176
ENSDARG00000044176
ENSDARG00000044613
ENSDARG00000044613
ENSDARG00000044613
ENSDARG00000044613
ENSDARG00000044625
ENSDARG00000044625
ENSDARG00000044936
ENSDARG00000044936
ENSDARG00000044936
ENSDARG00000044975
ENSDARG00000044975
ENSDARG00000044975
ENSDARG00000044975
ENSDARG00000044975
ENSDARG00000044983
ENSDARG00000045180
ENSDARG00000045230
ENSDARG00000045230
ENSDARG00000045230
ENSDARG00000045230
ENSDARG00000045230
ENSDARG00000045230
ENSDARG00000045230
ENSDARG00000045230
ENSDARG00000045407
ENSDARG00000045407
ENSDARG00000045407

ENSDART00000024462
ENSDART00000064157
ENSDART00000064157
ENSDART00000064157
ENSDART00000064157
ENSDART00000064157
ENSDART00000064157
ENSDART00000064157
ENSDART00000064542
ENSDART00000064542
ENSDART00000064542
ENSDART00000064542
ENSDART00000064579
ENSDART00000064586
ENSDART00000064586
ENSDART00000064586
ENSDART00000064586
ENSDART00000064597
ENSDART00000064597
ENSDART00000064591
ENSDART00000064591
ENSDART00000064591
ENSDART00000064591
ENSDART00000064591
ENSDART00000064596
ENSDART00000064596
ENSDART00000064596
ENSDART00000064596
ENSDART00000064753
ENSDART00000064753
ENSDART00000064789
ENSDART00000064789
ENSDART00000064858
ENSDART00000064858
ENSDART00000064858
ENSDART00000064858
ENSDART00000064858
ENSDART00000064858
ENSDART00000064858
ENSDART00000064858
ENSDART00000014927
ENSDART00000014927
ENSDART00000014927
ENSDART00000014927
ENSDART00000065562
ENSDART00000065562
ENSDART00000066051
ENSDART00000066051
ENSDART00000066051
ENSDART00000030103
ENSDART00000030103
ENSDART00000030103
ENSDART00000030103
ENSDART00000030103
ENSDART00000066126
ENSDART00000066430
ENSDART00000066506
ENSDART00000066506
ENSDART00000066506
ENSDART00000066506
ENSDART00000066506
ENSDART00000066506
ENSDART00000066506
ENSDART00000066506
ENSDART00000066773
ENSDART00000066773
ENSDART00000066773

ENSDARG00000045567

ENSDART00000067004

ENSDARG00000045567

ENSDART00000067004

ENSDARG00000045567
ENSDARG00000045585
ENSDARG00000045585
ENSDARG00000045678
ENSDARG00000045678
ENSDARG00000045678
ENSDARG00000045678
ENSDARG00000045678

ENSDART00000067004
ENSDART00000067027
ENSDART00000067027
ENSDART00000067159
ENSDART00000067159
ENSDART00000067159
ENSDART00000067159
ENSDART00000067159

Dr.1605.1.S1_at
Dr.1605.1.S1_at
Dr.19877.1.S1_at
Dr.19877.1.S1_at
Dr.19877.1.S1_at
Dr.19877.1.S1_at
Dr.19877.1.S1_at
Dr.19877.1.S1_at
Dr.19877.1.S1_at
Dr.6147.1.A1_at
Dr.6147.1.A1_at
Dr.6147.1.A1_at
Dr.6147.1.A1_at
Dr.7806.1.A1_at
Dr.11609.1.S1_at
Dr.11609.1.S1_at
Dr.11609.1.S1_at
Dr.11609.1.S1_at
Dr.20815.3.A1_at
Dr.20815.3.A1_at
Dr.11609.1.S1_at,Dr.11609.1.S1_at
Dr.11609.1.S1_at,Dr.11609.1.S1_at
Dr.11609.1.S1_at,Dr.11609.1.S1_at
Dr.11609.1.S1_at,Dr.11609.1.S1_at
Dr.11609.1.S1_at,Dr.11609.1.S1_at
Dr.11609.1.S1_at,Dr.11609.1.S1_at
Dr.11609.1.S1_at,Dr.11609.1.S1_at
Dr.11609.1.S1_at,Dr.11609.1.S1_at
Dr.11609.1.S1_at,Dr.11609.1.S1_at
Dr.18135.1.A1_at
Dr.18135.1.A1_at
Dr.8723.1.S1_at
Dr.8723.1.S1_at
Dr.23470.1.S1_s_at,Dr.8198.1.A1_at
Dr.23470.1.S1_s_at,Dr.8198.1.A1_at
Dr.23470.1.S1_s_at,Dr.8198.1.A1_at
Dr.23470.1.S1_s_at,Dr.8198.1.A1_at
Dr.23470.1.S1_s_at,Dr.8198.1.A1_at
Dr.23470.1.S1_s_at,Dr.8198.1.A1_at
Dr.23470.1.S1_s_at,Dr.8198.1.A1_at
Dr.23470.1.S1_s_at,Dr.8198.1.A1_at
Dr.14041.1.S1_at
Dr.14041.1.S1_at
Dr.14041.1.S1_at
Dr.14041.1.S1_at
Dr.14268.1.A1_at,Dr.18893.1.S1_at
Dr.14268.1.A1_at,Dr.18893.1.S1_at
Dr.7110.1.S1_at
Dr.7110.1.S1_at
Dr.7110.1.S1_at
Dr.1361.1.S1_at
Dr.1361.1.S1_at
Dr.1361.1.S1_at
Dr.1361.1.S1_at
Dr.1361.1.S1_at
Dr.7110.1.S1_at
Dr.20277.1.A1_at
Dr.956.1.S1_at
Dr.956.1.S1_at
Dr.956.1.S1_at
Dr.956.1.S1_at
Dr.956.1.S1_at
Dr.956.1.S1_at
Dr.956.1.S1_at
Dr.956.1.S1_at
Dr.10879.1.A1_at
Dr.10879.1.A1_at
Dr.10879.1.A1_at
Dr.13994.1.S1_x_at,Dr.13994.2.A1_a_at,Dr.13994.1.S1_at,Dr.13994.2.A1_x_
at,Dr.2819.1.A1_at
Dr.13994.1.S1_x_at,Dr.13994.2.A1_a_at,Dr.13994.1.S1_at,Dr.13994.2.A1_x_
at,Dr.2819.1.A1_at
Dr.13994.1.S1_x_at,Dr.13994.2.A1_a_at,Dr.13994.1.S1_at,Dr.13994.2.A1_x_
at,Dr.2819.1.A1_at
Dr.13689.1.S1_at
Dr.13689.1.S1_at
Dr.15819.1.A1_at,Dr.17776.1.A1_at
Dr.15819.1.A1_at,Dr.17776.1.A1_at
Dr.15819.1.A1_at,Dr.17776.1.A1_at
Dr.15819.1.A1_at,Dr.17776.1.A1_at
Dr.15819.1.A1_at,Dr.17776.1.A1_at

Symbol

Description

NM_001013259.1
zgc:66133
zgc:66133
zgc:66133
zgc:66133
zgc:66133
zgc:66133
zgc:66133
zgc:77150
zgc:77150
zgc:77150
zgc:77150

serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 (serpina1), mRNA
[Source:RefSeq_dna;Acc:NM_001013259]
serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 (serpina1), mRNA
[Source:RefSeq_dna;Acc:NM_001013259]
hypothetical protein LOC393468 [Source:RefSeq_peptide;Acc:NP_956790]
hypothetical protein LOC393468 [Source:RefSeq_peptide;Acc:NP_956790]
hypothetical protein LOC393468 [Source:RefSeq_peptide;Acc:NP_956790]
hypothetical protein LOC393468 [Source:RefSeq_peptide;Acc:NP_956790]
hypothetical protein LOC393468 [Source:RefSeq_peptide;Acc:NP_956790]
hypothetical protein LOC393468 [Source:RefSeq_peptide;Acc:NP_956790]
hypothetical protein LOC393468 [Source:RefSeq_peptide;Acc:NP_956790]
hypothetical protein LOC406587 [Source:RefSeq_peptide;Acc:NP_999913]
hypothetical protein LOC406587 [Source:RefSeq_peptide;Acc:NP_999913]
hypothetical protein LOC406587 [Source:RefSeq_peptide;Acc:NP_999913]
hypothetical protein LOC406587 [Source:RefSeq_peptide;Acc:NP_999913]

Q7SZD0_BRARE
Q7SZD0_BRARE
Q7SZD0_BRARE
Q7SZD0_BRARE
NP_999858.1
NP_999858.1
NP_001002187.1
NP_001002187.1
NP_001002187.1
NP_001002187.1
NP_001002187.1
NP_001002187.1
NP_001002187.1
NP_001002187.1
NP_001002187.1
zgc:92568
zgc:92568
zgc:92903
zgc:92903
krml2.2
krml2.2
krml2.2
krml2.2
krml2.2
krml2.2
krml2.2
krml2.2
NP_001005976.1
NP_001005976.1
NP_001005976.1
NP_001005976.1
zgc:92226
zgc:92226
zgc:77614
zgc:77614
zgc:77614

LOC402847 protein (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q7SZD0]
LOC402847 protein (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q7SZD0]
LOC402847 protein (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q7SZD0]
LOC402847 protein (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q7SZD0]
chimera galectin Gal3 [Source:RefSeq_peptide;Acc:NP_999858]
chimera galectin Gal3 [Source:RefSeq_peptide;Acc:NP_999858]
hypothetical protein LOC431734 [Source:RefSeq_peptide;Acc:NP_001002187]
hypothetical protein LOC431734 [Source:RefSeq_peptide;Acc:NP_001002187]
hypothetical protein LOC431734 [Source:RefSeq_peptide;Acc:NP_001002187]
hypothetical protein LOC431734 [Source:RefSeq_peptide;Acc:NP_001002187]
hypothetical protein LOC431734 [Source:RefSeq_peptide;Acc:NP_001002187]
hypothetical protein LOC431734 [Source:RefSeq_peptide;Acc:NP_001002187]
hypothetical protein LOC431734 [Source:RefSeq_peptide;Acc:NP_001002187]
hypothetical protein LOC431734 [Source:RefSeq_peptide;Acc:NP_001002187]
hypothetical protein LOC431734 [Source:RefSeq_peptide;Acc:NP_001002187]
zgc:92568 [Source:RefSeq_peptide;Acc:NP_001005937]
zgc:92568 [Source:RefSeq_peptide;Acc:NP_001005937]
zgc:92903 [Source:RefSeq_peptide;Acc:NP_001002461]
zgc:92903 [Source:RefSeq_peptide;Acc:NP_001002461]
Kreisler (mouse) maf-related leucine zipper homolog 2.2 [Source:RefSeq_peptide;Acc:NP_571917]
Kreisler (mouse) maf-related leucine zipper homolog 2.2 [Source:RefSeq_peptide;Acc:NP_571917]
Kreisler (mouse) maf-related leucine zipper homolog 2.2 [Source:RefSeq_peptide;Acc:NP_571917]
Kreisler (mouse) maf-related leucine zipper homolog 2.2 [Source:RefSeq_peptide;Acc:NP_571917]
Kreisler (mouse) maf-related leucine zipper homolog 2.2 [Source:RefSeq_peptide;Acc:NP_571917]
Kreisler (mouse) maf-related leucine zipper homolog 2.2 [Source:RefSeq_peptide;Acc:NP_571917]
Kreisler (mouse) maf-related leucine zipper homolog 2.2 [Source:RefSeq_peptide;Acc:NP_571917]
Kreisler (mouse) maf-related leucine zipper homolog 2.2 [Source:RefSeq_peptide;Acc:NP_571917]
hypothetical protein LOC449803 [Source:RefSeq_peptide;Acc:NP_001005976]
hypothetical protein LOC449803 [Source:RefSeq_peptide;Acc:NP_001005976]
hypothetical protein LOC449803 [Source:RefSeq_peptide;Acc:NP_001005976]
hypothetical protein LOC449803 [Source:RefSeq_peptide;Acc:NP_001005976]
hypothetical protein LOC492341 [Source:RefSeq_peptide;Acc:NP_001007308]
hypothetical protein LOC492341 [Source:RefSeq_peptide;Acc:NP_001007308]
hypothetical protein LOC393868 [Source:RefSeq_peptide;Acc:NP_957188]
hypothetical protein LOC393868 [Source:RefSeq_peptide;Acc:NP_957188]
hypothetical protein LOC393868 [Source:RefSeq_peptide;Acc:NP_957188]

NP_997785.1
NP_001002695.1
NP_001002695.1
NP_001002695.1
NP_001002695.1
NP_001002695.1
NP_001002695.1
NP_001002695.1
NP_001002695.1
NP_001018414.1
NP_001018414.1
NP_001018414.1

actin, alpha 2, smooth muscle, aorta [Source:RefSeq_peptide;Acc:NP_997785]
zgc:92631 [Source:RefSeq_peptide;Acc:NP_001002695]
zgc:92631 [Source:RefSeq_peptide;Acc:NP_001002695]
zgc:92631 [Source:RefSeq_peptide;Acc:NP_001002695]
zgc:92631 [Source:RefSeq_peptide;Acc:NP_001002695]
zgc:92631 [Source:RefSeq_peptide;Acc:NP_001002695]
zgc:92631 [Source:RefSeq_peptide;Acc:NP_001002695]
zgc:92631 [Source:RefSeq_peptide;Acc:NP_001002695]
zgc:92631 [Source:RefSeq_peptide;Acc:NP_001002695]
hypothetical protein LOC553602 [Source:RefSeq_peptide;Acc:NP_001018414]
hypothetical protein LOC553602 [Source:RefSeq_peptide;Acc:NP_001018414]
hypothetical protein LOC553602 [Source:RefSeq_peptide;Acc:NP_001018414]

NM_001013259.1

zgc:101086
zgc:101086
zgc:101086
zgc:66449
zgc:66449
tph1l
tph1l
tph1l
tph1l
tph1l

hypothetical protein LOC445172 [Source:RefSeq_peptide;Acc:NP_001003566]
hypothetical protein LOC445172 [Source:RefSeq_peptide;Acc:NP_001003566]
hypothetical protein LOC445172 [Source:RefSeq_peptide;Acc:NP_001003566]
Unknown (protein for MGC:66449) [Source:RefSeq_peptide;Acc:NP_956095]
Unknown (protein for MGC:66449) [Source:RefSeq_peptide;Acc:NP_956095]
tryptophan hydroxylase 1, like [Source:RefSeq_peptide;Acc:NP_001001843]
tryptophan hydroxylase 1, like [Source:RefSeq_peptide;Acc:NP_001001843]
tryptophan hydroxylase 1, like [Source:RefSeq_peptide;Acc:NP_001001843]
tryptophan hydroxylase 1, like [Source:RefSeq_peptide;Acc:NP_001001843]
tryptophan hydroxylase 1, like [Source:RefSeq_peptide;Acc:NP_001001843]
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Start
-2732
-2734
-2732

End
-2727
-2729
-2727

Strand
1
-1
1

Sequence
cgcgtg
cgcgtg
cgcgtg

-4819

-4814

1

agcgtg

-4143
-3071
-2789
-2454
-1360
-942
-105
-16
-3939
-4689
-552
-4539
-138
-2929
-600
-552
-67
-3720
-371
-3995
-4812
-4972
-1517
-439
-1653
-1300
-1140
-323
-4881
-475
-1108
-48
-3256
-1753
-76
-43
-3256
-1753
-76
-43
-3600
-3377
-58
-39
-4982
-251
-3792
-3267
-4066
-3650
-2276
-1621
-4656
-50
-3372
-2999
-3672
-3639
-3033
-1880
-294
-22
-4498
-4452
-3212
-877
-100

-4138
-3066
-2784
-2449
-1355
-937
-100
-11
-3934
-4684
-547
-4534
-133
-2924
-595
-547
-62
-3715
-366
-3990
-4807
-4967
-1512
-434
-1648
-1295
-1135
-318
-4876
-470
-1103
-43
-3251
-1748
-71
-38
-3251
-1748
-71
-38
-3595
-3372
-53
-34
-4977
-246
-3787
-3262
-4061
-3645
-2271
-1616
-4651
-45
-3367
-2994
-3667
-3634
-3028
-1875
-289
-17
-4493
-4447
-3207
-872
-95

1
-1
1
-1
1
-1
-1
-1
-1
1
1
1
1
-1
-1
-1
1
-1
-1
-1
-1
-1
1
-1
-1
-1
-1
-1
1
1
-1
1
-1
-1
1
1
-1
-1
1
1
1
1
-1
1
1
1
1
1
1
1
1
-1
-1
1
1
1
1
-1
-1
1
-1
-1
-1
-1
-1
1
-1

agcgtg
tgcgtg
cgcgtg
ggcgtg
ggcgtg
cgcgtg
cgcgtg
cgcgtg
agcgtg
cgcgtg
tgcgtg
tgcgtg
tgcgtg
agcgtg
tgcgtg
tgcgtg
ggcgtg
tgcgtg
tgcgtg
tgcgtg
agcgtg
tgcgtg
tgcgtg
tgcgtg
ggcgtg
tgcgtg
agcgtg
tgcgtg
ggcgtg
agcgtg
agcgtg
tgcgtg
agcgtg
tgcgtg
ggcgtg
agcgtg
agcgtg
tgcgtg
ggcgtg
agcgtg
ggcgtg
cgcgtg
tgcgtg
agcgtg
tgcgtg
agcgtg
tgcgtg
cgcgtg
tgcgtg
cgcgtg
agcgtg
ggcgtg
tgcgtg
agcgtg
agcgtg
agcgtg
tgcgtg
cgcgtg
agcgtg
ggcgtg
tgcgtg
ggcgtg
tgcgtg
tgcgtg
tgcgtg
agcgtg
agcgtg

-2856

-2851

-1

tgcgtg

-2844

-2839

-1

agcgtg

-2742
-2806
-4153
-3633
-1855
-1704
-240
-56

-2737
-2801
-4148
-3628
-1850
-1699
-235
-51

-1
-1
-1
1
1
-1
-1
1

ggcgtg
cgcgtg
tgcgtg
tgcgtg
agcgtg
agcgtg
agcgtg
cgcgtg

Supplementary Table 3. Location of putative EREs
Gene ID
Transcript ID
ENSDARG00000000935
ENSDART00000001053
ENSDARG00000001953
ENSDART00000003247
ENSDARG00000002667

ENSDART00000003004

ENSDARG00000002667
ENSDARG00000003323
ENSDARG00000003323

ENSDART00000003004
ENSDART00000017567
ENSDART00000017567

ENSDARG00000004296
ENSDARG00000005186
ENSDARG00000006526
ENSDARG00000008835
ENSDARG00000008835
ENSDARG00000008895
ENSDARG00000008895
ENSDARG00000009483
ENSDARG00000009483
ENSDARG00000013454
ENSDARG00000013613

ENSDART00000027026
ENSDART00000002285
ENSDART00000017312
ENSDART00000021286
ENSDART00000021286
ENSDART00000040312
ENSDART00000044775
ENSDART00000009889
ENSDART00000009889
ENSDART00000019328
ENSDART00000018408

ENSDARG00000013646
ENSDARG00000014209
ENSDARG00000015866
ENSDARG00000015866
ENSDARG00000015866
ENSDARG00000016448
ENSDARG00000016448
ENSDARG00000016448
ENSDARG00000016825
ENSDARG00000016825
ENSDARG00000016825
ENSDARG00000016825
ENSDARG00000016825
ENSDARG00000016825
ENSDARG00000016825
ENSDARG00000016825

ENSDART00000019664
ENSDART00000023208
ENSDART00000019110
ENSDART00000058963
ENSDART00000058964
ENSDART00000014979
ENSDART00000014979
ENSDART00000014979
ENSDART00000050238
ENSDART00000050238
ENSDART00000050238
ENSDART00000050238
ENSDART00000050238
ENSDART00000050238
ENSDART00000050238
ENSDART00000050238

ENSDARG00000017289

ENSDART00000047865

ENSDARG00000017289

ENSDART00000050670

ENSDARG00000017289

ENSDART00000047865

ENSDARG00000017289
ENSDARG00000017619
ENSDARG00000017619
ENSDARG00000017624
ENSDARG00000018529
ENSDARG00000019302
ENSDARG00000019862
ENSDARG00000020485
ENSDARG00000021443
ENSDARG00000023820
ENSDARG00000023963

ENSDART00000050670
ENSDART00000038499
ENSDART00000038499
ENSDART00000012644
ENSDART00000020541
ENSDART00000007649
ENSDART00000009054
ENSDART00000011573
ENSDART00000014168
ENSDART00000038657
ENSDART00000036075

ENSDARG00000024892

ENSDART00000033228

ENSDARG00000024892

ENSDART00000033228

ENSDARG00000024892

ENSDART00000033228

ENSDARG00000024892

ENSDART00000033228

ENSDARG00000025400

ENSDART00000044869

ENSDARG00000025400

ENSDART00000046418

ENSDARG00000025400

ENSDART00000061150

ENSDARG00000025400

ENSDART00000061161

ENSDARG00000025400
ENSDARG00000026039
ENSDARG00000026090

ENSDART00000061165
ENSDART00000038200
ENSDART00000035302

Affy IDs
Dr.24249.1.S1_at
Dr.7626.1.A1_at,Dr.7626.2.S1_at
Dr.23470.1.S1_s_at,Dr.8198.1.A1_at

Symbol
zc3hdc5
NP_998562.1

krml2.2
dcp1a
dcp1a

Description
zinc finger CCCH type domain containing 5 [Source:RefSeq_peptide;Acc:NP_956530]
zgc:73257 [Source:RefSeq_peptide;Acc:NP_998562]
Kreisler (mouse) maf-related leucine zipper homolog 2.2
[Source:RefSeq_peptide;Acc:NP_571917]
Kreisler (mouse) maf-related leucine zipper homolog 2.2
[Source:RefSeq_peptide;Acc:NP_571917]
decapping enzyme [Source:RefSeq_peptide;Acc:NP_878313]
decapping enzyme [Source:RefSeq_peptide;Acc:NP_878313]

zgc:66321
NP_956418.1
fn1b

sp4 transcription factor [Source:RefSeq_peptide;Acc:NP_956418]
fibronectin 1b (fn1b), mRNA [Source:RefSeq_dna;Acc:NM_001013261]

krml2.2
Dr.23470.1.S1_s_at,Dr.8198.1.A1_at

ENSDARG00000026680

ENSDART00000036600

ENSDARG00000026680
ENSDARG00000027088
ENSDARG00000027088
ENSDARG00000027088
ENSDARG00000027088

ENSDART00000036600
ENSDART00000039267
ENSDART00000039267
ENSDART00000039267
ENSDART00000039267

ENSDARG00000027924

ENSDART00000051147

ENSDARG00000027924

ENSDART00000051147

ENSDARG00000027924

ENSDART00000051147

Dr.12575.1.S1_at
Dr.12575.1.S1_at
Dr.2426.1.S1_at
Dr.26469.1.S1_at
Dr.24233.1.S1_at
Dr.4412.13.A1_x_at
Dr.4412.13.A1_x_at
Dr.1619.1.A1_at,Dr.1619.1.A1_at,Dr.1619.1.A1_at
Dr.1619.1.A1_at,Dr.1619.1.A1_at,Dr.1619.1.A1_at
Dr.25378.1.A1_at,Dr.24858.1.S1_at
Dr.25378.1.A1_at,Dr.24858.1.S1_at
Dr.16524.1.S1_at
Dr.16504.1.A1_at
Dr.1605.1.S1_at

similar to alpha-1-microglobulin/bikunin precursor [Source:RefSeq_peptide;Acc:NP_957412]

zgc:110540
zgc:110540
wu:fc12b04
zgc:112421

deoxycytidine kinase [Source:RefSeq_peptide;Acc:NP_001014374]
deoxycytidine kinase [Source:RefSeq_peptide;Acc:NP_001014374]
protein-glutamine gamma-glutamyltransferase [Source:RefSeq_peptide;Acc:NP_997821]
hypothetical protein LOC554118 [Source:RefSeq_peptide;Acc:NP_001019585]
serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
serpina1
[Source:RefSeq_peptide;Acc:NP_001013277]
NP_001017836.1 hypothetical protein LOC550534 [Source:RefSeq_peptide;Acc:NP_001017836]

Dr.15930.1.A1_at
Dr.728.4.S1_at,Dr.728.4.S1_at,Dr.728.4.S1_at
Dr.728.4.S1_at,Dr.728.4.S1_at,Dr.728.4.S1_at
Dr.728.4.S1_at,Dr.728.4.S1_at,Dr.728.4.S1_at
vg3
Dr.2978.1.S1_at
vg3
Dr.2978.1.S1_at
vg3
Dr.2978.1.S1_at
NP_739573.1
Dr.25009.6.A1_a_at,Dr.25009.1.S1_a_at
NP_739573.1
Dr.25009.6.A1_a_at,Dr.25009.1.S1_a_at
NP_739573.1
Dr.25009.6.A1_a_at,Dr.25009.1.S1_a_at
NP_739573.1
Dr.25009.6.A1_a_at,Dr.25009.1.S1_a_at
NP_739573.1
Dr.25009.6.A1_a_at,Dr.25009.1.S1_a_at
NP_739573.1
Dr.25009.6.A1_a_at,Dr.25009.1.S1_a_at
NP_739573.1
Dr.25009.6.A1_a_at,Dr.25009.1.S1_a_at
NP_739573.1
Dr.25009.6.A1_a_at,Dr.25009.1.S1_a_at
Dr.25331.1.S1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.25331.1.S1_at,Dr.25379.1.S1_a
t,Dr.3025.3.S1_at
Dr.25331.1.S1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.25331.1.S1_at,Dr.25379.1.S1_a
t,Dr.3025.3.S1_at
Dr.25331.1.S1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.25331.1.S1_at,Dr.25379.1.S1_a
t,Dr.3025.3.S1_at
Dr.25331.1.S1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.25331.1.S1_at,Dr.25379.1.S1_a
t,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at
krt4
Dr.4387.1.S1_at
lipf
Dr.4249.1.S1_at
zgc:73223
Dr.25285.1.S1_at,Dr.11211.1.S1_at
zgc:63909
Dr.913.1.S1_at
Dr.10314.1.S1_a_at
NP_955943.1
Dr.24122.1.A1_at
zgc:55420
Dr.8390.1.S1_at
Dr.913.1.S1_at
Dr.3025.2.S1_at,Dr.3025.3.S1_at,Dr.25331.1.S1_at,Dr.25379.1.S1_at,Dr.3025.2.S1_at,D
r.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.1.A1_at,Dr.3025.3.S1_at
Dr.3025.2.S1_at,Dr.3025.3.S1_at,Dr.25331.1.S1_at,Dr.25379.1.S1_at,Dr.3025.2.S1_at,D
r.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.1.A1_at,Dr.3025.3.S1_at
Dr.3025.2.S1_at,Dr.3025.3.S1_at,Dr.25331.1.S1_at,Dr.25379.1.S1_at,Dr.3025.2.S1_at,D
r.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.1.A1_at,Dr.3025.3.S1_at
Dr.3025.2.S1_at,Dr.3025.3.S1_at,Dr.25331.1.S1_at,Dr.25379.1.S1_at,Dr.3025.2.S1_at,D
r.3025.3.S1_at,Dr.25379.1.S1_at,Dr.3025.1.A1_at,Dr.3025.3.S1_at
Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_
at
Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_
at
Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_
at
Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_
at
Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_at,Dr.25009.4.A1_
at
cyp1a
Dr.9478.1.S1_at
zgc:64213
Dr.12833.1.A1_at
Dr.26139.1.A1_at,Dr.26139.1.A1_x_at
slc25a14
Dr.26139.1.A1_at,Dr.26139.1.A1_x_at
slc25a14
wu:fb11h03
Dr.1192.1.S1_at,Dr.1192.1.S1_a_at
wu:fb11h03
Dr.1192.1.S1_at,Dr.1192.1.S1_a_at
wu:fb11h03
Dr.1192.1.S1_at,Dr.1192.1.S1_a_at
wu:fb11h03
Dr.1192.1.S1_at,Dr.1192.1.S1_a_at
Dr.25593.2.A1_at,Dr.25593.1.S1_at,Dr.4412.12.A1_at,Dr.25593.2.A1_at,Dr.25593.1.S1_
at,Dr.4412.12.A1_at,Dr.25527.1.A1_x_at,Dr.25527.1.A1_at
Dr.25593.2.A1_at,Dr.25593.1.S1_at,Dr.4412.12.A1_at,Dr.25593.2.A1_at,Dr.25593.1.S1_
at,Dr.4412.12.A1_at,Dr.25527.1.A1_x_at,Dr.25527.1.A1_at
Dr.25593.2.A1_at,Dr.25593.1.S1_at,Dr.4412.12.A1_at,Dr.25593.2.A1_at,Dr.25593.1.S1_
at,Dr.4412.12.A1_at,Dr.25527.1.A1_x_at,Dr.25527.1.A1_at
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Vitellogenin 3 (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q9DFT9]
Vitellogenin 3 (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q9DFT9]
Vitellogenin 3 (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q9DFT9]
vitellogenin 1 [Source:RefSeq_peptide;Acc:NP_739573]
vitellogenin 1 [Source:RefSeq_peptide;Acc:NP_739573]
vitellogenin 1 [Source:RefSeq_peptide;Acc:NP_739573]
vitellogenin 1 [Source:RefSeq_peptide;Acc:NP_739573]
vitellogenin 1 [Source:RefSeq_peptide;Acc:NP_739573]
vitellogenin 1 [Source:RefSeq_peptide;Acc:NP_739573]
vitellogenin 1 [Source:RefSeq_peptide;Acc:NP_739573]
vitellogenin 1 [Source:RefSeq_peptide;Acc:NP_739573]

keratin 4 [Source:RefSeq_peptide;Acc:NP_571584]
lipase, gastric [Source:RefSeq_peptide;Acc:NP_998569]
hypothetical protein MGC73223 [Source:RefSeq_peptide;Acc:NP_957126]
tropomyosin 4 isoform 2 [Source:RefSeq_peptide;Acc:NP_998323]
CCCH zinc finger protein C3H-2 [Source:RefSeq_peptide;Acc:NP_955943]
hypothetical protein LOC406828 [Source:RefSeq_peptide;Acc:NP_998672]

cytochrome P450, family 1, subfamily A [Source:RefSeq_peptide;Acc:NP_571954]
hypothetical protein LOC393393 [Source:RefSeq_peptide;Acc:NP_956715]
solute carrier family 25 (mitochondrial carrier, brain), member 14
[Source:RefSeq_peptide;Acc:NP_956458]
solute carrier family 25 (mitochondrial carrier, brain), member 14
[Source:RefSeq_peptide;Acc:NP_956458]
prostaglandin D2 synthase [Source:RefSeq_peptide;Acc:NP_998799]
prostaglandin D2 synthase [Source:RefSeq_peptide;Acc:NP_998799]
prostaglandin D2 synthase [Source:RefSeq_peptide;Acc:NP_998799]
prostaglandin D2 synthase [Source:RefSeq_peptide;Acc:NP_998799]

Start
End
-2575
-2557
135
153

Strand
1
1

Sequence
aaagttaactgtgaccttt
aaaagcctctgtgacctgc

-1337

-1319

-1

tccagcaactgtgaccaac

-1337
-1949
-381

-1319
-1931
-363

-1
1
1

tccagcaactgtgaccaac
tcaaggacccatgacccga
gtgagtaaacatgacctga

-4061
-1496
-1176
-3795
-613
-3866
-3872
-2635
-2635
-4284
-2201

-4043
-1478
-1158
-3777
-595
-3848
-3854
-2617
-2617
-4266
-2183

-1
1
-1
1
1
1
1
1
1
1
1

atagtgtaatatgacccta
tgacgtcactgtgacgcgt
tccagttactatgaccatt
caagtttgacgtgacccta
gaagggcacggtgacattt
caacatcactctgaccaga
caacatcactctgaccaga
tcagttcattttgatctag
tcagttcattttgatctag
ggaggccgctgtgaactga
atggattgctttgacctgt

-267
-1492
-1647
-1945
-1647
-386
-386
-4076
-3275
-3275
-2166
-175
-3275
-3275
-2166
-175

-249
-1474
-1629
-1927
-1629
-368
-368
-4058
-3257
-3257
-2148
-157
-3257
-3257
-2148
-157

-1
1
-1
-1
-1
-1
1
1
1
-1
1
1
1
-1
1
1

ttatgggaccttgaccttt
tttttttactgtgacctga
gctatttattttgacctta
gctatttattttgacctta
gctatttattttgacctta
acaggtcaatgtgatcagt
actgatcacattgacctgt
actaataattttgacctta
acaggttaaagtgacattt
aaatgtcactttaacctgt
gcagggcaacctaacccaa
acaggccaggttaacctaa
acaggttaaagtgacattt
aaatgtcactttaacctgt
gcagggcaacctaacccaa
acaggccaggttaacctaa

-1425

-1407

1

tgagtctaaagtgacccgt

-1728

-1710

1

tgagtctaaagtgacccgt

-1425

-1407

1

tgagtctaaagtgacccgt

-1728
-503
-503
-937
-1057
29
-4507
-1349
-1795
-3604
-4731

-1710
-485
-485
-919
-1039
47
-4489
-1331
-1777
-3586
-4713

1
-1
-1
-1
1
-1
-1
-1
1
1
1

tgagtctaaagtgacccgt
tcaggacactctgatctac
tcaggacactctgatctac
ataggttgtggtgacctaa
tgatgtgggcgtgacctgt
accggataatgtgaccttt
tcaagagaatatgaccaaa
tcgggttgctgtggcctga
tccagttactatgaccatt
gcagcacacactgacccac
tcaagagaatatgaccaaa

-2075

-2057

-1

caaagtgtctctgacccaa

-4197

-4179

-1

gtaggattttgtgaccgga

-2075

-2057

-1

caaagtgtctctgacccaa

-4197

-4179

-1

gtaggattttgtgaccgga

-4281

-4263

1

aaagtgcagtgtgaccggg

-4281

-4263

1

aaagtgcagtgtgaccggg

-4380

-4362

1

aaagtgcagtgtgaccggg

-4281

-4263

1

aaagtgcagtgtgaccggg

-4281
-4819
-36

-4263
-4801
-18

1
1
-1

aaagtgcagtgtgaccggg
aaagttcactctgatctgt
ctagataaccttgaccgga

-774

-756

-1

tcaattcactgcgaccgga

-774
-740
-669
-740
-669

-756
-722
-651
-722
-651

-1
1
1
1
1

tcaattcactgcgaccgga
ttatgtcaaactgaccaaa
ataagttacaatgacccaa
ttatgtcaaactgaccaaa
ataagttacaatgacccaa

-2247

-2229

-1

taaaatcggtttgaccttt

-4561

-4543

-1

caagtttgacgtgacccta

-2247

-2229

-1

taaaatcggtttgaccttt

Supplementary Table 3 (cont.). Location of putative EREs
Gene ID
Transcript ID
Affy IDs
Dr.25593.2.A1_at,Dr.25593.1.S1_at,Dr.4412.12.A1_at,Dr.25593.2.A1_at,Dr.25593.1.S1_
ENSDARG00000027924
ENSDART00000051147
at,Dr.4412.12.A1_at,Dr.25527.1.A1_x_at,Dr.25527.1.A1_at
Dr.25593.2.A1_at,Dr.25593.1.S1_at,Dr.4412.12.A1_at,Dr.25593.2.A1_at,Dr.25593.1.S1_
ENSDARG00000027924
ENSDART00000051147
at,Dr.4412.12.A1_at,Dr.25527.1.A1_x_at,Dr.25527.1.A1_at
Dr.25593.2.A1_at,Dr.25593.1.S1_at,Dr.4412.12.A1_at,Dr.25593.2.A1_at,Dr.25593.1.S1_
ENSDARG00000027924
ENSDART00000051147
at,Dr.4412.12.A1_at,Dr.25527.1.A1_x_at,Dr.25527.1.A1_at
ENSDARG00000029086
ENSDART00000041921
Dr.1282.1.S1_at
ENSDARG00000030236
ENSDART00000011928
Dr.1368.7.S1_at
ENSDARG00000030662
ENSDART00000048550
Dr.9682.1.A1_at
ENSDARG00000031664
ENSDART00000049339
Dr.8215.1.A1_at
ENSDARG00000033735
ENSDART00000049874
Dr.2973.1.A1_at,Dr.2973.1.A1_at
ENSDARG00000033735
ENSDART00000049874
Dr.2973.1.A1_at,Dr.2973.1.A1_at
ENSDARG00000033735
ENSDART00000049874
Dr.2973.1.A1_at,Dr.2973.1.A1_at
ENSDARG00000033735
ENSDART00000050898
Dr.2973.1.A1_at,Dr.2973.1.A1_at
ENSDARG00000033735
ENSDART00000050898
Dr.2973.1.A1_at,Dr.2973.1.A1_at
ENSDARG00000033735
ENSDART00000050898
Dr.2973.1.A1_at,Dr.2973.1.A1_at
ENSDARG00000033770
ENSDART00000011961
Dr.25009.6.A1_a_at
ENSDARG00000035160
ENSDART00000050933
Dr.13775.1.S1_at
ENSDARG00000035743
ENSDART00000051853
Dr.14748.1.S1_at
ENSDARG00000036481
ENSDART00000053001
Dr.6550.1.A1_at
Dr.1411.1.S1_at
ENSDARG00000036517
ENSDART00000053070
ENSDARG00000036519
ENSDART00000053072
Dr.1411.1.S1_at
ENSDARG00000036519
ENSDART00000053072
Dr.1411.1.S1_at
ENSDARG00000036521
ENSDART00000053073
Dr.25155.1.S1_s_at
ENSDARG00000036527
ENSDART00000053078
Dr.1411.1.S1_at
ENSDARG00000036528
ENSDART00000053080
Dr.8723.1.S1_at
ENSDARG00000036531
ENSDART00000053083
Dr.1411.1.S1_at
ENSDARG00000036531
ENSDART00000053083
Dr.1411.1.S1_at
ENSDARG00000036535
ENSDART00000042396
Dr.25155.1.S1_s_at
Dr.16380.1.A1_at
ENSDARG00000036776
ENSDART00000053399
Dr.16380.1.A1_at
ENSDARG00000036776
ENSDART00000053399
ENSDARG00000036893
ENSDART00000053567
Dr.16206.1.A1_at,Dr.16206.1.A1_s_at
ENSDARG00000036893
ENSDART00000053567
Dr.16206.1.A1_at,Dr.16206.1.A1_s_at
ENSDARG00000036893
ENSDART00000053567
Dr.16206.1.A1_at,Dr.16206.1.A1_s_at
ENSDARG00000036893
ENSDART00000053567
Dr.16206.1.A1_at,Dr.16206.1.A1_s_at
ENSDARG00000039027
ENSDART00000056969
Dr.4797.1.S1_at,Dr.4797.1.S1_at
ENSDARG00000039150
ENSDART00000057192
Dr.24341.1.S1_at
ENSDARG00000039728
ENSDART00000037346
Dr.3581.1.S1_at,Dr.3581.1.S1_a_at
ENSDARG00000039747
ENSDART00000058095
Dr.4797.1.S1_at
ENSDARG00000040251
ENSDART00000011497
Dr.4048.1.S1_at
ENSDARG00000040251
ENSDART00000011497
Dr.4048.1.S1_at
ENSDARG00000040251
ENSDART00000011497
Dr.4048.1.S1_at
ENSDARG00000040251
ENSDART00000011497
Dr.4048.1.S1_at
ENSDARG00000040295
ENSDART00000058965
Dr.1246.1.S1_at
ENSDARG00000040527
ENSDART00000059311
Dr.20722.1.S1_at
ENSDARG00000040528
ENSDART00000059314
Dr.5853.1.A1_at
Dr.4212.1.S1_at
ENSDARG00000040856
ENSDART00000059886
Dr.25379.1.S1_at,Dr.23812.1.A1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.23812.1.A1_a
ENSDARG00000041639
ENSDART00000044076
t,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.23812.1.A1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.23812.1.A1_a
ENSDARG00000041639
ENSDART00000044076
t,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.23812.1.A1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.23812.1.A1_a
ENSDARG00000041639
ENSDART00000044076
t,Dr.25379.1.S1_at,Dr.3025.3.S1_at
Dr.25379.1.S1_at,Dr.23812.1.A1_at,Dr.25379.1.S1_at,Dr.3025.3.S1_at,Dr.23812.1.A1_a
ENSDARG00000041639
ENSDART00000044076
t,Dr.25379.1.S1_at,Dr.3025.3.S1_at
ENSDARG00000041653
ENSDART00000061043
Dr.25331.1.S1_at,Dr.25379.1.S1_at,Dr.25331.1.S1_at,Dr.25379.1.S1_at
ENSDARG00000041774
ENSDART00000061223
Dr.25009.6.A1_a_at
ENSDARG00000041774
ENSDART00000061223
Dr.25009.6.A1_a_at
ENSDARG00000042035
ENSDART00000061601
Dr.7110.1.S1_at
ENSDARG00000042040
ENSDART00000061613
Dr.7110.1.S1_at
ENSDARG00000042046
ENSDART00000061618
Dr.7110.1.S1_at
ENSDARG00000042391
ENSDART00000062156
Dr.14748.1.S1_at
ENSDARG00000043618
ENSDART00000064041
Dr.7236.1.A1_at,Dr.7236.1.A1_at
ENSDARG00000043618
ENSDART00000064044
Dr.7236.1.A1_at,Dr.7236.1.A1_at
Dr.1605.1.S1_at
ENSDARG00000043670
ENSDART00000024462
ENSDARG00000043960
ENSDART00000064542
Dr.6147.1.A1_at
ENSDARG00000043990
ENSDART00000064579
Dr.7806.1.A1_at
ENSDARG00000044002
ENSDART00000064591
Dr.11609.1.S1_at,Dr.11609.1.S1_at
ENSDARG00000044125
ENSDART00000064789
Dr.8723.1.S1_at
Dr.23470.1.S1_s_at,Dr.8198.1.A1_at
ENSDARG00000044176
ENSDART00000064858
Dr.23470.1.S1_s_at,Dr.8198.1.A1_at
ENSDARG00000044176
ENSDART00000064858
ENSDARG00000044613
ENSDART00000014927
Dr.14041.1.S1_at
ENSDARG00000044936
ENSDART00000066051
Dr.7110.1.S1_at
ENSDARG00000044936
ENSDART00000066051
Dr.7110.1.S1_at
ENSDARG00000045230
ENSDART00000066506
Dr.956.1.S1_at

Symbol

Description

krt8
zgc:91877

keratin 8 [Source:RefSeq_peptide;Acc:NP_956374]
hypothetical protein LOC337397 [Source:RefSeq_peptide;Acc:NP_997941]

sox21a
Q4Z8P3_BRARE
Q4Z8P3_BRARE
Q4Z8P3_BRARE
Q4Z8P3_BRARE
Q4Z8P3_BRARE
Q4Z8P3_BRARE
vg1

SRY-box 21 [Source:RefSeq_peptide;Acc:NP_571361]
Neutrophil cytosolic factor 1. [Source:Uniprot/SPTREMBL;Acc:Q4Z8P3]
Neutrophil cytosolic factor 1. [Source:Uniprot/SPTREMBL;Acc:Q4Z8P3]
Neutrophil cytosolic factor 1. [Source:Uniprot/SPTREMBL;Acc:Q4Z8P3]
Neutrophil cytosolic factor 1. [Source:Uniprot/SPTREMBL;Acc:Q4Z8P3]
Neutrophil cytosolic factor 1. [Source:Uniprot/SPTREMBL;Acc:Q4Z8P3]
Neutrophil cytosolic factor 1. [Source:Uniprot/SPTREMBL;Acc:Q4Z8P3]
Vitellogenin 1 (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q8JH36]

zgc:63985
Unknown (protein for MGC:63985) [Source:RefSeq_peptide;Acc:NP_956252]
Q6PG35_BRARE LOC407646 protein (Fragment). [Source:Uniprot/SPTREMBL;Acc:Q6PG35]
Novel protein similar to zebrafish hemoglobin alpha-adult 1 (Hbaa1).
si:xx-by187g17.1 [Source:Uniprot/SPTREMBL;Acc:Q6ZM17]
hbaa1
Hemoglobin alpha chain (Alpha globin aa1). [Source:Uniprot/SWISSPROT;Acc:Q90487]
hbaa1
Hemoglobin alpha chain (Alpha globin aa1). [Source:Uniprot/SWISSPROT;Acc:Q90487]
ba2
Hemoglobin beta-1 chain (BetaA1 globin). [Source:Uniprot/SWISSPROT;Acc:Q90486]
si:xx-by187g17.1 hemoglobin alpha adult-1 (hbaa1), mRNA [Source:RefSeq_dna;Acc:NM_131257]
NP_001002461.1 zgc:92903 [Source:RefSeq_peptide;Acc:NP_001002461]
hbaa1
Hemoglobin alpha chain (Alpha globin aa1). [Source:Uniprot/SWISSPROT;Acc:Q90487]
hbaa1
Hemoglobin alpha chain (Alpha globin aa1). [Source:Uniprot/SWISSPROT;Acc:Q90487]
ba2
Hemoglobin beta-1 chain (BetaA1 globin). [Source:Uniprot/SWISSPROT;Acc:Q90486]
NP_001004540.1
NP_001004540.1

aldehyde dehydrogenase 8 family, member A1 [Source:RefSeq_peptide;Acc:NP_001004540]
aldehyde dehydrogenase 8 family, member A1 [Source:RefSeq_peptide;Acc:NP_001004540]

zgc:76953
ctrb1

hypothetical protein LOC406625 [Source:RefSeq_peptide;Acc:NP_999924]
chymotrypsinogen B1 [Source:RefSeq_peptide;Acc:NP_997783]

zgc:110367
zgc:110367
zgc:110367
zgc:110367
apoeb
NP_956583.1
zgc:77059

hypothetical protein LOC550475 [Source:RefSeq_peptide;Acc:NP_001017778]
hypothetical protein LOC550475 [Source:RefSeq_peptide;Acc:NP_001017778]
hypothetical protein LOC550475 [Source:RefSeq_peptide;Acc:NP_001017778]
hypothetical protein LOC550475 [Source:RefSeq_peptide;Acc:NP_001017778]
Apolipoprotein Eb precursor (Apo-Eb). [Source:Uniprot/SWISSPROT;Acc:O42364]
similar to yolk sac gene 2 [Source:RefSeq_peptide;Acc:NP_956583]
hypothetical protein LOC405809 [Source:RefSeq_peptide;Acc:NP_998038]
L-lactate dehydrogenase A chain (EC 1.1.1.27) (LDH-A).
[Source:Uniprot/SWISSPROT;Acc:Q9PVK5]

ldha

zgc:77614

hypothetical protein LOC393868 [Source:RefSeq_peptide;Acc:NP_957188]

zgc:77614
zgc:63985

hypothetical protein LOC393868 [Source:RefSeq_peptide;Acc:NP_957188]
zgc:63985 (zgc:63985), mRNA [Source:RefSeq_dna;Acc:NM_199958]

serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
NM_001013259.1 (serpina1), mRNA [Source:RefSeq_dna;Acc:NM_001013259]
zgc:77150
hypothetical protein LOC406587 [Source:RefSeq_peptide;Acc:NP_999913]
NP_001002187.1 hypothetical protein LOC431734 [Source:RefSeq_peptide;Acc:NP_001002187]
zgc:92903
zgc:92903 [Source:RefSeq_peptide;Acc:NP_001002461]
Kreisler (mouse) maf-related leucine zipper homolog 2.2
krml2.2
[Source:RefSeq_peptide;Acc:NP_571917]
Kreisler (mouse) maf-related leucine zipper homolog 2.2
krml2.2
[Source:RefSeq_peptide;Acc:NP_571917]
NP_001005976.1 hypothetical protein LOC449803 [Source:RefSeq_peptide;Acc:NP_001005976]
zgc:77614
hypothetical protein LOC393868 [Source:RefSeq_peptide;Acc:NP_957188]
zgc:77614
hypothetical protein LOC393868 [Source:RefSeq_peptide;Acc:NP_957188]
NP_001002695.1 zgc:92631 [Source:RefSeq_peptide;Acc:NP_001002695]
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Start

End

Strand

Sequence

-4561

-4543

-1

caagtttgacgtgacccta

-2247

-2229

-1

taaaatcggtttgaccttt

-4561
-218
-3947
-1860
-4888
-3790
-2927
-1290
-3845
-2982
-1345
-179
-2271
-4293
-806

-4543
-200
-3929
-1842
-4870
-3772
-2909
-1272
-3827
-2964
-1327
-161
-2253
-4275
-788

-1
-1
1
1
1
-1
-1
1
-1
-1
1
1
-1
-1
-1

caagtttgacgtgacccta
gtaattcaatatgaccaga
gccattcacactgacctga
gcacgtgcctgtgacctgg
ctggagcaccttgaccttc
aaagcaaactgtgacctag
tgaggctatagtgacccag
tgatgctaatgtgacctta
aaagcaaactgtgacctag
tgaggctatagtgacccag
tgatgctaatgtgacctta
gcaggccaggttaacctaa
ttggtgaactctgacctgc
acagtgagctctgaccttg
aaatggaaatttgaccttc

-1664
-3250
-1642
-4267
-1664
-273
-3243
-1636
-4257

-1646
-3232
-1624
-4249
-1646
-255
-3225
-1618
-4239

1
1
1
-1
1
1
1
1
-1

tccgcgcggtgtgaccttc
acaattcactttgacttta
tccgcgcggtgtgaccttc
tccgcgcggtgtgaccttc
tccgcgcggtgtgaccttc
tcaagtcattctgacttgc
acaattcactttgacttta
tccgcgcggtgtgaccttc
tccgcgcggtgtgaccttc

-2837

-2819

1

acaaacttctttgacctgt

-549
-3911
-1045
-3911
-1045
-3691
-4485
-3957
-908
-3906
-3370
-2569
-1128
-1366
-3077
-4761

-531
-3893
-1027
-3893
-1027
-3673
-4467
-3939
-890
-3888
-3352
-2551
-1110
-1348
-3059
-4743

-1
-1
-1
-1
-1
-1
-1
-1
-1
1
-1
-1
-1
1
-1
-1

ataagctacaatgacctaa
taaagttatattgacccca
acagaaagttgtgaccaaa
taaagttatattgacccca
acagaaagttgtgaccaaa
ataagtaatcctgacccgt
gcgaataattttgacctta
tttgttaactctgacctgc
tcatgtcattttaaccttg
ttagggtttattgacctta
aggattgactttgacccag
ccagttaattgtgagcaaa
ctggaacaccttgaccttt
aaaagtaagtttgacctat
aaagattaatgtaacccaa
tcatgatcatgtgacctac

-404

-386

-1

ataggcagtattgacctta

-1784

-1766

1

agagatcaccatgacacaa

-1603

-1585

-1

tcttgccagtttgacctaa

-1784

-1766

1

agagatcaccatgacacaa

-1603
-4961
-1168
-190
-2474
-2186
-2155
-4265
-2063
-2063

-1585
-4943
-1150
-172
-2456
-2168
-2137
-4247
-2045
-2045

-1
-1
-1
1
1
1
1
-1
-1
-1

tcttgccagtttgacctaa
caaagtgtctctgacccag
acagtgaattctgaccaga
aaaggccagggtaacctaa
aacgcaaactctgacctaa
aacgcaaactctgacctaa
aacgcaaactctgacctaa
acagtgagctctgaccttg
ctggagcaccttgaccttc
ctggagcaccttgaccttc

-688
-831
-4078
-2977
-273

-670
-813
-4060
-2959
-255

1
-1
-1
-1
1

atgagttaacatgacctaa
tccatcccctgtgaccttc
tgcggtcaacttgaccatt
caagtttattttgacctag
tcaagtcattctgacttgc

-1466

-1448

-1

tccagcaactgtgaccaac

-1466
-4747
-2318
-4494
-68

-1448
-4729
-2300
-4476
-50

-1
1
1
-1
1

tccagcaactgtgaccaac
aaagacaaatttgaccttt
gccagatactgtgagctgc
actggacattttgaccagg
tcgtttcaatgtgacctga

